
<html lang="en"     class="pb-page"  data-request-id="a42884e9-c46a-45aa-99e7-d271b1c1947c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-17;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b00151;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?" /></meta><meta name="dc.Creator" content="Maria Laura  Bolognesi" /></meta><meta name="dc.Creator" content="Annachiara  Gandini" /></meta><meta name="dc.Creator" content="Federica  Prati" /></meta><meta name="dc.Creator" content="Elisa  Uliassi" /></meta><meta name="dc.Description" content="The recent literature signals a growing paradigm shift toward integrating therapeutics and diagnostics rather than developing and deploying them separately. In this gradual move toward more effecti..." /></meta><meta name="Description" content="The recent literature signals a growing paradigm shift toward integrating therapeutics and diagnostics rather than developing and deploying them separately. In this gradual move toward more effecti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 6, 2016" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00151" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00151" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00151" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00151" /></link>
        
    
    

<title>From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00151" /></meta><meta property="og:title" content="From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0011.jpeg" /></meta><meta property="og:description" content="The recent literature signals a growing paradigm shift toward integrating therapeutics and diagnostics rather than developing and deploying them separately. In this gradual move toward more effective and personalized medications, companion diagnostics are an intermediate stage. The next step may be “theranostics”, in which single chemical entities are developed to deliver therapy and diagnosis simultaneously. This strategy has been successfully exploited in oncology and is now emerging as a possibility for Alzheimer’s disease, where its feasibility has caught the attention of researchers from industry and academia. Medicinal chemists do not yet completely understand the nuances of theranostic action and consequently have not yet developed universally validated strategies for developing theranostic clinical applications against Alzheimer’s disease. However, given the emerging indications of the potentially enormous benefits that theranostics may bring to the fight against this devastating disease, further rigorous research is warranted." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00151"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00151">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00151&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00151&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00151&amp;href=/doi/10.1021/acs.jmedchem.6b00151" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7759-7770</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01932" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.6b01210" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Laura++Bolognesi">Maria Laura Bolognesi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Annachiara++Gandini">Annachiara Gandini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Prati">Federica Prati</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Uliassi">Elisa Uliassi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee DD1 5EH, U.K.</span></div><div class="corresp-info"><strong>*</strong>Phone: +39 0512099717. E-mail: <a href="/cdn-cgi/l/email-protection#2c414d5e454d404d595e4d024e4340434b42495f456c5942454e43024558"><span class="__cf_email__" data-cfemail="bfd2decdd6ded3decacdde91ddd0d3d0d8d1daccd6ffcad1d6ddd091d6cb">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00151&amp;href=/doi/10.1021%2Facs.jmedchem.6b00151" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7759–7770</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 28, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 January 2016</li><li><span class="item_label"><b>Published</b> online</span>6 May 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 September 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00151" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00151</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7759%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaria%2BLaura%2BBolognesi%252C%2BAnnachiara%2BGandini%252C%2BFederica%2BPrati%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D17%26contentID%3Dacs.jmedchem.6b00151%26title%3DFrom%2BCompanion%2BDiagnostics%2Bto%2BTheranostics%253A%2BA%2BNew%2BAvenue%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%253F%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7770%26publicationDate%3DSeptember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00151"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2546</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00151" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Laura Bolognesi&quot;},{&quot;first_name&quot;:&quot;Annachiara&quot;,&quot;last_name&quot;:&quot;Gandini&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Prati&quot;},{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Uliassi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7759-7770&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00151&quot;},&quot;abstract&quot;:&quot;The recent literature signals a growing paradigm shift toward integrating therapeutics and diagnostics rather than developing and deploying them separately. In this gradual move toward more effective and personalized medications, companion diagnostics are an intermediate stage. The next step may be “theranostics”, in which single chemical entities are developed to deliver therapy and diagnosis simultaneously. This strategy has been successfully exploited in oncology and is now emerging as a possibility for Alzheimer’s disease, where its feasibility has caught the attention of researchers from industry and academia. Medicinal chemists do not yet completely understand the nuances of theranostic action and consequently have not yet developed universally validated strategies for developing theranostic clinical applications against Alzheimer’s disease. However, given the emerging indications of the potentially enormous benefits that theranostics may bring to the fight against this devastating disease, further rigo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00151&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00151" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00151&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00151" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00151&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00151" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00151&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00151&amp;href=/doi/10.1021/acs.jmedchem.6b00151" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00151" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00151" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00151%26sid%3Dliteratum%253Aachs%26pmid%3D27124551%26genre%3Darticle%26aulast%3DBolognesi%26date%3D2016%26atitle%3DFrom%2BCompanion%2BDiagnostics%2Bto%2BTheranostics%253A%2BA%2BNew%2BAvenue%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D17%26spage%3D7759%26epage%3D7770%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291113" title="Diagnostic imaging">Diagnostic imaging</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=291731" title="Theranostics">Theranostics</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/jmcmar.2016.59.issue-17/20160908/jmcmar.2016.59.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The recent literature signals a growing paradigm shift toward integrating therapeutics and diagnostics rather than developing and deploying them separately. In this gradual move toward more effective and personalized medications, companion diagnostics are an intermediate stage. The next step may be “theranostics”, in which single chemical entities are developed to deliver therapy and diagnosis simultaneously. This strategy has been successfully exploited in oncology and is now emerging as a possibility for Alzheimer’s disease, where its feasibility has caught the attention of researchers from industry and academia. Medicinal chemists do not yet completely understand the nuances of theranostic action and consequently have not yet developed universally validated strategies for developing theranostic clinical applications against Alzheimer’s disease. However, given the emerging indications of the potentially enormous benefits that theranostics may bring to the fight against this devastating disease, further rigorous research is warranted.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 2014, Cummings published the first-ever analysis of clinical trials of drugs to prevent, cure, or treat symptoms of Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> “Alzheimer’s Disease Drug Development Pipeline: Few Candidates, Frequent Failures” confirmed AD to be a most challenging and puzzling disease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The paper highlighted that since the approval of memantine in 2003, no new AD drug candidate has successfully completed a phase III trial. In particular, between 2002 and 2012, 244 compounds were assessed in 413 trials for their ability to prevent, cure, or treat AD symptoms. Only memantine secured FDA approval to reach the market (0.4% success rate). At 99.6%, this overall drug failure rate is much higher for AD than for similarly serious diseases such as cancer (where it falls to 81%). Moreover, when the paper was written, there were only about 80 AD drugs in the pipeline compared to 300 cancer drugs.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These findings are especially alarming given the growing incidence of AD. According to Alzheimer’s Disease International, there were an estimated 46.8 million people with dementia worldwide in 2015.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This number is expected to rise to 131.5 million in 2050, driven by global patterns of population aging. Moreover, AD is no longer a problem for rich developed countries only. Around two-thirds of all dementia patients live in India, Brazil, and China, and that proportion is set to increase to three-quarters by 2050.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The high personal, familial, societal, and financial burden of this disease demands bold and urgent action. Many countries and international organizations have thus developed national plans and analytical reports to address the problem.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> G7 nations have reinvigorated efforts to find disease-modifying treatments or cures for dementia by 2025. The AD research budget for the U.S. National Institutes of Health was recently increased to nearly $1 billion per year.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p last">A similarly bold action would be a move toward personalized medicine to combat AD.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Early signs of this paradigm shift are already evident and could revolutionize AD healthcare. Tests that assist in diagnosis and treatment choice are becoming available for clinical practice.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Radiologists can now directly visualize amyloid plaques in AD patients using tests based on positron emission tomography (PET) and approved by the FDA and European Medicines Agency. Researchers are developing several companion diagnostics (CDx) to identify those patients most likely to benefit from a given therapy and to tailor dosages to a patient’s specific needs. Another approach involves theranostics, wherein diagnostic and targeted therapeutic properties are combined in a single small molecule. The full clinical impact of theranostics in AD is far from clear; however, there are initial indications of success. Herein, we provide examples of CDx and theranostics from the very recent literature to substantiate these concepts. We focus in particular on the medicinal chemistry issues that arise when designing such cutting-edge tools and envision their potential future impact.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Diagnostics in AD: The Status Quo</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While AD drug discovery has experienced a profound productivity crisis in recent years,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> the field of diagnostics has been booming. In 2012, the FDA approved the first radioactive diagnostic to help clinicians detect causes of dementia other than AD. PET ligand <b>1</b> ([<sup>18</sup>F]florbetapir)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> is indicated for the brain imaging of cognitively impaired adults undergoing evaluation for AD and other dementias (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Soon after, two more amyloid imaging agents were approved for clinical use, <b>2</b> ([<sup>18</sup>F]flutemetamol) and <b>3</b> ([<sup>18</sup>F]florbetaben).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> In addition to informing the differential diagnosis of cognitively impaired patients, these agents have emerged as a source of innovation and a valuable tool in the quest to reduce clinical dropout.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> At the clinical level, these agents create new possibilities for improving treatment and trials, by enabling patient-risk stratification, patient selection for Aβ-targeting therapies and monitoring of patients receiving such therapies.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> AD diagnostics could similarly impact translational medicine at a preclinical level. These agents could allow researchers to establish whether a promising drug candidate can reach and bind the biological target at an optimal concentration and sustain target engagement for the necessary period of time.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> From a chemistry point of view, the three compounds are strictly related: <b>2</b> is a derivative of 4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-<i>N</i>,<i>N</i>-dimethylaniline chloride (thioflavin T, ThT) dye, whereas <b>1</b> and <b>3</b> are diarylalkene analogs differing by only one atom (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Thus, they are a clear example of <i>me-too products</i>, further corroborating the strong interest of pharmaceutical and diagnostics companies in developing imaging agents for AD. Interestingly, several of these diagnostics were developed in academic laboratories.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><b>1</b> was discovered by Kung’s group at the University of Pennsylvania and then licensed for development by Avid, whereas <b>2</b> was developed at the University of Pittsburgh Medical Center as a [<sup>18</sup>F]fluorinated derivative of the “gold standard” amyloid [<sup>11</sup>C]-tracer <b>4</b> (PiB).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Amyloid PET imaging agents used in clinics (<b>1</b>–<b>3</b>) or in vivo human studies (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Needless to say, the current and future effectiveness of amyloid imaging agents strictly depends on the validity of the amyloid hypothesis.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Whether amyloid is the correct AD biomarker is still a matter of debate. This awareness, when combined with some incoherent data and unexplained anomalies reported in amyloid-PET imaging studies using <b>1</b>–<b>3</b>, calls for a critical examination of the modality.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Recent findings suggest that abnormal aggregation and/or physiological malfunction of tau protein is potentially more significant for neurodegeneration and indicate the severity of tau pathology to be an effective biomarker for the early diagnosis of AD.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Researchers are thus diversifying their approaches, with tau imaging agents emerging as an active area of academic and industrial investigation. This area has been comprehensively reviewed elsewhere.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> We note that the in vivo proof of concept has already been achieved for 5-((1<i>E</i>,3<i>E</i>)-4-(6-[<sup>11</sup>C]methylamino)pyridin-3-yl)buta-1,3-dien-1-yl)benzo[<i>d</i>]thiazol-6-ol ([<sup>11</sup>C]PBB3),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> which has been clinically validated as a PET tau imaging agent. Later, tau PET tracers 7-(6-[<sup>18</sup>F]fluoropyridin-3-yl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (T807),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> 6-(2-[<sup>18</sup>F]fluoroethoxy)-2-(4-aminophenyl)quinolone (THK-523),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and (<i>S</i>)-1-(fluoro-[<sup>18</sup>F])-3-((2-(6-(methylamino)pyridin-3-yl)quinolin-6-yl)oxy)propan-2-ol (THK-5351)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> have reached clinical trials. These compounds could thus be useful for the differential diagnosis of neurological conditions in elderly patients, opening the door for new research to elucidate mechanisms of tau-mediated neurodegeneration, as well as tau-focused biomarkers and therapies.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">3 Aβ and Tau Fluorescent Ligands as the AD Imaging Agents of the Future?</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PET is currently one of the most popular clinical imaging techniques. However, its routine use for AD is unlikely due to its financial and technical burdens. For some countries, the high cost of PET scans prevents the clinical use of the above-mentioned PET tracers.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> PET applications are further limited by the short half-lives of commonly used positron-emitting isotopes, which require the on-site synthesis of PET tracers and access to radiochemistry equipment and a cyclotron. In contrast, optical imaging is emerging as a cheaper and noninvasive in vivo tool with improved sensitivity and resolution with respect to other routinely used methodologies, such as magnetic resonance imaging (MRI) and computed tomography (CT).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Optical imaging also holds potential for AD.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">In 2005, the oxazine derivative 4,8-dimethyl-3,8,9,10-tetrahydro-2<i>H</i>-xantheno[2,3-<i>b</i>:7,6-<i>b</i>′]bis([1,4]oxazine)-4-ium tetrafluoroborate (AOI987)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> suggested for the first time the feasibility of noninvasively imaging cerebral β-amyloid deposits in living mice. Since then, the use of molecular fluorescence-based neuroimaging, particularly near-infrared (NIR) imaging, has rapidly gained momentum.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Molecular fluorescence-based neuroimaging avoids the technical difficulties of other modalities, such as the use of X-ray in CT and the facility requirements of PET probes.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Moreover, the first developed fluorescence methods, such as two-photon fluorescence microscopy, required craniotomy, cranial windows, and skull thinning, as the resolution of optical imaging decreases with increasing depth of the source of fluorescence emission.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Conversely, fluorescence molecular tomography (FMT) has the potential to circumvent these limitations by exploiting different light sources and different theoretical models of image reconstruction.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Additionally, researchers are quickly overcoming these weaknesses by developing hybrid techniques, multiphoton microscopes,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and novel imaging agents.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> For example, resolution and tissue penetration can be significantly improved by combining FMT with CT<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and micro-CT<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or MRI<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (see refs <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a> and <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a> for a more detailed description). Additionally, the group of optical imaging pioneer Ntziachristos recently developed multispectral optoacoustic tomography (MSOT).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> MSOT has allowed high-resolution visualization of glioblastoma deep inside tissues by the NIR fluorophore indocyanine green, through the intact mouse head.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">The impressive technological advances in fluorescent imaging have stimulated tremendous research efforts to develop novel agents with optimized biophysical and imaging properties. In particular, researchers are designing NIR fluorescent probes, since the light in the NIR spectral range (650–900 nm) minimizes autofluorescence (due to the fact that fluorescence from biosamples or living animals is normally below 600 nm) and increases penetration depth (due to the reduced absorbance from blood hemoglobin).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p last">Since 2005,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> many fluorescent imaging probes have been published together with several more recent reviews of a wider scope.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> The interested reader is directed to these publications for information regarding the design and application of fluorescent probes for in vitro or in vivo imaging of Aβ plaques, both in AD mice and in patients. Although at the moment NIR imaging is primarily limited to preclinical studies, those reported so far substantiate the potential of fluorescent imaging approach to advance personalized medicine in AD.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> We are confident that even in the worst case, such studies will be very informative in a research context. We believe that they have already contributed to the preliminary development of the companion diagnostics and theranostics discussed herein.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">4 Emergence of Companion Diagnostics in AD</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Given the setbacks, lack of breakthroughs, and phase III clinical trial flops that have characterized AD drug development in recent years, the pharmaceutical industry has been reconsidering how best to approach this pathology. One major switch is the goal of treating AD in its early stages, since it may be irreversible by the time clinical symptoms fully appear.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> This approach considers early diagnosis, identification of the right target patients, and early intervention to be the key elements of a successful AD treatment.</div><div class="NLM_p">Ideally, any pharmacological therapy decision should be timely and based on a comprehensive understanding of the disease biology and the drug mechanism of action. Although the end goal is not yet achieved, recent advances in AD molecular medicine and diagnostics have provided reasonable insights into how drug discovery, development, and pharmacotherapy could shift to a more rational biomarker-driven approach. As the field advances, pharmaceutical companies are moving to develop novel devices, such as CDx assays, to support AD drug research and therapy. Drawing together the definitions proposed by various regulatory authorities and pharmaceutical companies,<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> a CDx assay is a safe and effective in vitro diagnostic assay to measure a recognized indicator of either normal biological/pathogenic processes or pharmacological responses to a therapeutic. As such, CDx provide biological and/or clinical data that allow researchers and clinicians to reach suitable and timely decisions. These include decisions concerning early drug development as well as the administration of personalized drug therapy during routine clinical care.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">Broadly, CDx have four potential applications: (1) selection of patients for a specific/targeted treatment; (2) staging markers to adapt the therapeutic strategy; (3) predictive markers for drug response (efficacy), resistance, and safety; (4) follow-up markers to check the therapeutic response (therapy monitoring) and to adjust therapy (alternative, dosing, duration) if required.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">CDx are changing the management of several diseases, as the old “population treatment” approach gives way to the groundbreaking concept of personalized medicine. In personalized medicine, subpopulations of patients are identified according to their “molecular profile”, with certain subpopulations most likely to benefit from a targeted treatment and others at particularly high risk of experiencing side effects.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> This strategy has been successfully applied to several therapeutic areas, providing excellent examples of CDx drug development, especially in oncology and virology.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> AD drug research is moving in this direction, with big pharma seeking to develop reliable CDx assays for use in the design of clinical trials.</div><div class="NLM_p">In this respect, both neuroimaging and cerebrospinal fluid (CSF) biomarkers (Aβ<sub>42</sub>, total tau, and phosphorylated tau levels) have now been included in diagnostic criteria for AD and are regularly incorporated into clinical trials. The interested reader is directed to exhaustive reviews on the application of fluid biomarkers to the development of AD therapeutics,<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> while examples of AD clinical programs that recently used the newly approved diagnostic PET tracer scans as CDx tools are discussed below (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). For instance, <b>1</b> is currently being used in phase III trials of the experimental anti-Aβ antibodies gantenerumab (Roche Holding AG)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and solanezumab (Eli Lilly)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> as a pharmacodynamic measure of changes in brain amyloid load over time in mild and early stage AD, respectively.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. CDx Assays Used in Current AD Clinical Trials and Preclinical Research</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CDx/exptl drug</th><th class="colsep0 rowsep0" align="center">in vivo imaging</th><th class="colsep0 rowsep0" align="center">biomarker</th><th class="colsep0 rowsep0" align="center">drug MOA</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]florbetapir/gantenerumab</td><td class="colsep0 rowsep0" align="left">PET</td><td class="colsep0 rowsep0" align="left">Aβ</td><td class="colsep0 rowsep0" align="left">anti-Aβ antibody</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]florbetapir/solanezumab</td><td class="colsep0 rowsep0" align="left">PET</td><td class="colsep0 rowsep0" align="left">Aβ</td><td class="colsep0 rowsep0" align="left">anti-Aβ antibody</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]flutemetamol/verubecestat</td><td class="colsep0 rowsep0" align="left">PET</td><td class="colsep0 rowsep0" align="left">Aβ</td><td class="colsep0 rowsep0" align="left">BACE-1 inhibitor</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">52</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Luminex device/verubecestat</td><td class="colsep0 rowsep0" align="left">Luminex’s xMAP</td><td class="colsep0 rowsep0" align="left">Aβ<sub>42</sub> and tau</td><td class="colsep0 rowsep0" align="left">BACE-1 inhibitor</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">53</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b>/<b>7</b></td><td class="colsep0 rowsep0" align="left">NIR</td><td class="colsep0 rowsep0" align="left">Aβ</td><td class="colsep0 rowsep0" align="left">BACE-1 inhibitor</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">55</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b>/<b>8</b></td><td class="colsep0 rowsep0" align="left">NIR</td><td class="colsep0 rowsep0" align="left">Aβ</td><td class="colsep0 rowsep0" align="left">metal-mediated Aβ<sub>42</sub> cross-linking inhibitor</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">55</a></td></tr></tbody></table></div></div><div class="NLM_p">This is not the first time that Roche has used PET technology to support AD clinical investigations. In 2012, it launched a pioneering phase II/III trial of gantenerumab (SCarlet RoAD) in prodromal (predementia) AD, using PET amyloid imaging to recruit participants (positive for amyloid PET) and to monitor Aβ brain level over time.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Although discontinued in 2014, this study was among the first examples of novel diagnostic criteria being incorporated into a large clinical trial. Moreover, the innovative screening process was successful in enrolling a homogeneous population of early symptomatic AD patients, confirming the importance of CDx assays in designing robust and reliable trials.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Before SCarlet RoAD was discontinued, Roche’s diagnostic division announced they would be developing a novel CDx assay for future use.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">Similarly, soon after its approval, <b>2</b> was licensed by GE Healthcare to Merck, Johnson & Johnson, and Eisai as a CDx for identifying appropriate patients for clinical trials and developing potential AD drugs.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In December 2012, Merck and GE Healthcare announced a collaboration to use <b>2</b> to support a phase II/III trial of Merck’s drug candidate <b>5</b> (MK-8931, verubecestat,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) in patients with prodromal AD.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a><b>5</b> is a promising small molecule inhibitor of the β-secretase enzyme (BACE-1), which cleaves the amyloid precursor protein (APP), initiating the neurotoxic amyloid cascade.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of BACE-1 inhibitor <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In March 2013, Merck signed a deal with Luminex to develop a novel CDx assay to further support its ongoing <b>5</b> clinical program (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Luminex will manage the development, regulatory submission, and commercialization of the candidate CDx device. This device will use Luminex’s innovative xMAP technology to measure concentrations of two candidate biomarkers (Aβ<sub>42</sub> and tau) in CSF samples from patients with mild cognitive impairment (MCI). The candidate device will be evaluated as a tool for identifying subjects with MCI who have a higher risk of developing AD, as well as a tool for supporting patient selection and enrollment for the <b>5</b> clinical program.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p">A substudy of the <b>5</b> study protocol will use the Luminex investigational tau/amyloid assay to evaluate response to treatment in CSF-positive participants (i.e., those with defined tau/amyloid-β<sub>42</sub> ratio in CSF) and to evaluate changes in CSF concentrations of Aβ-related peptides, total tau, and phosphorylated tau.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">The results of these trials should prove invaluable in answering important questions for BACE-1 inhibitor clinical development. For example, at what level should the BACE-1 inhibition be and at what AD stage should treatment be delivered for optimal efficacy?<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p">Although several PET tracers have been used to evaluate the efficacy of experimental AD drugs in human clinical trials, PET imaging is rarely used to monitor drug treatment in small animals. This is because of the complicated experimental procedures and data analysis in small animals and the high cost of synthesis and scanning of PET probes combined with the use of radioactive material in the very early stages of drug discovery. In 2015, Moore and Ran proposed overcoming these challenges by using the curcumin analogue <b>6</b> (CRANAD-3)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> as an NIR imaging probe to monitor the Aβ-lowering effectiveness of two different therapeutics in an AD mouse model (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). As already noted, NIR imaging is generally more suitable than PET imaging for animal studies because of its lower cost, simpler operation, and easier data analysis. In previous studies, the same group showed that <b>12</b> (CRANAD-2 in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, see below),<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> a curcumin-based NIR imaging probe, displayed a significant increase in fluorescence intensity upon interacting with insoluble Aβ aggregates. However, <b>12</b> could not detect soluble Aβ species.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> These are considered to be the most neurotoxic species and could thus potentially serve as biomarkers for the AD presymptomatic stage. On this basis, they synthesized a new derivative, <b>6</b>, by replacing the two phenyl rings of <b>12</b> with two pyridyls to establish hydrogen-bonding contacts with the engaged Aβ fragment. <b>6</b> displayed an emission peak at 730 nm and showed excellent fluorescence response toward soluble Aβ species. In vivo two-photon microscopic and NIR imaging also indicated that <b>6</b> is able to penetrate the BBB and is specific toward Aβ aggregates.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> On the basis of these encouraging data, the authors investigated the ability of <b>6</b> to monitor the therapeutic effectiveness in APP/PS1 mice of two experimental drugs (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), the BACE-1 inhibitor <b>7</b> (LY2811376) and the metal-mediated Aβ<sub>42</sub> cross-linking inhibitor <b>8</b> (CRANAD-17), developed by the same group (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Structurally, <b>7</b> is an aminothiazine derivative, whereas <b>8</b> is an imidazole-containing curcumin analogue.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a><b>6</b> was successfully used to evaluate the therapeutic efficacy of both drug treatments in short and chronic mouse treatment studies, indicating that it could be considered the first NIR CDx suitable for monitoring the Aβ-lowering effectiveness of drugs. This seminal work also corroborated that fluorescence imaging agents could be valid alternatives to PET tracers as effective CDx.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Development of the first fluorescent CDx validated in an AD mouse model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The <b>6</b>/<b>8</b> pair is one of the first examples in the AD field of a drug-diagnostic codevelopment model (i.e., a diagnostic assay developed in conjunction with a targeted drug). The positive results suggest this strategy as an exceptionally strong investigational tool for AD drug research.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">5 Theranostics and the Prospects of Personalized Medicine in AD</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In parallel to CDx, “theranostics” uses single chemical entities to deliver therapy and diagnosis simultaneously and is a more recent and equally innovative way of implementing translational medicine and personalized approaches.</div><div class="NLM_p">The term was coined in 1998 by John Funkhouser<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> for the company Cardiovascular Diagnostics to describe a material that allows the combined diagnosis, treatment, and follow-up of a disease. Although its definition is still evolving, the following concepts, highlighted in the dedicated journal <i>Theranostics</i>, are illuminating: “Theranostics is a concept that was originally raised to refer to the efforts of integrating imaging and therapy. As an emerging interdiscipline, it is related to but different from traditional imaging and therapeutics.”<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The theranostics concept is tightly intertwined with personalized medicine. It allows the selection of patient subpopulations, according to their “molecular profile” at a given time, who are most likely to benefit from a targeted therapy or at higher risk of adverse effects. Ideally, the simultaneous and fully integrated development of the drug and its diagnostic counterpart will distinguish theranostics from classical drug/diagnostic test combinations.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">Although still in its infancy, the field of theranostics has exploded over the past couple of years, with new agents reaching clinical trials at a rapid pace, especially in the field of cancer (see Kojima, 2015,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> for a recent review). The literature dealing with theranostics and AD has grown steadily. It is thought that these agents could potentially offer new hope to patients and real gains for pharmaceutical and diagnostic companies.<a onclick="showRef(event, 'ref5 ref61 ref62 ref35 ref63'); return false;" href="javascript:void(0);" class="ref ref5 ref61 ref62 ref35 ref63">(5, 61, 62, 35, 63)</a></div><div class="NLM_p">By analysis of the theranostic-related literature, the approaches reported to date involve two molecule classes: nanomedicines and small organic compounds. Oncology researchers have established a plethora of nanomedicines (including polymer–drug conjugates, liposomes, polymeric micelles, and inorganic nanoparticles) with distinctive chemical compositions and physical properties. Compared with traditional molecular-based contrast agents or therapeutic drugs, these new nanoplatforms are extremely versatile, allowing ultrasensitive imaging and therapy to be incorporated into one system in a highly integrated manner.<a onclick="showRef(event, 'ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66">(64-66)</a> However, the development of theranostic nanomedicines for AD could be hindered by the limited ability of these molecules to cross the BBB and exploit CNS drug delivery, together with a somewhat unacceptable invasiveness, not compatible with a chronic treatment.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Despite this, several groups are actively engaged in the field and their efforts have recently been reviewed elsewhere.<a onclick="showRef(event, 'ref68 ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70 ref71">(68-71)</a></div><div class="NLM_p">In principle, the above hurdles to the development of AD theranostics may be surmounted by the use of small molecules. But even here and despite tremendous potential, the rational design of small molecules with a predefined theranostic profile presents new and unexplored challenges. The discovery phase is likely to be particularly complex, as the medicinal chemistry community must consider new identification and optimization strategies.</div><div class="NLM_p">From the examples already reported, we identify two main rational strategies: (i) linking structural elements from diagnostic and therapeutic agents to make a new conjugate molecule; (ii) the diagnostic and therapeutic moiety overlap that are highly integrated in a single chemical entity (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design strategy of theranostics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the first approach, conjugated ligands contain the two starting units, one carrying the therapeutic properties and the other carrying the diagnostic properties, chemically connected by a spacer of a variable nature and length. In principle, the second approach has narrower applicability, since the basic prerequisite is that an imaging probe and a drug share a common structural scaffold. This design concept involves a single interacting protein that is both the therapeutic target and the biomarker. This could be the case for theranostic compounds developed to label and simultaneously inhibit aggregation of fibrils of pathological Aβ or tau. A particular strength in this scenario is that there can be overlap between the molecular properties responsible for recognizing and consequently inhibiting these amyloid proteins and those responsible for their fluorescence imaging. Extended π-conjugated flat systems are considered important features for binding and interfering with amyloids.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> But they also result in increased electronic delocalization, which induces a small band gap between the excited and ground states, leading to an emission wavelength in the desired NIR spectral window.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><div class="NLM_p">Of course, ligands designed by a conjugating approach are more likely to have a high molecular weight and less likely to have favorable BBB permeation, whereas overlapped compounds are likely to have lower molecular weight and, in principle, better druglike properties. However, the linking strategy opens up possibilities to address PK issues with appropriate linker design. In principle, some of the problems associated with high hydrophobicity of the conjugate can be overcome by the use of PEG-containing hydrophilic linkers.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">Despite these challenges, an ever-increasing number of theranostics are being developed against AD. Notably, Moore and Ran’s group has produced most of them. In addition to these elegant, rational approaches, the literature contains examples where the deliberate aim of generating a theranostic is not explicitly stated. However, the resulting small molecules have true theranostic potential because they can both image and inhibit Aβ peptides. In this respect, actual developments in the field may not be fully represented in the literature, since some authors use terms such as “multifunctional” or “bifunctional” rather than “theranostics”.</div><div class="NLM_p">In 2012, for example, Li, Yung, and Wong<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> developed what they called “multifunctional fluorophores” able to directly image the dynamics of Aβ fibrillogenesis and inhibit its aggregation. They based their investigation upon previously identified carbazole-based cyanine fluorophores reported to bind to Aβ with concomitant strong fluorescence enhancement.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The carbazole scaffold was then variously functionalized to ameliorate key functional properties, such as Aβ-binding, cytotoxicity, and BBB permeability. Structure–activity relationship studies led to the discovery of the promising compound <b>9</b> (SLOH in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> After the characterization of the intrinsic fluorescence properties, <b>9</b> demonstrated a strong and progressive increase in its fluorescence intensity, concomitant with a blue shift of the emission maximum, indicating a direct interaction with the Aβ peptide. Moreover, the fluorescence enhancement was much stronger for Aβ fibrils than for Aβ peptide. After validating <b>9</b>’s diagnostic capacity, the authors disclosed a therapeutic inhibitory effect on both the Aβ nucleation and elongation processes. The mechanism of the anti-amyloid profile was also confirmed by circular dichroism studies. Thus, after verifying that treatment with different concentrations of <b>9</b> was not toxic to SH-SY5Y cell line, the group investigated its effect on Aβ-induced cytotoxicity on the same cell line and on mouse primary cortical cells.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Significantly, <b>9</b> displayed a strong neuroprotective effect on both cell models. Finally, the authors demonstrated <b>9</b>’s abilities to pass the BBB in vivo and to ex vivo label Aβ plaques in APP/PS1 Tg mice.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Taken together, these results are suggestive of <b>9</b>’s theranostic potential. However, in vivo studies are needed to demonstrate the effective therapeutic and safety profile of <b>9</b>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Theranostic profile of <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2013, members of our group developed the styrylquinoline <b>10</b> (G8),<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> one of the first small molecules to be intentionally proposed as an in vitro theranostic (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Our inspiration was the finding that several styryl derivatives, designed to improve the pharmacokinetic properties of Congo red and ThT, had been successfully employed as amyloid imaging agents in vivo.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> In addition to staining amyloid fibrils with high affinity, many of these molecules were found to block their aggregation. We thus sought to develop a novel theranostic by exploiting a styrylquinoline core structure.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Theranostic profile of <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We selected the quinoline for its “privileged scaffold” nature, which, in principle, displays desirable pharmacokinetic properties and druglikeness. Among other derivatives, we selected <b>10</b> and evaluated its theranostic profile for potentially diagnosing, delivering therapy, and monitoring responses in AD and prion diseases.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> This double activity was proposed on the basis of the ever-increasing neuropathological commonalities found between these two devastating neurodegenerative diseases.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Thus, after verifying <b>10</b>’s encouraging fluorescence properties and its good BBB permeability, we separately evaluated its therapeutic and diagnostic activities. Inhibition toward Aβ<sub>42</sub> aggregation was assessed by the classical ThT-based fluorometric assay, where <b>10</b> significantly decreased the fluorescence signal, confirming its ability to act as a fibrilization inhibitor.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Moreover, when the emission spectra in the absence and presence of Aβ aggregates were measured, <b>10</b> showed a strong hypsochromic shift of the emission maximum, concomitant with a hyperchromic effect upon binding. This clearly highlighted its potential as an amyloid sensor. Finally, displacement studies suggested that <b>10</b> may have a primary high-affinity binding site distinct from ThT and a secondary low-affinity binding site in common with ThT. As expected, a similar antiaggregating activity was observed when <b>10</b> was tested against prion protein in an in vitro amyloid seeding assay. On the basis of these promising outcomes, we evaluated the global theranostic potential of <b>10</b> in the ScGT1 cellular model of prion diseases. After excluding that treatment of <b>10</b> was toxic to the cells, we evaluated its inhibitory activity against prion replication and found a relevant submicromolar antiprion effect.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> To corroborate the labeling of fibrillar aggregates in living cells, fluorescent staining with <b>10</b> was carried out using the same prion cell model. Treatment with <b>10</b> allowed us to visualize a number of localized fluorescent spots in the infected cells examined by fluorescent microscopy. Even more significant in terms of selectivity, we observed no spots in the control uninfected cells. Thus, although our study is limited to a cellular context and does not definitively prove <b>10</b>’s theranostic potential, it offers a promising starting point for developing novel theranostic tools to in vivo diagnose, deliver targeted therapy, and monitor responses to therapy in both AD and prion diseases. For toxicity, although we did not find any sign of cytotoxicity up to 10 μM, compound <b>10</b> presents both aniline and a styryl olefin, two moieties known to bring safety issues in drug candidates.</div><div class="NLM_p">The curcumin analogue <b>11</b> (CRANAD-28 in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), proposed in 2014 by Moore and Ran,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> is another example of a rationally designed theranostic agent. Moore and Ran began with a previously developed curcumin analogue (<b>12</b> in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) that could detect soluble and insoluble Aβ species<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> but was endowed with low quantum yield (QY). To overcome this, the authors proposed replacing its phenyl rings with pyrazoles.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> They reasoned that the inductive electron-withdrawing effect of the nitrogen of pyrazole could lead to a low tendency of electron delocalization in the system, which would decrease tautomerization, increasing the QY. This idea was supported by their previous studies, which showed that imidazole curcumin analogues effectively interfere with the coordination of Cu<sup>2+</sup> and thus attenuate the pathological cross-linking of Aβ that is mediated by this metal.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Rational pathway to curcumin-based theranostic <b>11</b> and its theranostic profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On these logical foundations, they synthesized <b>13</b> (CRANAD-44 in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>)<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> so that the pyrazoles could interfere with Cu<sup>2+</sup> coordination while simultaneously reducing tautomerization and increasing QY. To improve <b>13</b>’s properties, they developed the corresponding N-1 phenyl derivative <b>11</b>, which underwent extensive investigation for its theranostic potential in comparison to <b>13</b>.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">First, they characterized the fluorescence properties and QY of both molecules. As expected, the QY of <b>11</b> was higher than that of <b>13</b>.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> They then tested the ability of <b>11</b> to interact with Aβ (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Interestingly, <b>11</b>’s fluorescence intensity was quenched by Aβ, indicating a direct interaction. Staining APP/PS1 mouse brain slices with both molecules showed that <b>11</b> provided an excellent contrast for Aβ plaques, while <b>13</b> did not, suggesting that the phenyl rings at the N-1 position successfully enhance Aβ binding in accordance with <b>11</b>’s rational design. Finally, after assessing the BBB permeation, the authors validated the capability of <b>11</b> for the in vivo two-photon imaging of APP/PS1 mice.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> As anticipated, Aβ plaques were clearly labeled and cerebral amyloid angiopathies (CAAs) were also highlighted. To definitively validate <b>11</b>’s theranostic potential, the authors sought to verify the ability of the pyrazole rings to coordinate Cu<sup>2+</sup> and thus exert the desired therapeutic effect.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Western blotting analysis showed that, unlike <b>13</b>, <b>11</b> significantly inhibited Cu<sup>2+</sup>-induced cross-linking of Aβ. Accordingly, <b>11</b>’s great significance for theranostics is that despite emitting outside the intended NIR wavelength region (λ<sub>em</sub> > 578), it has provided the first in vivo proof of principle in an AD mouse model. Despite CRANAD derivatives <b>11</b>–<b>13</b> are extremely promising starting point for theranostic development, it should be pointed out that curcumin analogues present possible Michael acceptor moieties. To the best of our knowledge, possible safety liabilities linked to this functionality have not been addressed in the previously mentioned studies.</div><div class="NLM_p">In 2014, Moore and Ran proposed another enlightening approach to the development of Aβ-directed theranostics, by exploiting a linking approach.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> It is widely known that crown ethers form stable complexes with protonated amines through hydrogen-bond formation. In particular, positively charged Aβ fibrils are highly cytotoxic, whereas neutralizing the charges reduces neuronal toxicity. The authors hypothesized that crown ethers could form noncovalent complexes with Aβ peptides with positively charged basic amino acids such as K16 and K28,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> which form intrapeptide salt bridges with D23 leading to the stabilization of the misfolded peptides.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Their working hypothesis was that breaking down these salt bridges could attenuate the Aβ aggregation process. As a preliminary test of their hypothesis, they assessed the antiaggregating ability of a 12-crown-4 ether, rationally selected for its low molecular weight, its effective ability to form complexes with charged amino acids, and its insignificant disturbance of physiological ion homeostasis. Both ThT testing and dot blotting indicated that this molecule could efficiently inhibit Aβ aggregation. To achieve a selective targeting, the authors therefore linked the 12-crown-4 ether at the amino group of <b>4</b>, leading to the conjugate <b>14</b> (PiB-C in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Encouragingly, <b>14</b> was more potent than <b>4</b>, indicating that the crown-ether moiety markedly contributed to the inhibitory effect against Aβ aggregation.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Theranostic profile of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The authors then treated SH-SY5Y cells with Aβ<sub>42</sub> in the absence or presence of 12-crown-4 ether and <b>14</b>.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Both molecules lowered the toxicity of Aβ<sub>42</sub>, while <b>4</b> did not, indicating that <b>14</b>’s neuroprotective ability was not due to the presence of the <b>4</b> moiety. Finally, since <b>14</b> efficiently crossed the BBB, the authors tested its ability to specifically label Aβ plaques in vitro and in vivo, using two-photon imaging. As expected, <b>14</b> could clearly image plaques in APP/PS1 mouse brains in vitro and, more importantly, in vivo.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Moreover, <b>14</b> could also efficiently label CAAs in a similar manner as <b>4</b>.</div><div class="NLM_p"><b>15</b> (TBT in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), developed in 2015 by Yao and Wang,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> is the most recently proposed theranostic small molecule. They followed a very similar approach to that reported by Moore and Ran for <b>14</b>. Here, the inspiration was the therapeutic potential of metal chelators to reduce metal-induced Aβ aggregation and neurotoxicity in AD.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> The authors thus developed a novel fluorescent chelator (<b>15</b>) as a dual functional probe and disaggregating agent for Aβ aggregation induced by Zn<sup>2+</sup> and Cu<sup>2+</sup>.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Following a linking approach very similar to that used for <b>14</b>, they designed <b>15</b>, which comprises a metal-chelating 1,4,7,10-tetraazacyclododecane (cyclen) group and, again, the <b>4</b> Aβ-recognizing scaffold.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Theranostic profile of <b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As a positive feature of the chelating profile, <b>15</b> can tightly bind to Zn<sup>2+</sup> or Cu<sup>2+</sup> while exhibiting high selectivity over other biologically relevant metal ions. In terms of its anti-amyloid profile, <b>15</b>’s high binding affinity for Aβ aggregates was disclosed using the ThT fluorescence competition assay.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The authors found that the high affinity of <b>15</b> for Zn<sup>2+</sup>-Aβ<sub>40</sub> aggregates results from a synergistic effect of the two functional moieties. Additionally, molecular docking analysis showed that <b>15</b> competes with ThT due to the overlapping binding sites in Aβ and captures metal ions from metal-Aβ species. After confirming that <b>15</b> specifically inhibits Zn<sup>2+</sup>- and Cu<sup>2+</sup>-induced Aβ<sub>40</sub> aggregation over metal-free Aβ<sub>40</sub> aggregation in vitro, the authors monitored the disaggregation of Aβ<sub>40</sub> aggregates in brain homogenates of APPswe/PSEN1 Tg mice.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> These results, together with <b>15</b>’s specificity, neuroprotection, and efficient BBB permeability, highlight this fluorescent chelator’s potential as a theranostic tool for AD.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">6 Conclusion and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">“Few candidates, frequent failures” is the best description for the current status of AD drug development. Summing up what we have discussed in this Miniperspective, CDx and theranostics emerge as powerful tools to change the status quo by potentially derisking development projects, shortening development timelines, allowing faster new product approval, and ultimately generating revenue streams.</div><div class="NLM_p">CDx are becoming a well-established approach for many major diseases, particularly cancer. Their underlying concept is that such major diseases are immensely heterogeneous, and the existing treatments are effective only for limited patient populations and at particular stages of disease development. Thus, a close marriage of diagnosis and therapeutics could better tailor therapeutic practices to individuals, offering improved prognoses.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> This also applies to AD, for which, more crucially, there are currently no disease-modifying treatments.</div><div class="NLM_p">In parallel to CDx, the development of theranostics is growing in feasibility and attractiveness as a strategy. In the CDx approaches discussed above, imaging probes and drugs are pursued separately, which is resource-hungry, time-consuming, and costly. Moreover, in some cases, their use has led to mixed results in clinical trials. Conversely, developing single agents with both imaging and therapy properties could be inherently simpler and more economical, expediting the drug discovery process. More importantly, theranostics could overcome a problem related to the use of biomarkers and CDx and identified by the Alzheimer’s Association’s Research Roundtable.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Even if a biomarker is relevant to AD and can be monitored by a corresponding imaging agent, the imaging agent’s clinical utility as a CDx is not guaranteed. For example, both bapineuzumab and solanezumab are monoclonal antibodies directed against the Aβ<sub>42</sub> peptide.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> However, they show different relations between the cerebral amyloid burden imaged by <b>4</b> PET scanning and the clinical outcome. This may be due to differences in the binding properties of these two antibodies. While bapineuzumab has a higher affinity for amyloid plaques than soluble Aβ, solanezumab showed preferential binding to soluble Aβ but not to aggregated Aβ. This indicates that not all biomarkers, and consequently CDx imaging agents, are interchangeable for use in all trials. However, “overlapped” theranostics overcomes this problem, since the target for therapy and the biomarker for disease-monitoring coincide. Recent examples of theranostics’ potential are highly gratifying and augur well for their future applicability to AD. However, their full value will not be realized until their diagnostic and therapeutic applications are deployed at the clinical level.</div><div class="NLM_p last">Can researchers take theranostics to clinical trials? It will require a blend of pragmatism, utopia, and cooperation. Identifying future paths to radical improvement will require a rigorous, detailed understanding of the most critical challenges (pharmaceutical, clinical, regulatory). At the same time, the theranostics concept demands a drastic rethink of the way we develop drugs and diagnostics. Collaboration between pharmaceutical and diagnostic companies will be crucial to fostering this innovation. Thus, we could be on the cusp of curing AD, but bold and sustained action is required from many actors to fully exploit these scientific opportunities. Given the current unmet medical needs and the advantages if successful, this bold step is warranted.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00151" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Laura Bolognesi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d0bdb1a2b9b1bcb1a5a2b1feb2bfbcbfb7beb5a3b990a5beb9b2bffeb9a4"><span class="__cf_email__" data-cfemail="8fe2eefde6eee3eefafdeea1ede0e3e0e8e1eafce6cffae1e6ede0a1e6fb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annachiara Gandini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Neuroscience, Scuola Internazionale
Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Prati</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">College of Life Sciences,
Sir James Black Centre, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Uliassi</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, Alma Mater
Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Maria Laura Bolognesi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=BIO-d165e1301-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Maria Laura Bolognesi</b> is an Associate Professor of Medicinal Chemistry at the Department of Pharmacy and Biotechnology of the University of Bologna, Italy. She received her Ph.D. in Pharmaceutical Sciences in 1996 and carried out postdoctoral work at the University of Minnesota, Minneapolis, MN. She was recently awarded the position of Distinguished Visiting Professor at the University of Brasilia, Brazil. Her research interests include developing multitarget and theranostic ligands against neurodegenerative and neglected tropical diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Annachiara Gandini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=BIO-d165e1306-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Annachiara Gandini</b> received her Master’s degree in Chemistry and Pharmaceutical Technology in 2014 from the University of Bologna, Italy. Currently, she is a doctoral student under the supervision of Prof. M. L. Bolognesi at the University of Bologna. Her research project concerns the development of small molecules as theranostics for neurodegenerative diseases, in collaboration with Prof. G. Legname of SISSA, Trieste.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Federica Prati</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=BIO-d165e1311-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Federica Prati</b> received her Master’s degree in Chemistry and Pharmaceutical Technology in 2010 from the University of Bologna, Italy. She obtained a Ph.D. in Drug Discovery in 2014 from the University of Genoa, Italy, working on a project in collaboration with the Italian Institute of Technology to develop novel lead compounds against Alzheimer’s disease, under the supervision of Prof. M. L. Bolognesi. In 2013, as part of her Ph.D. program, she was a Visiting Scholar in Prof. I. H. Gilbert’s group at the Drug Discovery Unit (DDU) of Dundee, U.K. She was recently awarded a Tres Cantos Open Lab Foundation Cofund Fellowship to develop novel compounds against tuberculosis working at GlaxoSmithKline site in Tres Cantos in close partnership with the DDU of Dundee.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Elisa Uliassi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=BIO-d165e1316-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elisa Uliassi</b> received her Master’s degree in Chemistry and Pharmaceutical Technology in 2012 from the University of Bologna, Italy. She is currently a temporary Research Fellow in the Bolognesi lab, admitted to the final oral defense by the Ph.D. board in Chemistry at the same institution. From 2014 to 2015, as part of her Ph.D. program, she was a visiting Ph.D. student in Dr. Kenneth A. Jacobson’s group at the National Institutes of Health (Bethesda, MD). Her research work focuses on developing small molecules as chemical probes for stem cell applications in the field of Alzheimer’s disease.</p></figure></div><div class="ack" id="ACK-d165e1442-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the University of Bologna (Grant RFO 2014). E.U. acknowledges the University of Bologna for a postdoctoral grant (assegno di ricerca). We thank Grace Fox for copyediting and proofreading the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i13" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i13"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i14" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i14"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">CDx</td><td class="NLM_def"><p class="first last">companion diagnostics</p></td></tr><tr><td class="NLM_term">ThT</td><td class="NLM_def"><p class="first last">thioflavin T</p></td></tr><tr><td class="NLM_term">MRI</td><td class="NLM_def"><p class="first last">magnetic resonance imaging</p></td></tr><tr><td class="NLM_term">CT</td><td class="NLM_def"><p class="first last">computed tomography</p></td></tr><tr><td class="NLM_term">NIR</td><td class="NLM_def"><p class="first last">near-infrared</p></td></tr><tr><td class="NLM_term">FMT</td><td class="NLM_def"><p class="first last">fluorescence molecular tomography</p></td></tr><tr><td class="NLM_term">MSOT</td><td class="NLM_def"><p class="first last">multispectral optoacoustic tomography</p></td></tr><tr><td class="NLM_term">QY</td><td class="NLM_def"><p class="first last">quantum yield</p></td></tr><tr><td class="NLM_term">BACE-1</td><td class="NLM_def"><p class="first last">β-secretase enzyme</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">MCI</td><td class="NLM_def"><p class="first last">mild cognitive impairment</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CAA</td><td class="NLM_def"><p class="first last">cerebral amyloid angiopathy</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17151" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17151" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 86 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eYAa6IKHt6--Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>World Alzheimer Report 2015: The global impact of dementia, Alzheimer’s Disease International 2015. <a href="http://www.alz.co.uk/research/statistics" class="extLink">http://www.alz.co.uk/research/statistics</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report+2015%3A+The+global+impact+of+dementia%2C+Alzheimer%E2%80%99s+Disease+International+2015.+http%3A%2F%2Fwww.alz.co.uk%2Fresearch%2Fstatistics+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Fargo, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Au, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drachman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrup, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khachaturian, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khachaturian, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukull, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logsdon, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plassman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span> </span><span class="NLM_article-title">2014 Report on the milestones for the US national plan to address Alzheimer’s Disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">S430</span><span class="NLM_x">–</span> <span class="NLM_lpage">S452</span><span class="refDoi"> DOI: 10.1016/j.jalz.2014.08.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.jalz.2014.08.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=S430-S452&author=K.+N.+Fargoauthor=P.+Aisenauthor=M.+Albertauthor=R.+Auauthor=M.+M.+Corradaauthor=S.+DeKoskyauthor=D.+Drachmanauthor=H.+Fillitauthor=L.+Gitlinauthor=M.+Haasauthor=K.+Herrupauthor=C.+Kawasauthor=A.+S.+Khachaturianauthor=Z.+S.+Khachaturianauthor=W.+Klunkauthor=D.+Knopmanauthor=W.+A.+Kukullauthor=B.+Lambauthor=R.+G.+Logsdonauthor=P.+Maruffauthor=M.+Mesulamauthor=W.+Mobleyauthor=R.+Mohsauthor=D.+Morganauthor=R.+A.+Nixonauthor=S.+Paulauthor=R.+Petersenauthor=B.+Plassmanauthor=W.+Potterauthor=E.+Reimanauthor=B.+Reisbergauthor=M.+Sanoauthor=R.+Schindlerauthor=L.+S.+Schneiderauthor=P.+J.+Snyderauthor=R.+A.+Sperlingauthor=K.+Yaffeauthor=L.+J.+Bainauthor=W.+H.+Thiesauthor=M.+C.+Carrillo&title=2014+Report+on+the+milestones+for+the+US+national+plan+to+address+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.jalz.2014.08.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.08.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.08.103%26sid%3Dliteratum%253Aachs%26aulast%3DFargo%26aufirst%3DK.%2BN.%26aulast%3DAisen%26aufirst%3DP.%26aulast%3DAlbert%26aufirst%3DM.%26aulast%3DAu%26aufirst%3DR.%26aulast%3DCorrada%26aufirst%3DM.%2BM.%26aulast%3DDeKosky%26aufirst%3DS.%26aulast%3DDrachman%26aufirst%3DD.%26aulast%3DFillit%26aufirst%3DH.%26aulast%3DGitlin%26aufirst%3DL.%26aulast%3DHaas%26aufirst%3DM.%26aulast%3DHerrup%26aufirst%3DK.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3DKhachaturian%26aufirst%3DA.%2BS.%26aulast%3DKhachaturian%26aufirst%3DZ.%2BS.%26aulast%3DKlunk%26aufirst%3DW.%26aulast%3DKnopman%26aufirst%3DD.%26aulast%3DKukull%26aufirst%3DW.%2BA.%26aulast%3DLamb%26aufirst%3DB.%26aulast%3DLogsdon%26aufirst%3DR.%2BG.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DMesulam%26aufirst%3DM.%26aulast%3DMobley%26aufirst%3DW.%26aulast%3DMohs%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DNixon%26aufirst%3DR.%2BA.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DPetersen%26aufirst%3DR.%26aulast%3DPlassman%26aufirst%3DB.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DReiman%26aufirst%3DE.%26aulast%3DReisberg%26aufirst%3DB.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DYaffe%26aufirst%3DK.%26aulast%3DBain%26aufirst%3DL.%2BJ.%26aulast%3DThies%26aufirst%3DW.%2BH.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26atitle%3D2014%2520Report%2520on%2520the%2520milestones%2520for%2520the%2520US%2520national%2520plan%2520to%2520address%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3DS430%26epage%3DS452%26doi%3D10.1016%2Fj.jalz.2014.08.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Reardon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledford, H.</span><span> </span><span class="NLM_article-title">Biomedicine wins big in US budget deal</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">528</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="refDoi"> DOI: 10.1038/nature.2015.19057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnature.2015.19057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=528&publication_year=2015&pages=446&author=S.+Reardonauthor=C.+Cesareauthor=H.+Ledford&title=Biomedicine+wins+big+in+US+budget+deal&doi=10.1038%2Fnature.2015.19057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature.2015.19057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2015.19057%26sid%3Dliteratum%253Aachs%26aulast%3DReardon%26aufirst%3DS.%26aulast%3DCesare%26aufirst%3DC.%26aulast%3DLedford%26aufirst%3DH.%26atitle%3DBiomedicine%2520wins%2520big%2520in%2520US%2520budget%2520deal%26jtitle%3DNature%26date%3D2015%26volume%3D528%26spage%3D446%26doi%3D10.1038%2Fnature.2015.19057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Amyloid chemical probes and theranostics: steps toward personalized medicine in neurodegenerative diseases</span>. In  <span class="citation_source-book">Medicinal Chemistry Approaches to Personalized Medicine</span>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span>, DOI: <span class="refDoi"> DOI: 10.1002/9783527677252.ch09</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2F9783527677252.ch09" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=211-226&author=M.+L.+Bolognesi&title=Medicinal+Chemistry+Approaches+to+Personalized+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F9783527677252.ch09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677252.ch09%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DAmyloid%2520chemical%2520probes%2520and%2520theranostics%253A%2520steps%2520toward%2520personalized%2520medicine%2520in%2520neurodegenerative%2520diseases%26btitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Personalized%2520Medicine%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2013%26spage%3D211%26epage%3D226%26doi%3D10.1002%2F9783527677252.ch09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Souslova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marple, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiekerman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, A. A.</span><span> </span><span class="NLM_article-title">Personalized medicine in Alzheimer’s disease and depression</span> <span class="citation_source-journal">Contemp. Clin. Trials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1016/j.cct.2013.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.cct.2013.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23816492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC3sjntV2jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=616-623&author=T.+Souslovaauthor=T.+C.+Marpleauthor=A.+M.+Spiekermanauthor=A.+A.+Mohammad&title=Personalized+medicine+in+Alzheimer%E2%80%99s+disease+and+depression&doi=10.1016%2Fj.cct.2013.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Personalized medicine in Alzheimer's disease and depression</span></div><div class="casAuthors">Souslova Tatiana; Marple Teresa C; Spiekerman A Michael; Mohammad Amin A</div><div class="citationInfo"><span class="NLM_cas:title">Contemporary clinical trials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">616-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Latest research in the mental health field brings new hope to patients and promises to revolutionize the field of psychiatry.  Personalized pharmacogenetic tests that aid in diagnosis and treatment choice are now becoming available for clinical practice.  Amyloid beta peptide biomarkers in the cerebrospinal fluid of patients with Alzheimer's disease are now available.  For the first time, radiologists are able to visualize amyloid plaques specific to Alzheimer's disease in live patients using Positron Emission Tomography-based tests approved by the FDA.  A novel blood-based assay has been developed to aid in the diagnosis of depression based on activation of the HPA axis, metabolic, inflammatory and neurochemical pathways.  Serotonin reuptake inhibitors have shown increased remission rates in specific ethnic subgroups and Cytochrome P450 gene polymorphisms can predict antidepressant tolerability.  The latest research will help to eradicate "trial and error" prescription, ushering in the most personalized medicine to date.  Like all major medical breakthroughs, integration of new algorithms and technologies requires sound science and time.  But for many mentally ill patients, diagnosis and effective therapy cannot happen fast enough.  This review will describe the newest diagnostic tests, treatments and clinical studies for the diagnosis and treatment of Alzheimer's disease and unipolar, major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyswBhY31_vthSDZx9hyjKfW6udTcc2eZqIU6-vJfGAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjntV2jtw%253D%253D&md5=33a0c6b1220658c92e3ddb38f7f6cbf2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cct.2013.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cct.2013.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DSouslova%26aufirst%3DT.%26aulast%3DMarple%26aufirst%3DT.%2BC.%26aulast%3DSpiekerman%26aufirst%3DA.%2BM.%26aulast%3DMohammad%26aufirst%3DA.%2BA.%26atitle%3DPersonalized%2520medicine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520depression%26jtitle%3DContemp.%2520Clin.%2520Trials%26date%3D2013%26volume%3D36%26spage%3D616%26epage%3D623%26doi%3D10.1016%2Fj.cct.2013.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieves, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganley, C.</span><span> </span><span class="NLM_article-title">Brain amyloid imaging-FDA approval of florbetapir F18 injection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1056/NEJMp1208061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1056%2FNEJMp1208061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22931256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlChsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=885-887&author=L.+Yangauthor=D.+Rievesauthor=C.+Ganley&title=Brain+amyloid+imaging-FDA+approval+of+florbetapir+F18+injection&doi=10.1056%2FNEJMp1208061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Brain amyloid imaging - FDA approval of florbetapir F18 injection</span></div><div class="casAuthors">Yang, Lucie; Rieves, Dwaine; Ganley, Charles</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">885-887</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquQxrP57ikw7Vg90H21EOLACvtfcHk0lhduzl5efii6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlChsLnK&md5=d28e3e41b842a718ca63f2ee53294986</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1208061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1208061%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DRieves%26aufirst%3DD.%26aulast%3DGanley%26aufirst%3DC.%26atitle%3DBrain%2520amyloid%2520imaging-FDA%2520approval%2520of%2520florbetapir%2520F18%2520injection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D885%26epage%3D887%26doi%3D10.1056%2FNEJMp1208061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography radioligands for in vivo imaging of Abeta plaques</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1002/jlcr.2989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fjlcr.2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24285314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=89-95&author=N.+S.+Masonauthor=C.+A.+Mathisauthor=W.+E.+Klunk&title=Positron+emission+tomography+radioligands+for+in+vivo+imaging+of+Abeta+plaques&doi=10.1002%2Fjlcr.2989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span></div><div class="casAuthors">Mason, N. Scott; Mathis, Chester A.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) radioligands for the non-invasive imaging of amyloid-β plaque burden has been the focus of intense research efforts over the last decade.  A variety of structural backbones have been investigated and several radiolabeled mols. have been evaluated in phase I (and later) clin. studies.  These efforts have been driven by the desire not only to develop a suitable diagnostic imaging agent but also to develop a means to evaluate potential therapies for Alzheimer's disease.  This review focuses on the development of these ligands, as well as the radiochem. and current regulatory status of these PET radioligands.  Particular attention is given to those ligands that have progressed to the later stages of drug development (phase II/III clin. trial studies) or approved New Drug Application status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhPmau7iHILVg90H21EOLACvtfcHk0lg4wPc4Y3loeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D&md5=423e02bcc2709e718d7a32adb552f81f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2989%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520Abeta%2520plaques%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D89%26epage%3D95%26doi%3D10.1002%2Fjlcr.2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span> </span><span class="NLM_article-title">Discovery of innovative therapeutics: today’s realities and tomorrow’s vision. 2. Pharma’s challenges and their commitment to innovation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5525</span><span class="NLM_x">–</span> <span class="NLM_lpage">5553</span><span class="refDoi"> DOI: 10.1021/jm401564r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401564r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5525-5553&author=M.+Abou-Gharbiaauthor=W.+E.+Childers&title=Discovery+of+innovative+therapeutics%3A+today%E2%80%99s+realities+and+tomorrow%E2%80%99s+vision.+2.+Pharma%E2%80%99s+challenges+and+their+commitment+to+innovation&doi=10.1021%2Fjm401564r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision. 2. Pharma's Challenges and Their Commitment to Innovation</span></div><div class="casAuthors">Abou-Gharbia, Magid; Childers, Wayne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is facing enormous challenges, including reduced efficiency, stagnant success rate, patent expirations for key drugs, fierce price competition from generics, high regulatory hurdles, and the industry's perceived tarnished image.  Pharma has responded by embarking on a range of initiatives.  Other sectors, including NIH, have also responded.  Academic drug discovery groups have appeared to support the transition of innovative academic discoveries and ideas into attractive drug discovery opportunities.  Part 1 of this two-part series discussed the criticisms that have been leveled at the pharmaceutical industry over the past 3 decades and summarized the supporting data for and against these criticisms.  This second installment will focus on the current challenges facing the pharmaceutical industry and Pharma's responses, focusing on the industry's changing perspective and new business models for coping with the loss of talent and declining clin. pipelines as well as presenting some examples of recent drug discovery successes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4lpJv0KTwLVg90H21EOLACvtfcHk0lg4wPc4Y3loeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D&md5=81598458e7db3879f2e5bb67d5b40eb3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401564r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401564r%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26atitle%3DDiscovery%2520of%2520innovative%2520therapeutics%253A%2520today%25E2%2580%2599s%2520realities%2520and%2520tomorrow%25E2%2580%2599s%2520vision.%25202.%2520Pharma%25E2%2580%2599s%2520challenges%2520and%2520their%2520commitment%2520to%2520innovation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5525%26epage%3D5553%26doi%3D10.1021%2Fjm401564r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">The beta-amyloid hypothesis in Alzheimer’s disease: seeing is believing</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1021/ml300058m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300058m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=265-267&author=H.+F.+Kung&title=The+beta-amyloid+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+seeing+is+believing&doi=10.1021%2Fml300058m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml300058m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300058m%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DThe%2520beta-amyloid%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520seeing%2520is%2520believing%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D265%26epage%3D267%26doi%3D10.1021%2Fml300058m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span> </span><span class="NLM_article-title">Contributions of academic laboratories to the discovery and development of chemical biology tools</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7161</span><span class="NLM_x">–</span> <span class="NLM_lpage">7176</span><span class="refDoi"> DOI: 10.1021/jm400132d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400132d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7161-7176&author=D.+M.+Hurynauthor=L.+O.+Resnickauthor=P.+Wipf&title=Contributions+of+academic+laboratories+to+the+discovery+and+development+of+chemical+biology+tools&doi=10.1021%2Fjm400132d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm400132d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400132d%26sid%3Dliteratum%253Aachs%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DResnick%26aufirst%3DL.%2BO.%26aulast%3DWipf%26aufirst%3DP.%26atitle%3DContributions%2520of%2520academic%2520laboratories%2520to%2520the%2520discovery%2520and%2520development%2520of%2520chemical%2520biology%2520tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7161%26epage%3D7176%26doi%3D10.1021%2Fjm400132d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0liuCrWlcnxhsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghbel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langstrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoilund-Carlsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Amyloid-beta positron emission tomography imaging probes: a critical review</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span><span class="refDoi"> DOI: 10.3233/JAD-130485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3233%2FJAD-130485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23648516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=613-631&author=V.+Kepeauthor=M.+C.+Moghbelauthor=B.+Langstromauthor=H.+Zaidiauthor=H.+V.+Vintersauthor=S.+C.+Huangauthor=N.+Satyamurthyauthor=D.+Doudetauthor=E.+Mishaniauthor=R.+M.+Cohenauthor=P.+F.+Hoilund-Carlsenauthor=A.+Alaviauthor=J.+R.+Barrio&title=Amyloid-beta+positron+emission+tomography+imaging+probes%3A+a+critical+review&doi=10.3233%2FJAD-130485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review</span></div><div class="casAuthors">Kepe, Vladimir; Moghbel, Mateen C.; Langstroem, Bengt; Zaidi, Habib; Vinters, Harry V.; Huang, Sung-Cheng; Satyamurthy, Nagichettiar; Doudet, Doris; Mishani, Eyal; Cohen, Robert M.; Hoilund-Carlsen, Poul F.; Alavi, Abass; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-631</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The rapidly rising prevalence and cost of Alzheimer's disease in recent decades has made the imaging of amyloid-β deposits the focus of intense research.  Several amyloid imaging probes with purported specificity for amyloid-β plaques are currently at various stages of FDA approval.  However, a no. of factors appear to preclude these probes from clin. utilization.  As the available "amyloid specific" positron emission tomog. imaging probes have failed to demonstrate diagnostic value and have shown limited utility for monitoring therapeutic interventions in humans, a debate on their significance has emerged.  The aim of this review is to identify and discuss critically the scientific issues contributing to the extensive inconsistencies reported in the literature on their purported in vivo amyloid specificity and potential utilization in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVE_xuB1karVg90H21EOLACvtfcHk0liuCrWlcnxhsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI&md5=deefdf403451d2621afdbc31ae9cc4a9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJAD-130485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130485%26sid%3Dliteratum%253Aachs%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DMoghbel%26aufirst%3DM.%2BC.%26aulast%3DLangstrom%26aufirst%3DB.%26aulast%3DZaidi%26aufirst%3DH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DDoudet%26aufirst%3DD.%26aulast%3DMishani%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DR.%2BM.%26aulast%3DHoilund-Carlsen%26aufirst%3DP.%2BF.%26aulast%3DAlavi%26aufirst%3DA.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DAmyloid-beta%2520positron%2520emission%2520tomography%2520imaging%2520probes%253A%2520a%2520critical%2520review%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D36%26spage%3D613%26epage%3D631%26doi%3D10.3233%2FJAD-130485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/S1474-4422(14)70252-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions&doi=10.1016%2FS1474-4422%2814%2970252-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2eZ54BGQeBTsG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124%26doi%3D10.1016%2FS1474-4422%2814%2970252-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span> </span><span class="NLM_article-title">Tau positron emission tomography (PET) imaging: past, present, and future</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4382</span><span class="refDoi"> DOI: 10.1021/jm5017544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4365-4382&author=M.+Arizaauthor=H.+C.+Kolbauthor=D.+Moecharsauthor=F.+Romboutsauthor=J.+I.+Andres&title=Tau+positron+emission+tomography+%28PET%29+imaging%3A+past%2C+present%2C+and+future&doi=10.1021%2Fjm5017544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future</span></div><div class="casAuthors">Ariza, Manuela; Kolb, Hartmuth C.; Moechars, Dieder; Rombouts, Frederik; Andres, Jose Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4365-4382</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population.  The good correlation of the d. and neocortical spread of neurofibrillary tangles (NFTs) with clin. AD disease progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging technique such as positron emission tomog. (PET).  Thus, PET imaging of NFTs not only holds promise as a diagnostic tool but also may enable the development of disease modifying therapeutics for AD.  In this review, we focus on the structural diversity of tau PET tracers, the challenges related to the identification of high affinity and highly selective NFT ligands, and recent progress in the clin. development of tau PET radioligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr59qS3XVaWtrVg90H21EOLACvtfcHk0lgycZI1yi7Ugg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D&md5=4d6974529735d3483482e5d7365440e0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017544%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26atitle%3DTau%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4365%26epage%3D4382%26doi%3D10.1021%2Fjm5017544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Characteristics of tau and its ligands in PET imaging</span> <span class="citation_source-journal">Biomolecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="refDoi"> DOI: 10.3390/biom6010007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3390%2Fbiom6010007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=7&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=T.+Tagoauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=Characteristics+of+tau+and+its+ligands+in+PET+imaging&doi=10.3390%2Fbiom6010007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fbiom6010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom6010007%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DCharacteristics%2520of%2520tau%2520and%2520its%2520ligands%2520in%2520PET%2520imaging%26jtitle%3DBiomolecules%26date%3D2016%26volume%3D6%26spage%3D7%26doi%3D10.3390%2Fbiom6010007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.07.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.neuron.2013.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24050400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1094-1108&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.+R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.+K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+a+tauopathy+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls&doi=10.1016%2Fj.neuron.2013.07.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls</span></div><div class="casAuthors">Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M.-Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1108</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies.  Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders.  In vivo optical and positron emission tomog. (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs.  A pyridinated PBB, [11C]PBB3, was next applied in a clin. PET study, and its robust signal in the AD hippocampus wherein tau pathol. is enriched contrasted strikingly with that of a senile plaque radioligand, [11C]Pittsburgh Compd.-B ([11C]PIB). [11C]PBB3-PET data were also consistent with the spreading of tau pathol. with AD progression.  Furthermore, increased [11C]PBB3 signals were found in a corticobasal syndrome patient neg. for [11C]PIB-PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD931Df6cdi7Vg90H21EOLACvtfcHk0liTi7e6chfw3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL&md5=7f1092519ce6b0f9c33a67e5364ba7b6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520a%2520tauopathy%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1094%26epage%3D1108%26doi%3D10.1016%2Fj.neuron.2013.07.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Xia, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.+F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B%2818%29F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2ebHJ3hdd8oEyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.%2BF.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B%252818%2529F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span><span class="refDoi"> DOI: 10.1007/s00259-013-2681-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1007%2Fs00259-013-2681-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24514874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=816-826&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=J.+Hodgesauthor=R.+Haradaauthor=P.+Yatesauthor=O.+Piguetauthor=S.+Pejoskaauthor=V.+Doreauthor=K.+Yanaiauthor=C.+L.+Mastersauthor=Y.+Kudoauthor=C.+C.+Roweauthor=N.+Okamura&title=In+vivo+evaluation+of+a+novel+tau+imaging+tracer+for+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-013-2681-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle T.; Mulligan, Rachel S.; Hodges, John; Harada, Ryuichi; Yates, Paul; Piguet, Olivier; Pejoska, Svetlana; Dore, Vincent; Yanai, Kazuhiko; Masters, Colin L.; Kudo, Yukitsuka; Rowe, Christopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Diagnosis of tauopathies such as Alzheimer's disease (AD) still relies on post-mortem examn. of the human brain.  A non-invasive method of detg. brain tau burden in vivo would allow a better understanding of the pathophysiol. of tauopathies.  The purpose of the study was to evaluate 18F-THK523 as a potential tau imaging tracer.  Methods: Ten healthy elderly controls, three semantic dementia (SD) and ten AD patients underwent neuropsychol. examn., MRI as well as 18F-THK523 and 11C-Pittsburgh compd. B (PIB) positron emission tomog. (PET) scans.  Composite memory and non-memory scores, global and hippocampal brain vol., and partial vol.-cor. tissue ratios for 18F-THK523 and 11C-PIB were estd. for all participants.  Correlational analyses were performed between global and regional 18F-THK523, 11C-PIB, cognition and brain volumetrics.  Results: 18F-THK523 presented with fast reversible kinetics.  Significantly higher 18F-THK523 retention was obsd. in the temporal, parietal, orbitofrontal and hippocampi of AD patients when compared to healthy controls and SD patients.  White matter retention was significantly higher than gray matter retention in all participants.  The pattern of cortical 18F-THK523 retention did not correlate with Aβ distribution as assessed by 11C-PIB and followed the known distribution of tau in the AD brain, being higher in temporal and parietal areas than in the frontal region.  Unlike 11C-PIB, hippocampal 18F-THK523 retention was correlated with several cognitive parameters and with hippocampal atrophy.  Conclusion: 18F-THK523 does not bind to Aβ in vivo, while following the known distribution of paired helical filaments (PHF)-tau in the brain.  Significantly higher cortical 18F-THK523 retention in AD patients as well as the assocn. of hippocampal 18F-THK523 retention with cognitive parameters and hippocampal vol. suggests 18F-THK523 selectively binds to tau in AD patients.  Unfortunately, the very high 18F-THK523 retention in white matter precludes simple visual inspection of the images, preventing its use in research or clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkefkNuzPCr7Vg90H21EOLACvtfcHk0liTi7e6chfw3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D&md5=d995c47f394f706c5164913e7024f1fa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2681-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2681-7%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHodges%26aufirst%3DJ.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPiguet%26aufirst%3DO.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DDore%26aufirst%3DV.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520a%2520novel%2520tau%2520imaging%2520tracer%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D816%26epage%3D826%26doi%3D10.1007%2Fs00259-013-2681-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.2967/jnumed.115.164848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2967%2Fjnumed.115.164848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26541774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=208-214&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=T.+Tagoauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=18F-THK5351%3A+a+novel+PET+radiotracer+for+imaging+neurofibrillary+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.115.164848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Tago, Tetsuro; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Imaging of neurofibrillary pathol. in the brain helps in diagnosing dementia, tracking disease progression, and evaluating the therapeutic efficacy of antidementia drugs.  The radiotracers used in this imaging must be highly sensitive and specific for tau protein fibrils in the human brain.  We developed a novel tau PET tracer, 18F-THK5351, through compd. optimization of arylquinoline derivs.  Methods: The in vitro binding properties, pharmacokinetics, and safety of 18F-THK5351 were investigated, and a clin. study on Alzheimer disease (AD) patients was performed.  Results:18F-THK5351 demonstrated higher binding affinity for hippocampal homogenates from AD brains and faster dissocn. from white-matter tissue than did 18F-THK5117.  The THK5351 binding amt. correlated with the amt. of tau deposits in human brain samples.  Autoradiog. of brain sections revealed that THK5351 bound to neurofibrillary tangles selectively and with a higher signal-to-background ratio than did THK5117.  THK5351 exhibited favorable pharmacokinetics and no defluorination in mice.  In first-in-human PET studies in AD patients, 18F-THK5351 demonstrated faster kinetics, higher contrast, and lower retention in subcortical white matter than 18F-THK5117.  Conclusion:18F-THK5351 is a useful PET tracer for the early detection of neurofibrillary pathol. in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1_bH5nh_KBLVg90H21EOLACvtfcHk0lgP4XeFO-g_qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D&md5=f488c442abb7ca31d5b66fbe60afd14e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.164848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.164848%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D18F-THK5351%253A%2520a%2520novel%2520PET%2520radiotracer%2520for%2520imaging%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D208%26epage%3D214%26doi%3D10.2967%2Fjnumed.115.164848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Nordberg, A.</span><span> </span><span class="NLM_article-title">The use of amyloid imaging in clinical praxis: a critical review</span> <span class="citation_source-journal">Clin. Transl. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1007/s40336-015-0100-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1007%2Fs40336-015-0100-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=7-11&author=A.+Nordberg&title=The+use+of+amyloid+imaging+in+clinical+praxis%3A+a+critical+review&doi=10.1007%2Fs40336-015-0100-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs40336-015-0100-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40336-015-0100-8%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DThe%2520use%2520of%2520amyloid%2520imaging%2520in%2520clinical%2520praxis%253A%2520a%2520critical%2520review%26jtitle%3DClin.%2520Transl.%2520Imaging%26date%3D2015%26volume%3D3%26spage%3D7%26epage%3D11%26doi%3D10.1007%2Fs40336-015-0100-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Weissleder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahrendorf, M.</span><span> </span><span class="NLM_article-title">Advancing biomedical imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">14424</span><span class="NLM_x">–</span> <span class="NLM_lpage">14428</span><span class="refDoi"> DOI: 10.1073/pnas.1508524112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1073%2Fpnas.1508524112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=14424-14428&author=R.+Weisslederauthor=M.+Nahrendorf&title=Advancing+biomedical+imaging&doi=10.1073%2Fpnas.1508524112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1508524112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1508524112%26sid%3Dliteratum%253Aachs%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DNahrendorf%26aufirst%3DM.%26atitle%3DAdvancing%2520biomedical%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D14424%26epage%3D14428%26doi%3D10.1073%2Fpnas.1508524112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Patterson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saba, R.</span><span> </span><span class="NLM_article-title">The emerging use of in vivo optical imaging in the study of neurodegenerative diseases</span> <span class="citation_source-journal">BioMed Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">401306</span><span class="refDoi"> DOI: 10.1155/2014/401306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1155%2F2014%2F401306" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=401306&author=A.+P.+Pattersonauthor=S.+A.+Boothauthor=R.+Saba&title=The+emerging+use+of+in+vivo+optical+imaging+in+the+study+of+neurodegenerative+diseases&doi=10.1155%2F2014%2F401306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1155%2F2014%2F401306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F401306%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BP.%26aulast%3DBooth%26aufirst%3DS.%2BA.%26aulast%3DSaba%26aufirst%3DR.%26atitle%3DThe%2520emerging%2520use%2520of%2520in%2520vivo%2520optical%2520imaging%2520in%2520the%2520study%2520of%2520neurodegenerative%2520diseases%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D401306%26doi%3D10.1155%2F2014%2F401306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hintersteiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaton, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneuer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeckli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederhold, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremlich, H. U.</span><span> </span><span class="NLM_article-title">In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1038/nbt1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnbt1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=15834405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvV2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=577-583&author=M.+Hintersteinerauthor=A.+Enzauthor=P.+Freyauthor=A.+L.+Jatonauthor=W.+Kinzyauthor=R.+Kneuerauthor=U.+Neumannauthor=M.+Rudinauthor=M.+Staufenbielauthor=M.+Stoeckliauthor=K.+H.+Wiederholdauthor=H.+U.+Gremlich&title=In+vivo+detection+of+amyloid-beta+deposits+by+near-infrared+imaging+using+an+oxazine-derivative+probe&doi=10.1038%2Fnbt1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe</span></div><div class="casAuthors">Hintersteiner, Martin; Enz, Albert; Frey, Peter; Jaton, Anne-Lise; Kinzy, Willy; Kneuer, Rainer; Neumann, Ulf; Rudin, Markus; Staufenbiel, Matthias; Stoeckli, Markus; Wiederhold, Karl-Heinz; Gremlich, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">577-583</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As Alzheimer's disease pathogenesis is assocd. with the formation of insol. aggregates of amyloid β-peptide, approaches allowing the direct, noninvasive visualization of plaque growth in vivo would be beneficial for biomedical research.  Here we describe the synthesis and characterization of the near-IR fluorescence oxazine dye AOI987, which readily penetrates the intact blood-brain barrier and binds to amyloid plaques.  Using near-IR fluorescence imaging, we demonstrated specific interaction of AOI987 with amyloid plaques in APP23 transgenic mice in vivo, as confirmed by postmortem anal. of brain slices.  Quant. anal. revealed increasing fluorescence signal intensity with increasing plaque load of the animals, and significant binding of AOI987 was obsd. for APP23 transgenic mice aged 9 mo and older.  Thus, AOI987 is an attractive probe to noninvasively monitor disease progression in animal models of Alzheimer disease and to evaluate effects of potential Alzheimer disease drugs on the plaque load.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV-7ZQiYjcRrVg90H21EOLACvtfcHk0lhXoFRQxIKC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvV2ntbo%253D&md5=d4664e3400e16e4cf11eb5fefd5f05d6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnbt1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1085%26sid%3Dliteratum%253Aachs%26aulast%3DHintersteiner%26aufirst%3DM.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DFrey%26aufirst%3DP.%26aulast%3DJaton%26aufirst%3DA.%2BL.%26aulast%3DKinzy%26aufirst%3DW.%26aulast%3DKneuer%26aufirst%3DR.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRudin%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DStoeckli%26aufirst%3DM.%26aulast%3DWiederhold%26aufirst%3DK.%2BH.%26aulast%3DGremlich%26aufirst%3DH.%2BU.%26atitle%3DIn%2520vivo%2520detection%2520of%2520amyloid-beta%2520deposits%2520by%2520near-infrared%2520imaging%2520using%2520an%2520oxazine-derivative%2520probe%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D577%26epage%3D583%26doi%3D10.1038%2Fnbt1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Going deeper than microscopy: the optical imaging frontier in biology</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1038/nmeth.1483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnmeth.1483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=20676081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFWktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=603-614&author=V.+Ntziachristos&title=Going+deeper+than+microscopy%3A+the+optical+imaging+frontier+in+biology&doi=10.1038%2Fnmeth.1483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Going deeper than microscopy: the optical imaging frontier in biology</span></div><div class="casAuthors">Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">603-614</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Optical microscopy was a fundamental tool of biol. discovery for more than 3 centuries, but its in vivo tissue imaging ability was restricted by light scattering to superficial investigations, even when confocal or multiphoton methods are used.  Recent advances in optical and optoacoustic (photoacoustic) imaging now allow imaging at depths and resolns. unprecedented for optical methods.  These abilities are increasingly important to understand the dynamic interactions of cellular processes at different systems levels, a major challenge of postgenome biol.  This review discusses promising photonic methods that have the ability to visualize cellular and subcellular components in tissues across different penetration scales.  The methods are classified into microscopic, mesoscopic and macroscopic approaches, according to the tissue depth at which they operate.  Key characteristics assocd. with different imaging implementations are described and the potential of these technologies in biol. applications is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW-553UGo1rLVg90H21EOLACvtfcHk0lhXoFRQxIKC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFWktrw%253D&md5=fc156771476285e380880f6a20787839</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.1483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.1483%26sid%3Dliteratum%253Aachs%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DGoing%2520deeper%2520than%2520microscopy%253A%2520the%2520optical%2520imaging%2520frontier%2520in%2520biology%26jtitle%3DNat.%2520Methods%26date%3D2010%26volume%3D7%26spage%3D603%26epage%3D614%26doi%3D10.1038%2Fnmeth.1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Horton, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffer, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span> </span><span class="NLM_article-title">Three-photon microscopy of subcortical structures within an intact mouse brain</span> <span class="citation_source-journal">Nat. Photonics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1038/nphoton.2012.336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnphoton.2012.336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=205-209&author=N.+G.+Hortonauthor=K.+Wangauthor=D.+Kobatauthor=C.+G.+Clarkauthor=F.+W.+Wiseauthor=C.+B.+Schafferauthor=C.+Xu&title=Three-photon+microscopy+of+subcortical+structures+within+an+intact+mouse+brain&doi=10.1038%2Fnphoton.2012.336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo three-photon microscopy of subcortical structures within an intact mouse brain</span></div><div class="casAuthors">Horton, Nicholas G.; Wang, Ke; Kobat, Demirhan; Clark, Catharine G.; Wise, Frank W.; Schaffer, Chris B.; Xu, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Photonics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-209</span>CODEN:
                <span class="NLM_cas:coden">NPAHBY</span>;
        ISSN:<span class="NLM_cas:issn">1749-4885</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two-photon fluorescence microscopy enables scientists in various fields including neuroscience, embryol. and oncol. to visualize in vivo and ex vivo tissue morphol. and physiol. at a cellular level deep within scattering tissue.  However, tissue scattering limits the max. imaging depth of two-photon fluorescence microscopy to the cortical layer within mouse brain, and imaging subcortical structures currently requires the removal of overlying brain tissue or the insertion of optical probes.  Here, we demonstrate non-invasive, high-resoln., in vivo imaging of subcortical structures within an intact mouse brain using three-photon fluorescence microscopy at a spectral excitation window of 1,700 nm.  Vascular structures as well as red fluorescent protein-labeled neurons within the mouse hippocampus are imaged.  The combination of the long excitation wavelength and the higher-order nonlinear excitation overcomes the limitations of two-photon fluorescence microscopy, enabling biol. investigations to take place at a greater depth within tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopuI0wojw38rVg90H21EOLACvtfcHk0lhXoFRQxIKC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSmsro%253D&md5=5632c2e1351e985a9593236a6b2a35ae</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnphoton.2012.336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnphoton.2012.336%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DN.%2BG.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DKobat%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DWise%26aufirst%3DF.%2BW.%26aulast%3DSchaffer%26aufirst%3DC.%2BB.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DThree-photon%2520microscopy%2520of%2520subcortical%2520structures%2520within%2520an%2520intact%2520mouse%2520brain%26jtitle%3DNat.%2520Photonics%26date%3D2013%26volume%3D7%26spage%3D205%26epage%3D209%26doi%3D10.1038%2Fnphoton.2012.336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antaris, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atochin, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span> </span><span class="NLM_article-title">Through-skull fluorescence imaging of the brain in a new near-infrared window</span> <span class="citation_source-journal">Nat. Photonics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1038/nphoton.2014.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnphoton.2014.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=27642366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gqtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=723-730&author=G.+Hongauthor=S.+Diaoauthor=J.+Changauthor=A.+L.+Antarisauthor=C.+Chenauthor=B.+Zhangauthor=S.+Zhaoauthor=D.+N.+Atochinauthor=P.+L.+Huangauthor=K.+I.+Andreassonauthor=C.+J.+Kuoauthor=H.+Dai&title=Through-skull+fluorescence+imaging+of+the+brain+in+a+new+near-infrared+window&doi=10.1038%2Fnphoton.2014.166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Through-skull fluorescence imaging of the brain in a new near-infrared window</span></div><div class="casAuthors">Hong, Guosong; Diao, Shuo; Chang, Junlei; Antaris, Alexander L.; Chen, Changxin; Zhang, Bo; Zhao, Su; Atochin, Dmitriy N.; Huang, Paul L.; Andreasson, Katrin I.; Kuo, Calvin J.; Dai, Hongjie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Photonics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">NPAHBY</span>;
        ISSN:<span class="NLM_cas:issn">1749-4885</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To date, brain imaging has largely relied on X-ray computed tomog. and magnetic resonance angiog., with their limited spatial resoln. and long scanning times.  Fluorescence-based brain imaging in the visible and traditional near-IR regions (400-900 nm) is an alternative, but at present it requires craniotomy, cranial windows and skull-thinning techniques, and the penetration depth is limited to 1-2 mm due to light scattering.  Here, we report through-scalp and through-skull fluorescence imaging of mouse cerebral vasculature without craniotomy, utilizing the intrinsic photoluminescence of single-walled carbon nanotubes in the 1.3-1.4 μm near-IR window (NIR-IIa window).  Reduced photon scattering in this spectral region allows fluorescence imaging to a depth of >2 mm in mouse brain with sub-10-μm resoln.  An imaging rate of ∼5.3 frames per s allows for dynamic recording of blood perfusion in the cerebral vessels with sufficient temporal resoln., providing real-time assessment of a blood flow anomaly in a mouse middle cerebral artery occlusion stroke model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvhesxmHWpbLVg90H21EOLACvtfcHk0lhSYvONpeAMSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gqtr7P&md5=32b8a29327b6deb4e9113744f24373fe</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnphoton.2014.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnphoton.2014.166%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DG.%26aulast%3DDiao%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DAntaris%26aufirst%3DA.%2BL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DAtochin%26aufirst%3DD.%2BN.%26aulast%3DHuang%26aufirst%3DP.%2BL.%26aulast%3DAndreasson%26aufirst%3DK.%2BI.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26aulast%3DDai%26aufirst%3DH.%26atitle%3DThrough-skull%2520fluorescence%2520imaging%2520of%2520the%2520brain%2520in%2520a%2520new%2520near-infrared%2520window%26jtitle%3DNat.%2520Photonics%26date%3D2014%26volume%3D8%26spage%3D723%26epage%3D730%26doi%3D10.1038%2Fnphoton.2014.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolayev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohrs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.1038/nmeth.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnmeth.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22561987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFyjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=615-620&author=A.+Aleauthor=V.+Ermolayevauthor=E.+Herzogauthor=C.+Cohrsauthor=M.+H.+de+Angelisauthor=V.+Ntziachristos&title=FMT-XCT%3A+in+vivo+animal+studies+with+hybrid+fluorescence+molecular+tomography-X-ray+computed+tomography&doi=10.1038%2Fnmeth.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography</span></div><div class="casAuthors">Ale, Angelique; Ermolayev, Vladimir; Herzog, Eva; Cohrs, Christian; Hrabe de Angelis, Martin; Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">615-620</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of hybrid optical tomog. methods to improve imaging performance has been suggested over a decade ago and has been exptl. demonstrated in animals and humans.  Here we examd. in vivo performance of a camera-based hybrid fluorescence mol. tomog. (FMT) system for 360° imaging combined with X-ray computed tomog. (XCT).  Offering an accurately co-registered, information-rich hybrid data set, FMT-XCT has new imaging possibilities compared to stand-alone FMT and XCT.  We applied FMT-XCT to a s.c. 4T1 tumor mouse model, an Aga2 osteogenesis imperfecta model and a Kras lung cancer mouse model, using XCT information during FMT inversion.  We validated in vivo imaging results against post-mortem planar fluorescence images of cryoslices and histol. data.  Besides offering concurrent anatomical and functional information, FMT-XCT resulted in the most accurate FMT performance to date.  These findings indicate that addn. of FMT optics into the XCT gantry may be a potent upgrade for small-animal XCT systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdljBI7Q5QILVg90H21EOLACvtfcHk0lhSYvONpeAMSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFyjtrw%253D&md5=914e10e04cf96080a99d62408779fce6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2014%26sid%3Dliteratum%253Aachs%26aulast%3DAle%26aufirst%3DA.%26aulast%3DErmolayev%26aufirst%3DV.%26aulast%3DHerzog%26aufirst%3DE.%26aulast%3DCohrs%26aufirst%3DC.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DFMT-XCT%253A%2520in%2520vivo%2520animal%2520studies%2520with%2520hybrid%2520fluorescence%2520molecular%2520tomography-X-ray%2520computed%2520tomography%26jtitle%3DNat.%2520Methods%26date%3D2012%26volume%3D9%26spage%3D615%26epage%3D620%26doi%3D10.1038%2Fnmeth.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gremse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doleschel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafarnia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnen-Dechent, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lederle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, F.</span><span> </span><span class="NLM_article-title">Hybrid μCT-FMT imaging and image analysis</span> <span class="citation_source-journal">J. Visualized Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52770</span><span class="refDoi"> DOI: 10.3791/52770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3791%2F52770" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=e52770&author=F.+Gremseauthor=D.+Doleschelauthor=S.+Zafarniaauthor=A.+Bablerauthor=W.+Jahnen-Dechentauthor=T.+Lammersauthor=W.+Lederleauthor=F.+Kiessling&title=Hybrid+%CE%BCCT-FMT+imaging+and+image+analysis&doi=10.3791%2F52770"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3791%2F52770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F52770%26sid%3Dliteratum%253Aachs%26aulast%3DGremse%26aufirst%3DF.%26aulast%3DDoleschel%26aufirst%3DD.%26aulast%3DZafarnia%26aufirst%3DS.%26aulast%3DBabler%26aufirst%3DA.%26aulast%3DJahnen-Dechent%26aufirst%3DW.%26aulast%3DLammers%26aufirst%3DT.%26aulast%3DLederle%26aufirst%3DW.%26aulast%3DKiessling%26aufirst%3DF.%26atitle%3DHybrid%2520%25CE%25BCCT-FMT%2520imaging%2520and%2520image%2520analysis%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2015%26spage%3De52770%26doi%3D10.3791%2F52770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">McCann, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissleder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. W.</span><span> </span><span class="NLM_article-title">Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2008.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.neuroimage.2008.12.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2009&pages=360-369&author=C.+M.+McCannauthor=P.+Watermanauthor=J.+L.+Figueiredoauthor=E.+Aikawaauthor=R.+Weisslederauthor=J.+W.+Chen&title=Combined+magnetic+resonance+and+fluorescence+imaging+of+the+living+mouse+brain+reveals+glioma+response+to+chemotherapy&doi=10.1016%2Fj.neuroimage.2008.12.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2008.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2008.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DC.%2BM.%26aulast%3DWaterman%26aufirst%3DP.%26aulast%3DFigueiredo%26aufirst%3DJ.%2BL.%26aulast%3DAikawa%26aufirst%3DE.%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26atitle%3DCombined%2520magnetic%2520resonance%2520and%2520fluorescence%2520imaging%2520of%2520the%2520living%2520mouse%2520brain%2520reveals%2520glioma%2520response%2520to%2520chemotherapy%26jtitle%3DNeuroImage%26date%3D2009%26volume%3D45%26spage%3D360%26epage%3D369%26doi%3D10.1016%2Fj.neuroimage.2008.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Razansky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deliolanis, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinegoni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.2174/138920112799436258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2174%2F138920112799436258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22216767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=504-522&author=D.+Razanskyauthor=N.+C.+Deliolanisauthor=C.+Vinegoniauthor=V.+Ntziachristos&title=Deep+tissue+optical+and+optoacoustic+molecular+imaging+technologies+for+pre-clinical+research+and+drug+discovery&doi=10.2174%2F138920112799436258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery</span></div><div class="casAuthors">Razansky, Daniel; Deliolanis, Nikolaos C.; Vinegoni, Claudio; Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">504-522</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For centuries, biol. discoveries were based on optical imaging, in particular microscopy but also several chromophoric assays and photog. approaches.  With the recent emergence of methods appropriate for bio-marker in vivo staining, such as bioluminescence, fluorescent mol. probes and proteins, as well as nanoparticle-based targeted agents, significant attention has been shifted toward in vivo interrogations of different dynamic biol. processes at the mol. level.  This progress has been largely supported by the development of advanced tomog. imaging technologies suitable for obtaining volumetric visualization of bio-marker distributions in small animals at a whole-body or whole-organ scale, an imaging frontier that is not accessible by the existing tissue-sectioning microscopic techniques due to intensive light scattering beyond the depth of a few hundred microns.  Major examples of such recently developed optical imaging modalities are reviewed here, including bioluminescence tomog. (BLT), fluorescence mol. tomog. (FMT), and optical projection tomog. (OPT).  The pharmaceutical imaging community has quickly appropriated itself of these novel forms of optical imaging, since they come with very compelling advantages, such as quant. three-dimensional capabilities, direct correlation to the biol. cultures, easiness and cost-effectiveness of use, and the use of safe non-ionizing radiation.  Some multi-modality approaches, combining light with other imaging modalities such as X-Ray CT or MRI, giving the ability to acquire both an optical contrast reconstruction along with a hi-fidelity anatomical images, are also reviewed.  A sep. section is devoted to the hybrid imaging techniques based on the optoacoustic phenomenon, such as multispectral optoacoustic tomog. (MSOT), which are poised to leverage the traditional contrast and specificity advantages of optical spectrum by delivering an ever powerful set of capabilities, including real-time operation and high spatial resoln., not affected by the scattering nature of biol. tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvMxiifWfmUbVg90H21EOLACvtfcHk0ljjH9o2wMF49g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOnurY%253D&md5=52ae1b8c6bba956aed0c101a9d6b4478</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F138920112799436258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920112799436258%26sid%3Dliteratum%253Aachs%26aulast%3DRazansky%26aufirst%3DD.%26aulast%3DDeliolanis%26aufirst%3DN.%2BC.%26aulast%3DVinegoni%26aufirst%3DC.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DDeep%2520tissue%2520optical%2520and%2520optoacoustic%2520molecular%2520imaging%2520technologies%2520for%2520pre-clinical%2520research%2520and%2520drug%2520discovery%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2012%26volume%3D13%26spage%3D504%26epage%3D522%26doi%3D10.2174%2F138920112799436258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Taruttis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Advances in real-time multispectral optoacoustic imaging and its applications</span> <span class="citation_source-journal">Nat. Photonics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1038/nphoton.2015.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnphoton.2015.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1ahu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=219-227&author=A.+Taruttisauthor=V.+Ntziachristos&title=Advances+in+real-time+multispectral+optoacoustic+imaging+and+its+applications&doi=10.1038%2Fnphoton.2015.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in real-time multispectral optoacoustic imaging and its applications</span></div><div class="casAuthors">Taruttis, Adrian; Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Photonics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-227</span>CODEN:
                <span class="NLM_cas:coden">NPAHBY</span>;
        ISSN:<span class="NLM_cas:issn">1749-4885</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Optoacoustic imaging, or photoacoustic imaging, is insensitive to photon scattering within biol. tissue and, unlike conventional optical imaging methods, makes high-resoln. optical visualization deep within tissue possible.  Recent advances in laser technol., detection strategies and inversion techniques led to significant improvements in the capabilities of optoacoustic systems.  A key empowering feature is the development of video-rate multispectral imaging in two and three dimensions, which offers fast, spectral differentiation of distinct photoabsorbing moieties.  The authors review recent advances and capabilities in the technol. and its corresponding emerging biol. and clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxf52rualDXLVg90H21EOLACvtfcHk0ljjH9o2wMF49g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1ahu78%253D&md5=751cc66e5b6cd4ed71ecb78f70e55585</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnphoton.2015.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnphoton.2015.29%26sid%3Dliteratum%253Aachs%26aulast%3DTaruttis%26aufirst%3DA.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DAdvances%2520in%2520real-time%2520multispectral%2520optoacoustic%2520imaging%2520and%2520its%2520applications%26jtitle%3DNat.%2520Photonics%26date%3D2015%26volume%3D9%26spage%3D219%26epage%3D227%26doi%3D10.1038%2Fnphoton.2015.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Burton, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morscher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driessen, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claussen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beziere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jetzfellner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taruttis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razansky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Multispectral opto-acoustic tomography (MSOT) of the brain and glioblastoma characterization</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2012.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.neuroimage.2012.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=522-528&author=N.+C.+Burtonauthor=M.+Patelauthor=S.+Morscherauthor=W.+H.+Driessenauthor=J.+Claussenauthor=N.+Beziereauthor=T.+Jetzfellnerauthor=A.+Taruttisauthor=D.+Razanskyauthor=B.+Bednarauthor=V.+Ntziachristos&title=Multispectral+opto-acoustic+tomography+%28MSOT%29+of+the+brain+and+glioblastoma+characterization&doi=10.1016%2Fj.neuroimage.2012.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2012.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2012.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DN.%2BC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DMorscher%26aufirst%3DS.%26aulast%3DDriessen%26aufirst%3DW.%2BH.%26aulast%3DClaussen%26aufirst%3DJ.%26aulast%3DBeziere%26aufirst%3DN.%26aulast%3DJetzfellner%26aufirst%3DT.%26aulast%3DTaruttis%26aufirst%3DA.%26aulast%3DRazansky%26aufirst%3DD.%26aulast%3DBednar%26aufirst%3DB.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DMultispectral%2520opto-acoustic%2520tomography%2520%2528MSOT%2529%2520of%2520the%2520brain%2520and%2520glioblastoma%2520characterization%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D65%26spage%3D522%26epage%3D528%26doi%3D10.1016%2Fj.neuroimage.2012.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Pansare, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejazi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faenza, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prud’homme, R. K.</span><span> </span><span class="NLM_article-title">Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores and multifunctional nano carriers</span> <span class="citation_source-journal">Chem. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span><span class="refDoi"> DOI: 10.1021/cm2028367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cm2028367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=812-827&author=V.+Pansareauthor=S.+Hejaziauthor=W.+Faenzaauthor=R.+K.+Prud%E2%80%99homme&title=Review+of+long-wavelength+optical+and+NIR+imaging+materials%3A+contrast+agents%2C+fluorophores+and+multifunctional+nano+carriers&doi=10.1021%2Fcm2028367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores, and Multifunctional Nano Carriers</span></div><div class="casAuthors">Pansare, Vikram J.; Hejazi, Shahram; Faenza, William J.; Prud'homme, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Materials</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">812-827</span>CODEN:
                <span class="NLM_cas:coden">CMATEX</span>;
        ISSN:<span class="NLM_cas:issn">0897-4756</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The importance of long wavelength and near-IR (NIR) imaging has dramatically increased due to the desire to perform whole animal and deep tissue imaging.  The adoption of NIR imaging is also growing rapidly due to the availability of targeted biol. agents for diagnosis and basic medical research that can be imaged in vivo.  The wavelength range of 650-1450 nm falls in the region of the spectrum with the lowest absorption in tissue and therefore enables the deepest tissue penetration.  This is the wavelength range the authors focus on with this review.  To operate effectively, the imaging agents must both be excited and must emit in this long-wavelength window.  The authors review the agents used for imaging by absorption, scattering, and excitation (such as fluorescence).  Imaging agents comprise both aq. sol. and insol. species, both org. and inorg., and unimol. and supramol. constructs.  The interest in multimodal imaging, which involves delivery of actives, targeting, and imaging, requires nanoparticles or supramol. assemblies.  Nanoparticles for diagnostics also have advantages in increasing circulation time and increased imaging brightness relative to single mol. imaging agents.  This has led to rapid advances in nanocarriers for long-wavelength, NIR imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyBGiivmZ0ZrVg90H21EOLACvtfcHk0liIKYnj7sIk_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSkug%253D%253D&md5=600d4db2b41c5eb2e562c52339c33814</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcm2028367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcm2028367%26sid%3Dliteratum%253Aachs%26aulast%3DPansare%26aufirst%3DV.%26aulast%3DHejazi%26aufirst%3DS.%26aulast%3DFaenza%26aufirst%3DW.%26aulast%3DPrud%25E2%2580%2599homme%26aufirst%3DR.%2BK.%26atitle%3DReview%2520of%2520long-wavelength%2520optical%2520and%2520NIR%2520imaging%2520materials%253A%2520contrast%2520agents%252C%2520fluorophores%2520and%2520multifunctional%2520nano%2520carriers%26jtitle%3DChem.%2520Mater.%26date%3D2012%26volume%3D24%26spage%3D812%26epage%3D827%26doi%3D10.1021%2Fcm2028367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Staderini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, J. C.</span><span> </span><span class="NLM_article-title">Imaging of beta-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1819</span><span class="refDoi"> DOI: 10.1039/C4CS00337C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4CS00337C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25622714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=1807-1819&author=M.+Staderiniauthor=M.+A.+Martinauthor=M.+L.+Bolognesiauthor=J.+C.+Menendez&title=Imaging+of+beta-amyloid+plaques+by+near+infrared+fluorescent+tracers%3A+a+new+frontier+for+chemical+neuroscience&doi=10.1039%2FC4CS00337C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of β-amyloid plaques by near infrared fluorescent tracers- a new frontier for chemical neuroscience</span></div><div class="casAuthors">Staderini, Matteo; Martin, Maria Antonia; Bolognesi, Maria Laura; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1807-1819</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Brain amyloid depositions are the main hallmarks of Alzheimer's and other protein misfolding diseases.  Since they are believed to precede clin. symptoms by several years, imaging of such fibrillar aggregates is particularly suitable to diagnose the onset of the disease in its early stage and monitor its progression.  In this context, near IR (NIR) imaging has been proposed as a promising and non-invasive method to visualize amyloid plaques in vivo because of its acceptable depth of penetration and minimal degree of tissue damage.  In this tutorial review, we describe the main chem. and physicochem. features of probes assocd. with fluorescence emission in the NIR region.  The review focuses on the recent progress and improvements in the development of small-mol. NIR fluorescent probes and their in vivo application in living animals.  In addn., the possible therapeutic application of NIR probes to block the pathol. aggregation process will be discussed, raising the fascinating possibility of their exploitation as theranostic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoouYzHe3xvLVg90H21EOLACvtfcHk0liIKYnj7sIk_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSmtLk%253D&md5=ffcb2d0bfd335d235883e585714b7e75</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2FC4CS00337C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00337C%26sid%3Dliteratum%253Aachs%26aulast%3DStaderini%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26atitle%3DImaging%2520of%2520beta-amyloid%2520plaques%2520by%2520near%2520infrared%2520fluorescent%2520tracers%253A%2520a%2520new%2520frontier%2520for%2520chemical%2520neuroscience%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D1807%26epage%3D1819%26doi%3D10.1039%2FC4CS00337C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Tong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer’s disease</span> <span class="citation_source-journal">Acta Pharm. Sin. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1016/j.apsb.2014.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.apsb.2014.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26579421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=25-33&author=H.+J.+Tongauthor=K.+Y.+Louauthor=W.+Wang&title=Near-infrared+fluorescent+probes+for+imaging+of+amyloid+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.apsb.2014.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer s disease</span></div><div class="casAuthors">Tong Hongjuan; Lou Kaiyan; Wang Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-33</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">One of the early pathological hallmarks of Alzheimer s disease (AD) is the deposition of amyloid-β (Aβ) plaques in the brain.  There has been a tremendous interest in the development of Aβ plaques imaging probes for early diagnosis of AD in the past decades.  Optical imaging, particularly near-infrared fluorescence (NIRF) imaging, has emerged as a safe, low cost, real-time, and widely available technique, providing an attractive approach for in vivo detection of Aβ plaques among many different imaging techniques.  In this review, we provide a brief overview of the state-of-the-art development of NIRF Aβ probes and their in vitro and in vivo applications with special focus on design strategies and optical, binding, and brain-kinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFlwvupmecNw_lfW6udTcc2ebR1-DReVG2F7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOnsA%253D%253D&md5=3335b356fe9487e6d99214033d7399f3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2014.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2014.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DH.%2BJ.%26aulast%3DLou%26aufirst%3DK.%2BY.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DNear-infrared%2520fluorescent%2520probes%2520for%2520imaging%2520of%2520amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D25%26epage%3D33%26doi%3D10.1016%2Fj.apsb.2014.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Recent advances in molecular imaging probes for β-amyloid plaques</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1039/C4MD00365A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4MD00365A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=391-402&author=M.+Onoauthor=H.+Saji&title=Recent+advances+in+molecular+imaging+probes+for+%CE%B2-amyloid+plaques&doi=10.1039%2FC4MD00365A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC4MD00365A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00365A%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRecent%2520advances%2520in%2520molecular%2520imaging%2520probes%2520for%2520%25CE%25B2-amyloid%2520plaques%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D391%26epage%3D402%26doi%3D10.1039%2FC4MD00365A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span>Roche Media Release. <a href="http://www.roche.com/media/store/releases/med_pha_2011-09-21.htm" class="extLink">http://www.roche.com/media/store/releases/med_pha_2011-09-21.htm</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Roche+Media+Release.+http%3A%2F%2Fwww.roche.com%2Fmedia%2Fstore%2Freleases%2Fmed_pha_2011-09-21.htm+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span>FDA. Guidance for Industry and Food and Drug Administration Staff. In Vitro Companion Diagnostic Devices. <a href="http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM262327.pdf" class="extLink">http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM262327.pdf</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA.+Guidance+for+Industry+and+Food+and+Drug+Administration+Staff.+In+Vitro+Companion+Diagnostic+Devices.+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FMedicalDevices%2FDeviceRegulationandGuidance%2FGuidanceDocuments%2FUCM262327.pdf+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Nikolcheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, G.</span><span> </span><span class="NLM_article-title">Challenges in the development of companion diagnostics for neuropsychiatric disorders</span> <span class="citation_source-journal">Expert Rev. Mol. Diagn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1586/erm.11.67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1586%2Ferm.11.67" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22022945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGnsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=829-837&author=T.+Nikolchevaauthor=S.+Jagerauthor=T.+A.+Bushauthor=G.+Vargas&title=Challenges+in+the+development+of+companion+diagnostics+for+neuropsychiatric+disorders&doi=10.1586%2Ferm.11.67"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the development of companion diagnostics for neuropsychiatric disorders</span></div><div class="casAuthors">Nikolcheva, Tania; Jaeger, Stephan; Bush, Theresa Ambrose; Vargas, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Molecular Diagnostics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">829-837</span>CODEN:
                <span class="NLM_cas:coden">ERMDCW</span>;
        ISSN:<span class="NLM_cas:issn">1473-7159</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  There are few examples of successful CNS diagnostics owing to our poor understanding of the mechanisms of disease.  This article will discuss this and other challenges facing CNS diagnostic development with a focus on Alzheimer''s disease, along with a discussion of potential future diagnostic assays that may help in the development of new CNS medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHv-ozY6a1t7Vg90H21EOLACvtfcHk0lgViPE9ImMSfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGnsbbJ&md5=6db600e49d8ee5545e2b9774a13a1d69</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1586%2Ferm.11.67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Ferm.11.67%26sid%3Dliteratum%253Aachs%26aulast%3DNikolcheva%26aufirst%3DT.%26aulast%3DJager%26aufirst%3DS.%26aulast%3DBush%26aufirst%3DT.%2BA.%26aulast%3DVargas%26aufirst%3DG.%26atitle%3DChallenges%2520in%2520the%2520development%2520of%2520companion%2520diagnostics%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Diagn.%26date%3D2011%26volume%3D11%26spage%3D829%26epage%3D837%26doi%3D10.1586%2Ferm.11.67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Agarwal, A.</span><span> </span><span class="NLM_article-title">Do companion diagnostics make economic sense for drug developers?</span> <span class="citation_source-journal">New Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span><span class="refDoi"> DOI: 10.1016/j.nbt.2012.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.nbt.2012.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=695-708&author=A.+Agarwal&title=Do+companion+diagnostics+make+economic+sense+for+drug+developers%3F&doi=10.1016%2Fj.nbt.2012.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Do companion diagnostics make economic sense for drug developers?</span></div><div class="casAuthors">Agarwal, Amit</div><div class="citationInfo"><span class="NLM_cas:title">New Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-708</span>CODEN:
                <span class="NLM_cas:coden">NBEIBR</span>;
        ISSN:<span class="NLM_cas:issn">1871-6784</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Drug developers are grappling with the impact of personalized medicine on their portfolios.  The combination of mol. diagnostics with targeted biol. therapies has been hailed as a recent innovation with few historical analogs to guide behavior.  However, if the definition of companion diagnostics is broadened to include any drug whose FDA approved label requires diagnostic testing before prescription then over 50 drugs across multiple therapeutic areas arise.  Most importantly for current drug developers, these drugs represent a wide variety of market situations and with sufficient historical data to evaluate different commercialization strategies for the combination.  Included in these examples are drugs which were not initially launched with companion diagnostics but were required to implement companion diagnostics after they were on the market for a period of time.  The historical case studies demonstrate that companion diagnostics are neither a universal panacea nor an unmitigated disaster for drug developers but require an understanding of specific situations to det. the utility of companion diagnostics.  Numerous case studies highlight how companion diagnostics have been a boon to drug developers including Iressa, statins, Soriatane, Arthrotec, Promacta, Nplate, Letairis, and Tracleer.  Other examples provide lessons on how to avoid pitfalls such as Accutane, Ticlid, Tegretol, Ziagen, Actigall and Clozaril.  By carefully evaluating these case studies, drug developers can gain insight on the appropriate companion diagnostic strategy to implement for their specific situation and develop the elements of a successful companion diagnostic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruq7i3kgXksLVg90H21EOLACvtfcHk0lgViPE9ImMSfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KktbvM&md5=23e2857bb8d336884999ebfc4deea8d5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.nbt.2012.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbt.2012.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DA.%26atitle%3DDo%2520companion%2520diagnostics%2520make%2520economic%2520sense%2520for%2520drug%2520developers%253F%26jtitle%3DNew%2520Biotechnol.%26date%3D2012%26volume%3D29%26spage%3D695%26epage%3D708%26doi%3D10.1016%2Fj.nbt.2012.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Idee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louguet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corot, C.</span><span> </span><span class="NLM_article-title">Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint</span> <span class="citation_source-journal">Quant. Imaging Med. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.3978/j.issn.2223-4292.2013.12.06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3978%2Fj.issn.2223-4292.2013.12.06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24404442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2czjsVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=292-297&author=J.+M.+Ideeauthor=S.+Louguetauthor=S.+Balletauthor=C.+Corot&title=Theranostics+and+contrast-agents+for+medical+imaging%3A+a+pharmaceutical+company+viewpoint&doi=10.3978%2Fj.issn.2223-4292.2013.12.06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint</span></div><div class="casAuthors">Idee Jean-Marc; Louguet Stephanie; Ballet Sebastien; Corot Claire</div><div class="citationInfo"><span class="NLM_cas:title">Quantitative imaging in medicine and surgery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">292-7</span>
        ISSN:<span class="NLM_cas:issn">2223-4292</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQR362tXUKtAOR_TJajKxJDfW6udTcc2eboYZsR8Cor67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjsVygug%253D%253D&md5=d001890b95c0547f505ca8798e285764</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2223-4292.2013.12.06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2223-4292.2013.12.06%26sid%3Dliteratum%253Aachs%26aulast%3DIdee%26aufirst%3DJ.%2BM.%26aulast%3DLouguet%26aufirst%3DS.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DCorot%26aufirst%3DC.%26atitle%3DTheranostics%2520and%2520contrast-agents%2520for%2520medical%2520imaging%253A%2520a%2520pharmaceutical%2520company%2520viewpoint%26jtitle%3DQuant.%2520Imaging%2520Med.%2520Surg.%26date%3D2013%26volume%3D3%26spage%3D292%26epage%3D297%26doi%3D10.3978%2Fj.issn.2223-4292.2013.12.06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Jorgensen, J. T.</span><span> </span><span class="NLM_article-title">Companion diagnostics: the key to personalized medicine</span> <span class="citation_source-journal">Expert Rev. Mol. Diagn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1586/14737159.2015.1002470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1586%2F14737159.2015.1002470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25597758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=153-156&author=J.+T.+Jorgensen&title=Companion+diagnostics%3A+the+key+to+personalized+medicine&doi=10.1586%2F14737159.2015.1002470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Companion diagnostics: the key to personalized medicine</span></div><div class="casAuthors">Jorgensen, Jan Trost</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Molecular Diagnostics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-156</span>CODEN:
                <span class="NLM_cas:coden">ERMDCW</span>;
        ISSN:<span class="NLM_cas:issn">1473-7159</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This special focus issue of Expert Review of Mol. Diagnostics on in vitro companion diagnostics aims to provide the reader with up-to-date knowledge on this fast-evolving area of medical research.  Companion diagnostics takes up a central role in the development of targeted drugs and to a large extent, the success of this type of therapy depends on their performance.  Companion diagnostic assays have a single patient as a point of ref. and they will be decisive for the move toward a more precise and individualized pharmacotherapy.  The 'first generation' of companion diagnostic assays relies on single biomarker detection but with our increasing understanding of disease pathophysiol. a new generation of assays is under development, which will be based on patient profiling and multiplex platforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKMeLD5lxirbVg90H21EOLACvtfcHk0ljYDBXylq6-sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSitL4%253D&md5=42bf90287d2792494531438c45ac109c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1586%2F14737159.2015.1002470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737159.2015.1002470%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DJ.%2BT.%26atitle%3DCompanion%2520diagnostics%253A%2520the%2520key%2520to%2520personalized%2520medicine%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Diagn.%26date%3D2015%26volume%3D15%26spage%3D153%26epage%3D156%26doi%3D10.1586%2F14737159.2015.1002470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavedo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parnetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderstichele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herukka, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewczuk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeromin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsolaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarsland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinuevo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollenhauer, B.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1038/nrneurol.2014.232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnrneurol.2014.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25511894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKlsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=41-55&author=A.+Lleoauthor=E.+Cavedoauthor=L.+Parnettiauthor=H.+Vandersticheleauthor=S.+K.+Herukkaauthor=N.+Andreasenauthor=R.+Ghidoniauthor=P.+Lewczukauthor=A.+Jerominauthor=B.+Winbladauthor=M.+Tsolakiauthor=B.+Mroczkoauthor=P.+J.+Visserauthor=I.+Santanaauthor=P.+Svenningssonauthor=K.+Blennowauthor=D.+Aarslandauthor=J.+L.+Molinuevoauthor=H.+Zetterbergauthor=B.+Mollenhauer&title=Cerebrospinal+fluid+biomarkers+in+trials+for+Alzheimer+and+Parkinson+diseases&doi=10.1038%2Fnrneurol.2014.232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases</span></div><div class="casAuthors">Lleo, Alberto; Cavedo, Enrica; Parnetti, Lucilla; Vanderstichele, Hugo; Herukka, Sanna Kaisa; Andreasen, Niels; Ghidoni, Roberta; Lewczuk, Piotr; Jeromin, Andreas; Winblad, Bengt; Tsolaki, Magda; Mroczko, Barbara; Visser, Pieter Jelle; Santana, Isabel; Svenningsson, Per; Blennow, Kaj; Aarsland, Dag; Molinuevo, Jose Luis; Zetterberg, Henrik; Mollenhauer, Brit</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-55</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease (AD) and Parkinson disease (PD) are the most common neurodegenerative disorders.  For both diseases, early intervention is thought to be essential to the success of disease-modifying treatments.  Cerebrospinal fluid (CSF) can reflect some of the pathophysiol. changes that occur in the brain, and the no. of CSF biomarkers under investigation in neurodegenerative conditions has grown rapidly in the past 20 years.  In AD, CSF biomarkers are increasingly being used in clin. practice, and have been incorporated into the majority of clin. trials to demonstrate target engagement, to enrich or stratify patient groups, and to find evidence of disease modification.  In PD, CSF biomarkers have not yet reached the clinic, but are being studied in patients with parkinsonism, and are being used in clin. trials either to monitor progression or to demonstrate target engagement and downstream effects of drugs.  CSF biomarkers might also serve as surrogate markers of clin. benefit after a specific therapeutic intervention, although addnl. data are required.  It is anticipated that CSF biomarkers will have an important role in trials aimed at disease modification in the near future.  In this Review, we provide an overview of CSF biomarkers in AD and PD, and discuss their role in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowP6_zgSps8rVg90H21EOLACvtfcHk0ljYDBXylq6-sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKlsL7J&md5=9d9f24840016742c9a19b3d226411c32</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2014.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2014.232%26sid%3Dliteratum%253Aachs%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DCavedo%26aufirst%3DE.%26aulast%3DParnetti%26aufirst%3DL.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DHerukka%26aufirst%3DS.%2BK.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DGhidoni%26aufirst%3DR.%26aulast%3DLewczuk%26aufirst%3DP.%26aulast%3DJeromin%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DTsolaki%26aufirst%3DM.%26aulast%3DMroczko%26aufirst%3DB.%26aulast%3DVisser%26aufirst%3DP.%2BJ.%26aulast%3DSantana%26aufirst%3DI.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DAarsland%26aufirst%3DD.%26aulast%3DMolinuevo%26aufirst%3DJ.%2BL.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DMollenhauer%26aufirst%3DB.%26atitle%3DCerebrospinal%2520fluid%2520biomarkers%2520in%2520trials%2520for%2520Alzheimer%2520and%2520Parkinson%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2015%26volume%3D11%26spage%3D41%26epage%3D55%26doi%3D10.1038%2Fnrneurol.2014.232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ritter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span> </span><span class="NLM_article-title">Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">Front. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.3389/fneur.2015.00186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3389%2Ffneur.2015.00186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25699006" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-14&author=A.+Ritterauthor=J.+Cummings&title=Fluid+biomarkers+in+clinical+trials+of+Alzheimer%E2%80%99s+disease+therapeutics&doi=10.3389%2Ffneur.2015.00186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3389%2Ffneur.2015.00186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffneur.2015.00186%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DCummings%26aufirst%3DJ.%26atitle%3DFluid%2520biomarkers%2520in%2520clinical%2520trials%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DFront.%2520Neurol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D14%26doi%3D10.3389%2Ffneur.2015.00186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>A study of gantenerumab in patients with mild Alzheimer disease. <a href="https://clinicaltrials.gov/ct2/show/NCT02051608" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02051608</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+study+of+gantenerumab+in+patients+with+mild+Alzheimer+disease.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02051608+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span>Progress of mild Alzheimer’s disease in participants on solanezumab versus placebo (EXPEDITION 3). <a href="https://clinicaltrials.gov/ct2/show/NCT01900665?term=Eli+Lilly+and+Alzheimer&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01900665?term=Eli+Lilly+and+Alzheimer&rank=1</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Progress+of+mild+Alzheimer%E2%80%99s+disease+in+participants+on+solanezumab+versus+placebo+%28EXPEDITION+3%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01900665%3Fterm%3DEli%2BLilly%2Band%2BAlzheimer%26rank%3D1+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span>Alzforum therapeutics: gantenerumab. <a href="http://www.alzforum.org/therapeutics/gantenerumab" class="extLink">http://www.alzforum.org/therapeutics/gantenerumab</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzforum+therapeutics%3A+gantenerumab.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fgantenerumab+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>Q&A with Roche’s CNS leader Luca Santarelli. <a href="http://www.alzforum.org/news/conference-coverage/qa-roches-cns-leader-luca-santarelli" class="extLink">http://www.alzforum.org/news/conference-coverage/qa-roches-cns-leader-luca-santarelli</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Q%26A+with+Roche%E2%80%99s+CNS+leader+Luca+Santarelli.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fconference-coverage%2Fqa-roches-cns-leader-luca-santarelli+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Hollmer, M.</span><span> </span><span class="NLM_article-title">Eisai to deploy GE’s Alzheimer’s imaging agent for clinical trial screening</span>. <a href="http://www.fiercemedicaldevices.com/story/eisai-deploy-ges-alzheimers-imaging-agent-clinical-trial-screening/2013-04-24" class="extLink">http://www.fiercemedicaldevices.com/story/eisai-deploy-ges-alzheimers-imaging-agent-clinical-trial-screening/2013-04-24</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Hollmer&title=Eisai+to+deploy+GE%E2%80%99s+Alzheimer%E2%80%99s+imaging+agent+for+clinical+trial+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DHollmer%26aufirst%3DM.%26atitle%3DEisai%2520to%2520deploy%2520GE%25E2%2580%2599s%2520Alzheimer%25E2%2580%2599s%2520imaging%2520agent%2520for%2520clinical%2520trial%2520screening%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Stamford, A.</span><span> </span><span class="NLM_article-title">Discovery of MK-8931 (verubecestat) as a disease modifying treatment for Alzheimer’s disease</span>. <a href="http://www.bionomics.com.au/upload/research-development/poster-presentations-publications/cns-poster-presentations/Andy-Stamford_Bionomics_Merck.pdf" class="extLink">http://www.bionomics.com.au/upload/research-development/poster-presentations-publications/cns-poster-presentations/Andy-Stamford_Bionomics_Merck.pdf</a> (accessed Apr 7,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Stamford&title=Discovery+of+MK-8931+%28verubecestat%29+as+a+disease+modifying+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520MK-8931%2520%2528verubecestat%2529%2520as%2520a%2520disease%2520modifying%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span>Efficacy and safety trial of verubecestat (MK-8931) in participants with prodromal Alzheimer’s disease (MK-8931-019) (APECS). <a href="https://http://www.clinicaltrials.gov/ct2/show/NCT01953601?term=mk-8931&amp;rank=3" class="extLink">https://http://www.clinicaltrials.gov/ct2/show/NCT01953601?term=mk-8931&rank=3</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Efficacy+and+safety+trial+of+verubecestat+%28MK-8931%29+in+participants+with+prodromal+Alzheimer%E2%80%99s+disease+%28MK-8931-019%29+%28APECS%29.+https%3A%2F%2Fhttp%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01953601%3Fterm%3Dmk-8931%26rank%3D3+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span> </span><span class="NLM_article-title">Merck and Luminex corporation enter agreement to develop companion diagnostic to support investigational BACE inhibitor clinical development program for Alzheimer’s disease</span>. <a href="http://www.merck.com/licensing/our-partnership/luminex-partnership.html" class="extLink">http://www.merck.com/licensing/our-partnership/luminex-partnership.html</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+and+Luminex+corporation+enter+agreement+to+develop+companion+diagnostic+to+support+investigational+BACE+inhibitor+clinical+development+program+for+Alzheimer%E2%80%99s+disease.+http%3A%2F%2Fwww.merck.com%2Flicensing%2Four-partnership%2Fluminex-partnership.html+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DMerck%2520and%2520Luminex%2520corporation%2520enter%2520agreement%2520to%2520develop%2520companion%2520diagnostic%2520to%2520support%2520investigational%2520BACE%2520inhibitor%2520clinical%2520development%2520program%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="refDoi"> DOI: 10.1186/s13195-014-0089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1186%2Fs13195-014-0089-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25621019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=89&author=R.+Vassar&title=BACE1+inhibitor+drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13195-014-0089-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitor drugs in clinical trials for Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">89/1-89/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the prodn. of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiol. of Alzheimer's disease (AD).  As a result, BACE1 has emerged as a prime drug target for reducing the levels of Aβ in the AD brain, and the development of BACE1 inhibitors as therapeutic agents is being vigorously pursued.  It has proven difficult for the pharmaceutical industry to design BACE1 inhibitor drugs that pass the blood-brain barrier, however this challenge has recently been met and BACE1 inhibitors are now in human clin. trials to test for safety and efficacy in AD patients and individuals with pre-symptomatic AD.  Initial results suggest that some of these BACE1 inhibitor drugs are well tolerated, although others have dropped out because of toxicity and it is still too early to know whether any will be effective for the prevention or treatment of AD.  Addnl., based on newly identified BACE1 substrates and phenotypes of mice that lack BACE1, concerns have emerged about potential mechanism-based side effects of BACE1 inhibitor drugs with chronic administration.  It is hoped that a therapeutic window can be achieved that balances safety and efficacy.  This review summarizes the current state of progress in the development of BACE1 inhibitor drugs and the evaluation of their therapeutic potential for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-BPlLZzu7rVg90H21EOLACvtfcHk0liZ4Y0BWtPSfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D&md5=a9ec66c8f0254986406323efa56c6f5a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Fs13195-014-0089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-014-0089-7%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitor%2520drugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D89%26doi%3D10.1186%2Fs13195-014-0089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C. Z.</span><span> </span><span class="NLM_article-title">Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">9734</span><span class="NLM_x">–</span> <span class="NLM_lpage">9739</span><span class="refDoi"> DOI: 10.1073/pnas.1505420112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1073%2Fpnas.1505420112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26199414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2ku73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=9734-9739&author=X.+L.+Zhangauthor=Y.+L.+Tianauthor=C.+Zhangauthor=X.+Y.+Tianauthor=A.+W.+Rossauthor=R.+D.+Moirauthor=H.+B.+Sunauthor=R.+E.+Tanziauthor=A.+Mooreauthor=C.+Z.+Ran&title=Near-infrared+fluorescence+molecular+imaging+of+amyloid+beta+species+and+monitoring+therapy+in+animal+models+of+Alzheimer%E2%80%99s+disease&doi=10.1073%2Fpnas.1505420112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease</span></div><div class="casAuthors">Zhang, Xueli; Tian, Yanli; Zhang, Can; Tian, Xiaoyu; Ross, Alana W.; Moir, Robert D.; Sun, Hongbin; Tanzi, Rudolph E.; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9734-9739</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Near-IR fluorescence (NIRF) mol. imaging has been widely applied to monitoring therapy of cancer and other diseases in preclin. studies; however, this technol. has not been applied successfully to monitoring therapy for Alzheimer's disease (AD).  Although several NIRF probes for detecting amyloid beta (Aβ) species of AD have been reported, none of these probes has been used to monitor changes of Aβs during therapy.  In this article, we demonstrated that CRANAD-3, a curcumin analog, is capable of detecting both sol. and insol. Aβ species.  In vivo imaging showed that the NIRF signal of CRANAD-3 from 4-mo-old transgenic AD (APP/PS1) mice was 2.29-fold higher than that from age-matched wild-type mice, indicating that CRANAD-3 is capable of detecting early mol. pathol.  To verify the feasibility of CRANAD-3 for monitoring therapy, we first used the fast Aβ-lowering drug LY2811376, a well-characterized beta-amyloid cleaving enzyme-1 inhibitor, to treat APP/PS1 mice.  Imaging data suggested that CRANAD-3 could monitor the decrease in Aβs after drug treatment.  To validate the imaging capacity of CRANAD-3 further, we used it to monitor the therapeutic effect of CRANAD-17, a curcumin analog for inhibition of Aβ crosslinking.  The imaging data indicated that the fluorescence signal in the CRANAD-17-treated group was significantly lower than that in the control group, and the result correlated with ELISA anal. of brain extn. and Aβ plaque counting.  It was the first time, to our knowledge, that NIRF was used to monitor AD therapy, and we believe that our imaging technol. has the potential to have a high impact on AD drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLMElOHab2pbVg90H21EOLACvtfcHk0liZ4Y0BWtPSfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2ku73K&md5=c516dfe9c5930906a995c8cd5917f797</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1505420112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1505420112%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DTian%26aufirst%3DY.%2BL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DX.%2BY.%26aulast%3DRoss%26aufirst%3DA.%2BW.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BB.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%2BZ.%26atitle%3DNear-infrared%2520fluorescence%2520molecular%2520imaging%2520of%2520amyloid%2520beta%2520species%2520and%2520monitoring%2520therapy%2520in%2520animal%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D9734%26epage%3D9739%26doi%3D10.1073%2Fpnas.1505420112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medarova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">15257</span><span class="NLM_x">–</span> <span class="NLM_lpage">15261</span><span class="refDoi"> DOI: 10.1021/ja9047043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9047043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=15257-15261&author=C.+Ranauthor=X.+Xuauthor=S.+B.+Raymondauthor=B.+J.+Ferraraauthor=K.+Nealauthor=B.+J.+Bacskaiauthor=Z.+Medarovaauthor=A.+Moore&title=Design%2C+synthesis%2C+and+testing+of+difluoroboron-derivatized+curcumins+as+near-infrared+probes+for+in+vivo+detection+of+amyloid-beta+deposits&doi=10.1021%2Fja9047043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-β Deposits</span></div><div class="casAuthors">Ran, Chongzhao; Xu, Xiaoyin; Raymond, Scott B.; Ferrara, Brian J.; Neal, Krista; Bacskai, Brian J.; Medarova, Zdravka; Moore, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15257-15261</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) deposits have been identified as key players in the progression of Alzheimer's disease (AD).  Recent evidence indicates that the deposits probably precede and induce the neuronal atrophy.  Therefore, methods that enable monitoring the pathol. before clin. symptoms are obsd. would be beneficial for early AD detection.  Here, we report the design, synthesis, and testing of a curcumin-derivatized near-IR (NIR) probe, CRANAD-2.  Upon interacting with Aβ aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield.  Moreover, this probe also shows a high affinity for Aβ aggregates (Kd = 38.0 nM), a reasonable log P value (log P = 3), considerable stability in serum, and a weak interaction with albumin.  After i.v. injection of this probe, 19-mo-old Tg2576 mice exhibited significantly higher relative signal than that of the control mice over the same period of time.  In summary, CRANAD-2 meets all the requirements for a NIR contrast agent for the detection of Aβ plaques both in vitro and in vivo.  Our data point toward the feasibility of monitoring the progress of the disease by NIR imaging with CRANAD-2.  In addn., we believe that our probe could be potentially used as a tool for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVaezLehHv7Vg90H21EOLACvtfcHk0liDLPBI62mwYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artbfN&md5=e9c1f3cadd72bb69697404536ee66b16</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja9047043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9047043%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DRaymond%26aufirst%3DS.%2BB.%26aulast%3DFerrara%26aufirst%3DB.%2BJ.%26aulast%3DNeal%26aufirst%3DK.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DMedarova%26aufirst%3DZ.%26aulast%3DMoore%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520testing%2520of%2520difluoroboron-derivatized%2520curcumins%2520as%2520near-infrared%2520probes%2520for%2520in%2520vivo%2520detection%2520of%2520amyloid-beta%2520deposits%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D15257%26epage%3D15261%26doi%3D10.1021%2Fja9047043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C.</span><span> </span><span class="NLM_article-title">Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer’s disease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">16397</span><span class="NLM_x">–</span> <span class="NLM_lpage">16409</span><span class="refDoi"> DOI: 10.1021/ja405239v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405239v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Sqs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=16397-16409&author=X.+Zhangauthor=Y.+Tianauthor=Z.+Liauthor=X.+Tianauthor=H.+Sunauthor=H.+Liuauthor=A.+Mooreauthor=C.+Ran&title=Design+and+synthesis+of+curcumin+analogues+for+in+vivo+fluorescence+imaging+and+inhibiting+copper-induced+cross-linking+of+amyloid+beta+species+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fja405239v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer's Disease</span></div><div class="casAuthors">Zhang, Xueli; Tian, Yanli; Li, Zeng; Tian, Xiaoyu; Sun, Hongbin; Liu, Hong; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">16397-16409</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this article, the authors first designed and synthesized curcumin-based near-IR (NIR) fluorescence imaging probes for detecting both sol. and insol. amyloid beta (Aβ) species and then an inhibitor that could attenuate crosslinking of Aβ induced by copper.  According to the authors' previous results and the possible structural stereohindrance compatibility of the Aβ peptide and the hydrophobic/hydrophilic property of the Aβ13-20 (HHQKLVFF) fragment, NIR imaging probe CRANAD-58 was designed and synthesized.  As expected CRANAD-58 showed significant fluorescence property changes upon mixing with both sol. and insol. Aβ species in vitro.  In vivo NIR imaging revealed that CRANAD-58 was capable of differentiating transgenic and wild-type mice as young as 4 mo old, the age that lacks apparently visible Aβ plaques and Aβ is likely in its sol. forms.  According to the authors' limited studies on the interaction mechanism between CRANAD-58 and Aβ, the authors also designed CRANAD-17 to attenuate the crosslinking of Aβ42 induced by copper.  It is well-known that the coordination of copper with imidazoles on Histidine-13 and 14 (H13, H14) of Aβ peptides could initialize covalent crosslinking of Aβ.  In CRANAD-17, a curcumin scaffold was used as an anchoring moiety to usher the designed compd. to the vicinity of H13 and H14 of Aβ, and imidazole rings were incorporated to compete with H13/H14 for copper binding.  The results of SDS-PAGE gel and Western blot indicated that CRANAD-17 was capable of inhibiting Aβ42 crosslinking induced by copper.  This raises a potential for CRANAD-17 to be considered for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzVMWcgO7gBbVg90H21EOLACvtfcHk0liDLPBI62mwYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Sqs7bM&md5=a247779a9ee595e81bef7b43861ecbd7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja405239v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405239v%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520curcumin%2520analogues%2520for%2520in%2520vivo%2520fluorescence%2520imaging%2520and%2520inhibiting%2520copper-induced%2520cross-linking%2520of%2520amyloid%2520beta%2520species%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D16397%26epage%3D16409%26doi%3D10.1021%2Fja405239v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kelkar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reineke, T. M.</span><span> </span><span class="NLM_article-title">Theranostics: combining imaging and therapy</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span><span class="refDoi"> DOI: 10.1021/bc200151q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200151q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2jt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1879-1903&author=S.+S.+Kelkarauthor=T.+M.+Reineke&title=Theranostics%3A+combining+imaging+and+therapy&doi=10.1021%2Fbc200151q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostics: Combining Imaging and Therapy</span></div><div class="casAuthors">Kelkar, Sneha S.; Reineke, Theresa M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1879-1903</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Employing theranostic nanoparticles, which combine both therapeutic and diagnostic capabilities in one dose, has promise to propel the biomedical field toward personalized medicine.  This review presents an overview of different theranostic strategies developed for the diagnosis and treatment of disease, with an emphasis on cancer.  Herein, therapeutic strategies such as nucleic acid delivery, chemotherapy, hyperthermia (photothermal ablation), photodynamic, and radiation therapy are combined with one or more imaging functionalities for both in vitro and in vivo studies.  Different imaging probes, such as MRI contrast agents (T1 and T2 agents), fluorescent markers (org. dyes and inorg. quantum dots), and nuclear imaging agents (PET/SPECT agents), can be decorated onto therapeutic agents or therapeutic delivery vehicles in order to facilitate their imaging and, in so doing, gain information about the trafficking pathway, kinetics of delivery, and therapeutic efficacy; several such strategies are outlined.  The creative approaches being developed for these classes of therapies and imaging modalities are discussed, and the recent developments in this field along with examples of technologies that hold promise for the future of cancer medicine are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjaSl-ko7EubVg90H21EOLACvtfcHk0li5ty9Htjl3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2jt77K&md5=54add18153e2ad4c9c2aa30ba97dbc6d</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbc200151q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200151q%26sid%3Dliteratum%253Aachs%26aulast%3DKelkar%26aufirst%3DS.%2BS.%26aulast%3DReineke%26aufirst%3DT.%2BM.%26atitle%3DTheranostics%253A%2520combining%2520imaging%2520and%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D1879%26epage%3D1903%26doi%3D10.1021%2Fbc200151q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Chen, X. S.</span><span> </span><span class="NLM_article-title">Introducing Theranostics Journal - From the Editor-in-Chief</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">2</span><span class="refDoi"> DOI: 10.7150/thno/v01p0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.7150%2Fthno%2Fv01p0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=1-2&author=X.+S.+Chen&title=Introducing+Theranostics+Journal+-+From+the+Editor-in-Chief&doi=10.7150%2Fthno%2Fv01p0001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.7150%2Fthno%2Fv01p0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno%252Fv01p0001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%2BS.%26atitle%3DIntroducing%2520Theranostics%2520Journal%2520-%2520From%2520the%2520Editor-in-Chief%26jtitle%3DTheranostics%26date%3D2011%26volume%3D1%26spage%3D1%26epage%3D2%26doi%3D10.7150%2Fthno%2Fv01p0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Kojima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fussenegger, M.</span><span> </span><span class="NLM_article-title">Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2015.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.cbpa.2015.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26056952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=29-38&author=R.+Kojimaauthor=D.+Aubelauthor=M.+Fussenegger&title=Novel+theranostic+agents+for+next-generation+personalized+medicine%3A+small+molecules%2C+nanoparticles%2C+and+engineered+mammalian+cells&doi=10.1016%2Fj.cbpa.2015.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells</span></div><div class="casAuthors">Kojima, Ryosuke; Aubel, Dominique; Fussenegger, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Modern medicine is currently undergoing a paradigm shift from conventional disease treatments based on the diagnosis of a generalized disease state to a more personalized, customized treatment model based on mol.-level diagnosis.  This uses novel biosensors that can precisely ext. disease-related information from complex biol. systems.  Moreover, with the recent progress in chem. biol., materials science, and synthetic biol., it has become possible to simultaneously conduct diagnosis and targeted therapy (theranostics/theragnosis) by directly connecting the readout of a biosensor to a therapeutic output.  These advances pave the way for more advanced and better personalized treatment for intractable diseases with fewer side effects.  In this review, we describe recent advances in the development of cutting-edge theranostic agents that contain both diagnostic and therapeutic functions in a single integrated system.  By comparing the advantages and disadvantages of each modality, we discuss the future challenges and prospects of developing ideal theranostic agents for the next generation of personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXkVvWAJyRcrVg90H21EOLACvtfcHk0li5ty9Htjl3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL3E&md5=d6bfef7d34cb2ea39069872b19438dcc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2015.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2015.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DKojima%26aufirst%3DR.%26aulast%3DAubel%26aufirst%3DD.%26aulast%3DFussenegger%26aufirst%3DM.%26atitle%3DNovel%2520theranostic%2520agents%2520for%2520next-generation%2520personalized%2520medicine%253A%2520small%2520molecules%252C%2520nanoparticles%252C%2520and%2520engineered%2520mammalian%2520cells%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D28%26spage%3D29%26epage%3D38%26doi%3D10.1016%2Fj.cbpa.2015.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Aulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legname, G.</span><span> </span><span class="NLM_article-title">Small-molecule theranostic probes: a promising future in neurodegenerative diseases</span> <span class="citation_source-journal">Int. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">150952</span><span class="refDoi"> DOI: 10.1155/2013/150952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1155%2F2013%2F150952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24324497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2cflsVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=150952&author=S.+Aulicauthor=M.+L.+Bolognesiauthor=G.+Legname&title=Small-molecule+theranostic+probes%3A+a+promising+future+in+neurodegenerative+diseases&doi=10.1155%2F2013%2F150952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule theranostic probes: a promising future in neurodegenerative diseases</span></div><div class="casAuthors">Aulic Suzana; Bolognesi Maria Laura; Legname Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cell biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">150952</span>
        ISSN:<span class="NLM_cas:issn">1687-8876</span>.
    </div><div class="casAbstract">Prion diseases are fatal neurodegenerative illnesses, which include Creutzfeldt-Jakob disease in humans and scrapie, chronic wasting disease, and bovine spongiform encephalopathy in animals.  They are caused by unconventional infectious agents consisting primarily of misfolded, aggregated, β -sheet-rich isoforms, denoted prions, of the physiological cellular prion protein (PrP(C)).  Many lines of evidence suggest that prions (PrP(Sc)) act both as a template for this conversion and as a neurotoxic agent causing neuronal dysfunction and cell death.  As such, PrP(Sc) may be considered as both a neuropathological hallmark of the disease and a therapeutic target.  Several diagnostic imaging probes have been developed to monitor cerebral amyloid lesions in patients with neurodegenerative disorders (such as Alzheimer's disease, Parkinson's disease, and prion disease).  Examples of these probes are Congo red, thioflavin T, and their derivatives.  We synthesized a series of styryl derivatives, denoted theranostics, and studied their therapeutic and/or diagnostic potentials.  Here we review the salient traits of these small molecules that are able to detect and modulate aggregated forms of several proteins involved in protein misfolding diseases.  We then highlight the importance of further studies for their practical implications in therapy and diagnostics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJvBOhVCPyOOQ4Pl9hzjQhfW6udTcc2eaFlf9gJ4UnP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflsVejug%253D%253D&md5=b664149988ab2f7eab71c2e662b8f332</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1155%2F2013%2F150952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F150952%26sid%3Dliteratum%253Aachs%26aulast%3DAulic%26aufirst%3DS.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DLegname%26aufirst%3DG.%26atitle%3DSmall-molecule%2520theranostic%2520probes%253A%2520a%2520promising%2520future%2520in%2520neurodegenerative%2520diseases%26jtitle%3DInt.%2520J.%2520Cell%2520Biol.%26date%3D2013%26volume%3D2013%26spage%3D150952%26doi%3D10.1155%2F2013%2F150952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Bongarzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staderini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.4155/fmc.14.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.4155%2Ffmc.14.56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25068985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wqt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1017-1029&author=S.+Bongarzoneauthor=M.+Staderiniauthor=M.+L.+Bolognesi&title=Multitarget+ligands+and+theranostics%3A+sharpening+the+medicinal+chemistry+sword+against+prion+diseases&doi=10.4155%2Ffmc.14.56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases</span></div><div class="casAuthors">Bongarzone, Salvatore; Staderini, Matteo; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Prion diseases (PrDs) are fatal neurodegenerative disorders, for which no effective therapeutic and diagnostic tools exist.  The main pathogenic event has been identified as the misfolding of a disease-assocd. prion protein.  Nevertheless, pathogenesis seems to involve an intricate array of concomitant processes.  Thus, it may be unlikely that drugs acting on single targets can effectively control PrDs.  In addn., diagnosis occurs late in the disease process, by which point it is difficult to det. a successful therapeutic intervention.  In this context, multitarget ligands (MTLs) and theranostic ligands (TLs) emerge for their potential to effectively cure and diagnose PrDs.  In this review, we discuss the medicinal chem. challenges of identifying novel MTLs and TLs against PrDs, and envision their impact on prion drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgXqRu40_tbrVg90H21EOLACvtfcHk0lhF2if5_98GoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wqt7zI&md5=5afe39afa704e7324d694dc154124293</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.56%26sid%3Dliteratum%253Aachs%26aulast%3DBongarzone%26aufirst%3DS.%26aulast%3DStaderini%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DMultitarget%2520ligands%2520and%2520theranostics%253A%2520sharpening%2520the%2520medicinal%2520chemistry%2520sword%2520against%2520prion%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1017%26epage%3D1029%26doi%3D10.4155%2Ffmc.14.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Prati, F.; Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Tackling neurodegeneration with multi-target and theranostic small molecules</span>. In  <span class="citation_source-book">2015 Medicinal Chemistry Reviews</span>; <span class="NLM_contrib-group">Manoj, C. D.</span>, Ed.; <span class="NLM_publisher-name">ACS Division of Medicinal Chemistry</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">50</span>, Chapter 13, pp  <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=347-356&author=F.+Prati&author=M.+L.+Bolognesiauthor=C.+D.+Manoj&title=2015+Medicinal+Chemistry+Reviews"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26atitle%3DTackling%2520neurodegeneration%2520with%2520multi-target%2520and%2520theranostic%2520small%2520molecules%26btitle%3D2015%2520Medicinal%2520Chemistry%2520Reviews%26aulast%3DManoj%26aufirst%3DC.%2BD.%26pub%3DACS%2520Division%2520of%2520Medicinal%2520Chemistry%26date%3D2015%26volume%3D50%26spage%3D347%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Sumer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span> </span><span class="NLM_article-title">Theranostic nanomedicine for cancer</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.2217/17435889.3.2.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2217%2F17435889.3.2.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=18373419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BD1c3hvVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=137-140&author=B.+Sumerauthor=J.+Gao&title=Theranostic+nanomedicine+for+cancer&doi=10.2217%2F17435889.3.2.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic nanomedicine for cancer</span></div><div class="casAuthors">Sumer Baran; Gao Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, England)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS69fXHoqo4FhLDWw4HIq2sfW6udTcc2ea4A92M7IOq-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3hvVCqtw%253D%253D&md5=7f8a40ef7881a2aad40d944e6206ba09</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2217%2F17435889.3.2.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17435889.3.2.137%26sid%3Dliteratum%253Aachs%26aulast%3DSumer%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DTheranostic%2520nanomedicine%2520for%2520cancer%26jtitle%3DNanomedicine%26date%3D2008%26volume%3D3%26spage%3D137%26epage%3D140%26doi%3D10.2217%2F17435889.3.2.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Lammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aime, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennink, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, F.</span><span> </span><span class="NLM_article-title">Theranostic nanomedicine</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span><span class="refDoi"> DOI: 10.1021/ar200019c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar200019c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsF2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1029-1038&author=T.+Lammersauthor=S.+Aimeauthor=W.+E.+Henninkauthor=G.+Stormauthor=F.+Kiessling&title=Theranostic+nanomedicine&doi=10.1021%2Far200019c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Nanomedicines</span></div><div class="casAuthors">Lammers, Twan; Aime, Silvio; Hennink, Wim E.; Storm, Gert; Kiessling, Fabian</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1029-1038</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Nanomedicine formulations aim to improve the biodistribution and the target site accumulation of systemically administered (chemo)therapeutic agents.  Many different types of nanomedicines were evaluated over the years, including for instance liposomes, polymers, micelles and antibodies, and a significant amt. of evidence was obtained showing that these submicrometer-sized carrier materials are able to improve the balance between the efficacy and the toxicity of therapeutic interventions.  Besides for therapeutic purposes, nanomedicine formulations have in recent years also been increasingly employed for imaging applications.  Moreover, paralleled by advances in chem., biol., pharmacy, nanotechnol., medicine and imaging, several different systems were developed in the last decade in which disease diagnosis and therapy are combined.  These so-called (nano) theranostics contain both a drug and an imaging agent within a single formulation, and they can be used for various different purposes.  In this Account, the authors summarize several exemplary efforts in this regard, and the authors show that theranostic nanomedicines are highly suitable systems for monitoring drug delivery, drug release and drug efficacy.  The (pre)clin. most relevant applications of theranostic nanomedicines relate to their use for validating and optimizing the properties of drug delivery systems, and to their ability to be used for pre-screening patients and enabling personalized medicine.  Regarding the former, the combination of diagnostic and therapeutic agents within a single formulation provides real-time feedback on the pharmacokinetics, the target site localization and the (off-target) healthy organ accumulation of nanomedicines.  Various examples of this will be highlighted in this Account, illustrating that by non-invasively visualizing how well carrier materials are able to deliver pharmacol. active agents to the pathol. site, and how well they are able to prevent them from accumulating in potentially endangered healthy tissues, important information can be obtained for optimizing the basic properties of drug delivery systems, as well as for improving the balance between the efficacy and the toxicity of targeted therapeutic interventions.  Regarding personalized medicine, it can be reasoned that only in patients which show high levels of target site accumulation, and which respond well to the first couple of treatment cycles, targeted therapy should be continued, and that in those in which this is not the case, other therapeutic options should be considered.  Based on these insights, the authors expect that ever more efforts will be invested in developing theranostic nanomedicines, and that these systems and strategies will contribute substantially to realizing the potential of personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYgcECdOPk7Vg90H21EOLACvtfcHk0lheCWLMEcot4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsF2jsrk%253D&md5=4334d64042d373a73c4a59d6ad1e181b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Far200019c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far200019c%26sid%3Dliteratum%253Aachs%26aulast%3DLammers%26aufirst%3DT.%26aulast%3DAime%26aufirst%3DS.%26aulast%3DHennink%26aufirst%3DW.%2BE.%26aulast%3DStorm%26aufirst%3DG.%26aulast%3DKiessling%26aufirst%3DF.%26atitle%3DTheranostic%2520nanomedicine%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2011%26volume%3D44%26spage%3D1029%26epage%3D1038%26doi%3D10.1021%2Far200019c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Kunjachan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, T.</span><span> </span><span class="NLM_article-title">Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">10907</span><span class="NLM_x">–</span> <span class="NLM_lpage">10937</span><span class="refDoi"> DOI: 10.1021/cr500314d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500314d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=10907-10937&author=S.+Kunjachanauthor=J.+Ehlingauthor=G.+Stormauthor=F.+Kiesslingauthor=T.+Lammers&title=Noninvasive+imaging+of+nanomedicines+and+nanotheranostics%3A+principles%2C+progress%2C+and+prospects&doi=10.1021%2Fcr500314d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects</span></div><div class="casAuthors">Kunjachan, Sijumon; Ehling, Josef; Storm, Gert; Kiessling, Fabian; Lammers, Twan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10907-10937</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the most important applications of noninvasive imaging techniques such as PET, SPECT, CT, MRI, OI and US in the use of nanomedicines and nanotheranostics (e.g., liposomes, polymers, micelles, dendrimers, nanoparticles, antibodies) for facilitating disease diagnosis, disease treatment, and treatment monitoring, including drug delivery research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc0xfnWIO7yLVg90H21EOLACvtfcHk0lheCWLMEcot4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhsbrO&md5=49745089d09f174e7b80c6a48bb4ebb7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fcr500314d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500314d%26sid%3Dliteratum%253Aachs%26aulast%3DKunjachan%26aufirst%3DS.%26aulast%3DEhling%26aufirst%3DJ.%26aulast%3DStorm%26aufirst%3DG.%26aulast%3DKiessling%26aufirst%3DF.%26aulast%3DLammers%26aufirst%3DT.%26atitle%3DNoninvasive%2520imaging%2520of%2520nanomedicines%2520and%2520nanotheranostics%253A%2520principles%252C%2520progress%252C%2520and%2520prospects%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D10907%26epage%3D10937%26doi%3D10.1021%2Fcr500314d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Tosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandelli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruozi, B.</span><span> </span><span class="NLM_article-title">Nanomedicine and neurodegenerative disorders: so close yet so far</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1517/17425247.2015.1041374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1517%2F17425247.2015.1041374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1041-1044&author=G.+Tosiauthor=M.+A.+Vandelliauthor=F.+Forniauthor=B.+Ruozi&title=Nanomedicine+and+neurodegenerative+disorders%3A+so+close+yet+so+far&doi=10.1517%2F17425247.2015.1041374"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1517%2F17425247.2015.1041374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2015.1041374%26sid%3Dliteratum%253Aachs%26aulast%3DTosi%26aufirst%3DG.%26aulast%3DVandelli%26aufirst%3DM.%2BA.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DRuozi%26aufirst%3DB.%26atitle%3DNanomedicine%2520and%2520neurodegenerative%2520disorders%253A%2520so%2520close%2520yet%2520so%2520far%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2015%26volume%3D12%26spage%3D1041%26epage%3D1044%26doi%3D10.1517%2F17425247.2015.1041374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Brambilla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Droumaguet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashemi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghimi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvreur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieux, K.</span><span> </span><span class="NLM_article-title">Nanotechnologies for Alzheimer’s disease: diagnosis, therapy, and safety issues</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span><span class="refDoi"> DOI: 10.1016/j.nano.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.nano.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=21477665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=521-540&author=D.+Brambillaauthor=B.+Le+Droumaguetauthor=J.+Nicolasauthor=S.+H.+Hashemiauthor=L.+P.+Wuauthor=S.+M.+Moghimiauthor=P.+Couvreurauthor=K.+Andrieux&title=Nanotechnologies+for+Alzheimer%E2%80%99s+disease%3A+diagnosis%2C+therapy%2C+and+safety+issues&doi=10.1016%2Fj.nano.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues</span></div><div class="casAuthors">Brambilla, Davide; Le Droumaguet, Benjamin; Nicolas, Julien; Hashemi, S. Hossein; Wu, Lin-Ping; Moghimi, S. Moein; Couvreur, Patrick; Andrieux, Karine</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (Philadelphia, PA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">521-540</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) represents the most common form of dementia worldwide, affecting more than 35 million people.  Advances in nanotechnol. are beginning to exert a significant impact in neurol.  These approaches, which are often based on the design and engineering of a plethora of nanoparticulate entities with high specificity for brain capillary endothelial cells, are currently being applied to early AD diagnosis and treatment.  In addn., nanoparticles (NPs) with high affinity for the circulating amyloid-β (Aβ) forms may induce "sink effect" and improve the AD condition.  There are also developments in relation to in vitro diagnostics for AD, including ultrasensitive NP-based bio-barcodes, immunosensors, as well as scanning tunneling microscopy procedures capable of detecting Aβ1-40 and Aβ1-42.  However, there are concerns regarding the initiation of possible NP-mediated adverse events in AD, thus demanding the use of precisely assembled nanoconstructs from biocompatible materials.  Key advances and safety issues are reviewed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphirzpnSLDnbVg90H21EOLACvtfcHk0lheCWLMEcot4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLrM&md5=d03b38defb88c094343e1b2f802c05b7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBrambilla%26aufirst%3DD.%26aulast%3DLe%2BDroumaguet%26aufirst%3DB.%26aulast%3DNicolas%26aufirst%3DJ.%26aulast%3DHashemi%26aufirst%3DS.%2BH.%26aulast%3DWu%26aufirst%3DL.%2BP.%26aulast%3DMoghimi%26aufirst%3DS.%2BM.%26aulast%3DCouvreur%26aufirst%3DP.%26aulast%3DAndrieux%26aufirst%3DK.%26atitle%3DNanotechnologies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520diagnosis%252C%2520therapy%252C%2520and%2520safety%2520issues%26jtitle%3DNanomedicine%26date%3D2011%26volume%3D7%26spage%3D521%26epage%3D540%26doi%3D10.1016%2Fj.nano.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Laurent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ejtehadi, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehoe, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, M.</span><span> </span><span class="NLM_article-title">Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer’s disease</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">5008</span><span class="NLM_x">–</span> <span class="NLM_lpage">5033</span><span class="refDoi"> DOI: 10.1039/c2ra01374f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2Fc2ra01374f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=5008-5033&author=S.+Laurentauthor=M.+R.+Ejtehadiauthor=M.+Rezaeiauthor=P.+G.+Kehoeauthor=M.+Mahmoudi&title=Interdisciplinary+challenges+and+promising+theranostic+effects+of+nanoscience+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc2ra01374f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease</span></div><div class="casAuthors">Laurent, Sophie; Ejtehadi, Mohammad Reza; Rezaei, Meisam; Kehoe, Patrick G.; Mahmoudi, Morteza</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5008-5033</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  During the last decade, reports show that the incidence and prevalence of Alzheimer's disease (AD) and other dementias have significantly increased.  AD poses an enormous escalating threat to health services and resources.  Early diagnosis of AD is recognized as one of the major challenges and primary aims in scientific communities.  With the arrival of nanoscience and nanotechnol. to medicine, hopes for early diagnosis and treatment of AD have considerably increased.  To this end, nanobioresearchers are focused on three major areas consisting of early detection and recognition, biol. markers and diagnosis, and pharmacotherapy.  Several efforts are in progress for the discovery of new nanodrugs with a sufficient effort on the fast therapy of AD.  In this review, a comprehensive overview of the conventional theories together with new conflicts and challenges on the major causes of AD is provided.  In addn., the opportunities and challenges of nanoscience and nanotechnol. as theranostic agents for AD are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJTdkUizLlDrVg90H21EOLACvtfcHk0lhKr5ZeCR4OLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFOku7o%253D&md5=ace62f1f6a6361a73b9b45fba2d69fc4</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1039%2Fc2ra01374f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ra01374f%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DS.%26aulast%3DEjtehadi%26aufirst%3DM.%2BR.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DKehoe%26aufirst%3DP.%2BG.%26aulast%3DMahmoudi%26aufirst%3DM.%26atitle%3DInterdisciplinary%2520challenges%2520and%2520promising%2520theranostic%2520effects%2520of%2520nanoscience%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26spage%3D5008%26epage%3D5033%26doi%3D10.1039%2Fc2ra01374f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Amiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeidi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manafirad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbi, V.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span><span class="refDoi"> DOI: 10.1021/cn4001582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4001582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWku7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1417-1429&author=H.+Amiriauthor=K.+Saeidiauthor=P.+Borhaniauthor=A.+Manafiradauthor=M.+Ghavamiauthor=V.+Zerbi&title=Alzheimer%E2%80%99s+disease%3A+pathophysiology+and+applications+of+magnetic+nanoparticles+as+MRI+theranostic+agents&doi=10.1021%2Fcn4001582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: Pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents</span></div><div class="casAuthors">Amiri, Houshang; Saeidi, Kolsoum; Borhani, Parvin; Manafirad, Arash; Ghavami, Mahdi; Zerbi, Valerio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1429</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia.  During the recent decade, nanotechnol. has been widely considered, as a promising tool, for theranosis (diagnosis and therapy) of AD.  Here we first discuss pathophysiol. and characteristics of AD with a focus on the amyloid cascade hypothesis.  Then magnetic nanoparticles (MNPs) and recent works on their applications in AD, focusing on the superparamagnetic iron oxide nanoparticles (SPIONs), are reviewed.  Furthermore, the amyloid-nanoparticle interaction is highlighted, with the scope to be highly considered by the scientists aiming for diagnostics and/or treatment of AD employing nanoparticles.  Furthermore, recent findings on the "ignored" parameters (e.g., effect of protein "corona" at the surface of nanoparticles on amyloid-β (Aβ) fibrillation process) are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcaC_r5f9OFrVg90H21EOLACvtfcHk0lhKr5ZeCR4OLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWku7jK&md5=a77bafe1ace864d21ff3e90731a8f7a0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcn4001582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4001582%26sid%3Dliteratum%253Aachs%26aulast%3DAmiri%26aufirst%3DH.%26aulast%3DSaeidi%26aufirst%3DK.%26aulast%3DBorhani%26aufirst%3DP.%26aulast%3DManafirad%26aufirst%3DA.%26aulast%3DGhavami%26aufirst%3DM.%26aulast%3DZerbi%26aufirst%3DV.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520pathophysiology%2520and%2520applications%2520of%2520magnetic%2520nanoparticles%2520as%2520MRI%2520theranostic%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1417%26epage%3D1429%26doi%3D10.1021%2Fcn4001582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Ruozi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belletti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pederzoli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veratti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandelli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, G.</span><span> </span><span class="NLM_article-title">Nanotechnology and Alzheimer’s disease: what has been done and what to do</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4169</span><span class="NLM_x">–</span> <span class="NLM_lpage">4185</span><span class="refDoi"> DOI: 10.2174/0929867321666140716100056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2174%2F0929867321666140716100056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25039777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=4169-4185&author=B.+Ruoziauthor=D.+Bellettiauthor=F.+Pederzoliauthor=P.+Verattiauthor=F.+Forniauthor=M.+A.+Vandelliauthor=G.+Tosi&title=Nanotechnology+and+Alzheimer%E2%80%99s+disease%3A+what+has+been+done+and+what+to+do&doi=10.2174%2F0929867321666140716100056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnology and Alzheimer's Disease: What has been Done and What to Do'</span></div><div class="casAuthors">Ruozi, B.; Belletti, D.; Pederzoli, F.; Veratti, P.; Forni, F.; Vandelli, M. A.; Tosi, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4169-4185</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Up to date, Alzheimer's Disease (AD) is considered as an "urgency" for public health, since it represents one of the most dramatic causes of death in adults.  The drugs currently used for AD are only symptomatic, thus not curing the pathol., but only trying to slow or delay the progression of the pathol.  Moreover, there is a total lack of early identification, with only "probable'' or ''possible'' diagnosis of AD patients.  With this review, we aimed to individuate and to highlight the most promising approaches for AD therapy and diagnosis.  In this view, at the cutting-edge of innovation, nanocarriers as polymeric nanoparticles, liposomes, nanoassembly and dendrimers, have been studied and investigated in order to ameliorate the detection (in vitro and in vivo) and/or the therapeutic options in AD.  In this review, the most outstanding nanomedicine-driven approaches in AD imaging/detection and treatments are summarized in order to help in individuating values and criticisms.  Moreover, an overview of one of the most innovative strategies in AD management, namely theranostic nanomedicine, is reported and commented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI9IOKNIq2pLVg90H21EOLACvtfcHk0lgu0qagzkunWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vJ&md5=8d3989f32a1b789adff36a5b2c08b3b3</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140716100056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140716100056%26sid%3Dliteratum%253Aachs%26aulast%3DRuozi%26aufirst%3DB.%26aulast%3DBelletti%26aufirst%3DD.%26aulast%3DPederzoli%26aufirst%3DF.%26aulast%3DVeratti%26aufirst%3DP.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DVandelli%26aufirst%3DM.%2BA.%26aulast%3DTosi%26aufirst%3DG.%26atitle%3DNanotechnology%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520what%2520has%2520been%2520done%2520and%2520what%2520to%2520do%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D4169%26epage%3D4185%26doi%3D10.2174%2F0929867321666140716100056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Nesterov, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swager, T. M.</span><span> </span><span class="NLM_article-title">In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5452</span><span class="NLM_x">–</span> <span class="NLM_lpage">5456</span><span class="refDoi"> DOI: 10.1002/anie.200500845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fanie.200500845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=16059955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5452-5456&author=E.+E.+Nesterovauthor=J.+Skochauthor=B.+T.+Hymanauthor=W.+E.+Klunkauthor=B.+J.+Bacskaiauthor=T.+M.+Swager&title=In+vivo+optical+imaging+of+amyloid+aggregates+in+brain%3A+design+of+fluorescent+markers&doi=10.1002%2Fanie.200500845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo optical imaging of amyloid aggregates in brain: Design of fluorescent markers</span></div><div class="casAuthors">Nesterov, Evgueni E.; Skoch, Jesse; Hyman, Bradley T.; Klunk, William E.; Bacskai, Brian J.; Swager, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5452-5456</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Routine diagnostics and studies of Alzheimer's disease might benefit form the noninvasive optical imaging of amyloid-β plaques in the brain.  A rational design strategy for in vivo amyloid-imaging agents that enter the brain and selectively stain amyloid plaques is presented (see picture), and properties of a promising lead biomarker candidate are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5E9TYWs6pyLVg90H21EOLACvtfcHk0lgu0qagzkunWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D&md5=784428c9422af2b31caf739625afc87a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fanie.200500845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200500845%26sid%3Dliteratum%253Aachs%26aulast%3DNesterov%26aufirst%3DE.%2BE.%26aulast%3DSkoch%26aufirst%3DJ.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DSwager%26aufirst%3DT.%2BM.%26atitle%3DIn%2520vivo%2520optical%2520imaging%2520of%2520amyloid%2520aggregates%2520in%2520brain%253A%2520design%2520of%2520fluorescent%2520markers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5452%26epage%3D5456%26doi%3D10.1002%2Fanie.200500845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Cui, M.</span><span> </span><span class="NLM_article-title">Past and recent progress of molecular imaging probes for beta-amyloid plaques in the brain</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.2174/09298673113209990216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2174%2F09298673113209990216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23992340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=82-112&author=M.+Cui&title=Past+and+recent+progress+of+molecular+imaging+probes+for+beta-amyloid+plaques+in+the+brain&doi=10.2174%2F09298673113209990216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Past and Recent Progress of Molecular Imaging Probes for β-Amyloid Plaques in the Brain</span></div><div class="casAuthors">Cui, Mengchao</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-112</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The deposition of β-amyloid (Aβ) plaques in the parenchymal and cortical brain is accepted as the main pathol. hallmark of Alzheimer's disease (AD).  According to the amyloid cascade hypothesis, the Aβ deposition in the brain appears to be a good diagnostic biomarker for AD and may also be a good predictive biomarker of this disease.  Mol. imaging of Aβ plaques in the brain with positron emission tomog. (PET), single photon emission computed tomog. (SPECT) or mol. optical imaging represents a promising approach to the early diagnosis of AD and monitoring the effectiveness of novel therapies for this devastating disease.  Our review focuses on the past and recent knowledge in this field with respect to small org. mols. that have been utilized for the development of Aβ imaging probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDkW-1MI-9ZLVg90H21EOLACvtfcHk0lgu0qagzkunWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOhsbc%253D&md5=330b1b07dcabdb0a808183458702ec1b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990216%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DM.%26atitle%3DPast%2520and%2520recent%2520progress%2520of%2520molecular%2520imaging%2520probes%2520for%2520beta-amyloid%2520plaques%2520in%2520the%2520brain%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D82%26epage%3D112%26doi%3D10.2174%2F09298673113209990216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Fu, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. L.</span><span> </span><span class="NLM_article-title">Highly sensitive near-infrared fluorophores for in vivo detection of amyloid-beta plaques in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6972</span><span class="NLM_x">–</span> <span class="NLM_lpage">6983</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00861</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00861" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSmt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6972-6983&author=H.+L.+Fuauthor=M.+C.+Cuiauthor=L.+Zhaoauthor=P.+Y.+Tuauthor=K.+X.+Zhouauthor=J.+P.+Daiauthor=B.+L.+Liu&title=Highly+sensitive+near-infrared+fluorophores+for+in+vivo+detection+of+amyloid-beta+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b00861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease</span></div><div class="casAuthors">Fu, Hualong; Cui, Mengchao; Zhao, Liu; Tu, Peiyu; Zhou, Kaixiang; Dai, Jiapei; Liu, Boli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6972-6983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is pathol. characterized by the accumulation of β-amyloid (Aβ) deposits in the parenchymal and cortical brain.  In this work, we designed, synthesized, and evaluated a series of near-IR (NIR) probes with electron donor-acceptor end groups interacting through a π-conjugated system for the detection of Aβ deposits in the brain.  Among these probes, 3b and 3c had excellent fluorescent properties (emission maxima > 650 nm and high quantum yields) and displayed high sensitivity and high affinities to Aβ aggregates (3b, Kd = 8.8 nM; 3c, Kd = 1.9 nM).  Both 3b and 3c could readily penetrate the blood-brain barrier with high initial brain uptake and fast to moderate washout from the brain.  In vivo NIR imaging revealed that 3b and 3c could efficiently differentiate transgenic and wild-type mice.  In summary, our research provides new hints for developing smarter and more activatable NIR probes targeting Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAQ3V2vzvTB7Vg90H21EOLACvtfcHk0liYHhz2izy2AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSmt7nE&md5=454275cac002fcf02d97a8ba9d682b4c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00861%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%2BL.%26aulast%3DCui%26aufirst%3DM.%2BC.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DTu%26aufirst%3DP.%2BY.%26aulast%3DZhou%26aufirst%3DK.%2BX.%26aulast%3DDai%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DB.%2BL.%26atitle%3DHighly%2520sensitive%2520near-infrared%2520fluorophores%2520for%2520in%2520vivo%2520detection%2520of%2520amyloid-beta%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6972%26epage%3D6983%26doi%3D10.1021%2Facs.jmedchem.5b00861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Li, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span> </span><span class="NLM_article-title">Current drug research on PEGylation with small molecular agents</span> <span class="citation_source-journal">Prog. Polym. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/j.progpolymsci.2012.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.progpolymsci.2012.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=421-444&author=W.+J.+Liauthor=P.+Zhanauthor=E.+De+Clercqauthor=H.+X.+Louauthor=X.+Y.+Liu&title=Current+drug+research+on+PEGylation+with+small+molecular+agents&doi=10.1016%2Fj.progpolymsci.2012.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Current drug research on PEGylation with small molecular agents</span></div><div class="casAuthors">Li, Wenjun; Zhan, Peng; De Clercq, Erik; Lou, Hongxiang; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Polymer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">421-444</span>CODEN:
                <span class="NLM_cas:coden">PRPSB8</span>;
        ISSN:<span class="NLM_cas:issn">0079-6700</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  PEGylation, covalent attaching polyethylene glycol (PEG) polymers to therapeutic agents, is one of the most promising techniques to improve the therapeutic effect of drugs.  Initially, this technol. is mainly applied with macromol. drugs, such as proteins, enzymes, with ten PEGylated biomacromols. approved by the FDA for the treatment of related diseases.  The clin. successful use of PEGylated macromol. drug has promoted the application of this technol. with small mols. drugs to overcome shortcomings assocd. with therapy, such as possible low soly., high toxicity, undesirable pharmaceutical characteristics and nonspecific biodistribution profiles.  So far, 4 PEGylated small drugs were taken into clin. trials.  This review mainly focuses on the recent advances of PEGylated small mols., including their general configuration, and the current merits and limits of PEG modification.  Herein PEG delivery systems are distinguished by therapeutic application (anti-tumor, anti-inflammatory, etc.) and their corresponding PEGylated small mols. are described in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1c3uJ8cWgm7Vg90H21EOLACvtfcHk0liYHhz2izy2AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE&md5=eb609a4d59ce7e8cc5cf443ce8def9b4</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.progpolymsci.2012.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.progpolymsci.2012.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%2BJ.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLou%26aufirst%3DH.%2BX.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26atitle%3DCurrent%2520drug%2520research%2520on%2520PEGylation%2520with%2520small%2520molecular%2520agents%26jtitle%3DProg.%2520Polym.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D421%26epage%3D444%26doi%3D10.1016%2Fj.progpolymsci.2012.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. S.</span><span> </span><span class="NLM_article-title">Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1804</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span><span class="refDoi"> DOI: 10.1002/anie.201104150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fanie.201104150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC383isleitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1804-1810&author=W.+Yangauthor=Y.+Wongauthor=O.+T.+Ngauthor=L.+P.+Baiauthor=D.+W.+Kwongauthor=Y.+Keauthor=Z.+H.+Jiangauthor=H.+W.+Liauthor=K.+K.+Yungauthor=M.+S.+Wong&title=Inhibition+of+beta-amyloid+peptide+aggregation+by+multifunctional+carbazole-based+fluorophores&doi=10.1002%2Fanie.201104150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores</span></div><div class="casAuthors">Yang Wanggui; Wong Yi; Ng Olivia T W; Bai Li-Ping; Kwong Daniel W J; Ke Ya; Jiang Zhi-Hong; Li Hung-Wing; Yung Ken K L; Wong Man Shing</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1804-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRN-c5U5ISDLHHuJhbyicZfW6udTcc2eazYmt0rSqaxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383isleitA%253D%253D&md5=4b5e41db5ad9a5e5842249aa5b59f24e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2Fanie.201104150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201104150%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DO.%2BT.%26aulast%3DBai%26aufirst%3DL.%2BP.%26aulast%3DKwong%26aufirst%3DD.%2BW.%26aulast%3DKe%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%2BH.%26aulast%3DLi%26aufirst%3DH.%2BW.%26aulast%3DYung%26aufirst%3DK.%2BK.%26aulast%3DWong%26aufirst%3DM.%2BS.%26atitle%3DInhibition%2520of%2520beta-amyloid%2520peptide%2520aggregation%2520by%2520multifunctional%2520carbazole-based%2520fluorophores%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1804%26epage%3D1810%26doi%3D10.1002%2Fanie.201104150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Staderini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Ruiz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabezas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legname, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">A Fluorescent styrylquinoline with combined therapeutic and diagnostic activities against Alzheimer’s and prion diseases</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1021/ml3003605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=225-229&author=M.+Staderiniauthor=S.+Aulicauthor=M.+Bartoliniauthor=H.+N.+Tranauthor=V.+Gonzalez-Ruizauthor=D.+I.+Perezauthor=N.+Cabezasauthor=A.+Martinezauthor=M.+A.+Martinauthor=V.+Andrisanoauthor=G.+Legnameauthor=J.+C.+Menendezauthor=M.+L.+Bolognesi&title=A+Fluorescent+styrylquinoline+with+combined+therapeutic+and+diagnostic+activities+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fml3003605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fml3003605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003605%26sid%3Dliteratum%253Aachs%26aulast%3DStaderini%26aufirst%3DM.%26aulast%3DAulic%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DH.%2BN.%26aulast%3DGonzalez-Ruiz%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DCabezas%26aufirst%3DN.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DA%2520Fluorescent%2520styrylquinoline%2520with%2520combined%2520therapeutic%2520and%2520diagnostic%2520activities%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D225%26epage%3D229%26doi%3D10.1021%2Fml3003605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namm, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. T.</span><span> </span><span class="NLM_article-title">Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.1002/cbic.200700154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fcbic.200700154" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1679-1687&author=Q.+Liauthor=J.+K.+Minauthor=Y.+H.+Ahnauthor=J.+H.+Nammauthor=E.+M.+Kimauthor=R.+Luiauthor=H.+Y.+Kimauthor=Y.+Jiauthor=H.+Z.+Wuauthor=T.+Wisniewskiauthor=Y.+T.+Chang&title=Styryl-based+compounds+as+potential+in+vivo+imaging+agents+for+beta-amyloid+plaques&doi=10.1002%2Fcbic.200700154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700154%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMin%26aufirst%3DJ.%2BK.%26aulast%3DAhn%26aufirst%3DY.%2BH.%26aulast%3DNamm%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DE.%2BM.%26aulast%3DLui%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%2BZ.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DY.%2BT.%26atitle%3DStyryl-based%2520compounds%2520as%2520potential%2520in%2520vivo%2520imaging%2520agents%2520for%2520beta-amyloid%2520plaques%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1679%26epage%3D1687%26doi%3D10.1002%2Fcbic.200700154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Cell biology. A unifying role for prions in neurodegenerative diseases</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span><span class="refDoi"> DOI: 10.1126/science.1222951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1126%2Fscience.1222951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22723400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKmt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=1511-1513&author=S.+B.+Prusiner&title=Cell+biology.+A+unifying+role+for+prions+in+neurodegenerative+diseases&doi=10.1126%2Fscience.1222951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A unifying role for prions in neurodegenerative diseases</span></div><div class="casAuthors">Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6088</span>),
    <span class="NLM_cas:pages">1511-1513</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuklhpVrmWbVg90H21EOLACvtfcHk0ljIpUm5NUdi3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKmt7%252FN&md5=b2e3f8cec0e90aff1577b75a95095518</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222951%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DCell%2520biology.%2520A%2520unifying%2520role%2520for%2520prions%2520in%2520neurodegenerative%2520diseases%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D1511%26epage%3D1513%26doi%3D10.1126%2Fscience.1222951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaseen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutzendler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C. Z.</span><span> </span><span class="NLM_article-title">A bifunctional curcumin analogue for two-photon imaging and inhibiting crosslinking of amyloid beta in Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">11550</span><span class="NLM_x">–</span> <span class="NLM_lpage">11553</span><span class="refDoi"> DOI: 10.1039/C4CC03731F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4CC03731F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=11550-11553&author=X.+L.+Zhangauthor=Y.+L.+Tianauthor=P.+Yuanauthor=Y.+Y.+Liauthor=M.+A.+Yaseenauthor=J.+Grutzendlerauthor=A.+Mooreauthor=C.+Z.+Ran&title=A+bifunctional+curcumin+analogue+for+two-photon+imaging+and+inhibiting+crosslinking+of+amyloid+beta+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CC03731F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1039%2FC4CC03731F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC03731F%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DTian%26aufirst%3DY.%2BL.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DYaseen%26aufirst%3DM.%2BA.%26aulast%3DGrutzendler%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%2BZ.%26atitle%3DA%2520bifunctional%2520curcumin%2520analogue%2520for%2520two-photon%2520imaging%2520and%2520inhibiting%2520crosslinking%2520of%2520amyloid%2520beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D11550%26epage%3D11553%26doi%3D10.1039%2FC4CC03731F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Tian, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoup, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmaleh, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C. Z.</span><span> </span><span class="NLM_article-title">Crown ethers attenuate aggregation of amyloid beta of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">15792</span><span class="NLM_x">–</span> <span class="NLM_lpage">15795</span><span class="refDoi"> DOI: 10.1039/C4CC06029F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4CC06029F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25372154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVemsrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=15792-15795&author=Y.+L.+Tianauthor=X.+L.+Zhangauthor=Y.+Y.+Liauthor=T.+M.+Shoupauthor=X.+Tengauthor=D.+R.+Elmalehauthor=A.+Mooreauthor=C.+Z.+Ran&title=Crown+ethers+attenuate+aggregation+of+amyloid+beta+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CC06029F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease</span></div><div class="casAuthors">Tian, Yanli; Zhang, Xueli; Li, Yuyan; Shoup, Timothy M.; Teng, Xin; Elmaleh, David R.; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">99</span>),
    <span class="NLM_cas:pages">15792-15795</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this report, we reasoned that non-covalent modification of amyloid beta (Aβ) by crown ethers could inhibit its aggregation.  We demonstrated that PiB-C, a conjugate PiB and crown ether, could significantly reduce the aggregation in vitro.  Addnl., two-photon imaging showed that PiB-C could efficiently label Aβ plaques and CAAs in AD mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDHH0b6SuvcrVg90H21EOLACvtfcHk0liJn4HpbQa03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVemsrzP&md5=8da0a82f1f654f9ea84ac3d11e712c9e</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1039%2FC4CC06029F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC06029F%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DShoup%26aufirst%3DT.%2BM.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DElmaleh%26aufirst%3DD.%2BR.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%2BZ.%26atitle%3DCrown%2520ethers%2520attenuate%2520aggregation%2520of%2520amyloid%2520beta%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D15792%26epage%3D15795%26doi%3D10.1039%2FC4CC06029F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aucoin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Nostrand, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. O.</span><span> </span><span class="NLM_article-title">Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1038/nsmb.1799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnsmb.1799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=20383142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFalurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=561-567&author=M.+Ahmedauthor=J.+Davisauthor=D.+Aucoinauthor=T.+Satoauthor=S.+Ahujaauthor=S.+Aimotoauthor=J.+I.+Elliottauthor=W.+E.+Van+Nostrandauthor=S.+O.+Smith&title=Structural+conversion+of+neurotoxic+amyloid-beta%281-42%29+oligomers+to+fibrils&doi=10.1038%2Fnsmb.1799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils</span></div><div class="casAuthors">Ahmed, Mahiuddin; Davis, Judianne; Aucoin, Darryl; Sato, Takeshi; Ahuja, Shivani; Aimoto, Saburo; Elliott, James I.; Van Nostrand, William E.; Smith, Steven O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-567</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The amyloid-β1-42 (Aβ42) peptide rapidly aggregates to form oligomers, protofibrils and fibrils en route to the deposition of amyloid plaques assocd. with Alzheimer's disease.  We show that low-temp. and low-salt conditions can stabilize disk-shaped oligomers (pentamers) that are substantially more toxic to mouse cortical neurons than protofibrils and fibrils.  We find that these neurotoxic oligomers do not have the β-sheet structure characteristic of fibrils.  Rather, the oligomers are composed of loosely aggregated strands whose C termini are protected from solvent exchange and which have a turn conformation, placing Phe19 in contact with Leu34.  On the basis of NMR spectroscopy, we show that the structural conversion of Aβ42 oligomers to fibrils involves the assocn. of these loosely aggregated strands into β-sheets whose individual β-strands polymerize in a parallel, in-register orientation and are staggered at an intermonomer contact between Gln15 and Gly37.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXwa2kdCLS7Vg90H21EOLACvtfcHk0liJn4HpbQa03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFalurY%253D&md5=0d0c19141fd3cfe17fe5ee788eb248ab</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1799%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DAucoin%26aufirst%3DD.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DAimoto%26aufirst%3DS.%26aulast%3DElliott%26aufirst%3DJ.%2BI.%26aulast%3DVan%2BNostrand%26aufirst%3DW.%2BE.%26aulast%3DSmith%26aufirst%3DS.%2BO.%26atitle%3DStructural%2520conversion%2520of%2520neurotoxic%2520amyloid-beta%25281-42%2529%2520oligomers%2520to%2520fibrils%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D561%26epage%3D567%26doi%3D10.1038%2Fnsmb.1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Specific self-monitoring of metal-associated amyloid-beta peptide disaggregation by a fluorescent chelator</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2245</span><span class="NLM_x">–</span> <span class="NLM_lpage">2248</span><span class="refDoi"> DOI: 10.1039/C5CC08898D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC5CC08898D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=2245-2248&author=T.+Yangauthor=X.+Wangauthor=C.+Zhangauthor=X.+Maauthor=K.+Wangauthor=Y.+Wangauthor=J.+Luoauthor=L.+Yangauthor=C.+Yaoauthor=X.+Wang&title=Specific+self-monitoring+of+metal-associated+amyloid-beta+peptide+disaggregation+by+a+fluorescent+chelator&doi=10.1039%2FC5CC08898D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1039%2FC5CC08898D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC08898D%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSpecific%2520self-monitoring%2520of%2520metal-associated%2520amyloid-beta%2520peptide%2520disaggregation%2520by%2520a%2520fluorescent%2520chelator%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D2245%26epage%3D2248%26doi%3D10.1039%2FC5CC08898D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Bolognin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatta, P.</span><span> </span><span class="NLM_article-title">Chelation therapy for neurodegenerative diseases</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1002/med.20148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fmed.20148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=19177468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVaitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=547-570&author=S.+Bologninauthor=D.+Dragoauthor=L.+Messoriauthor=P.+Zatta&title=Chelation+therapy+for+neurodegenerative+diseases&doi=10.1002%2Fmed.20148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Chelation therapy for neurodegenerative diseases</span></div><div class="casAuthors">Bolognin, Silvia; Drago, Denise; Messori, Luigi; Zatta, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">547-570</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Mounting evidence suggests a central role for transition biometals in the etiopathogenesis of neurodegenerative diseases (ND).  Indeed, while studying the mol. basis for this heterogeneous group of diseases, it has become increasingly evident that biometals and nonphysiol. Al are often involved in pathol. onset and progression, either by affecting the conformation of specific proteins or by exacerbating local oxidative stress.  The apparently crit. role played by metal dishomeostasis in ND makes chelation therapy an attractive pharmacol. option.  However, classical metal chelation approaches, relying on potent metal ligands, turned out to be successful only in those rare cases where exceptional brain metal accumulation occurs due to specific defects in metal metab.  In contrast, metal-targeted approaches using ligand of intermediate strength seem to be more appropriate in fighting the major ND, although their benefits are still questioned.  We report here a survey of recent evidences supporting the use of a variety of metal ligands, and even functionalized nanoparticles, for the treatment of the most common ND.  The beneficial neuropharmacol. actions of metal-targeted agents most likely arise from local metal redistribution rather than from massive metal removal.  The perspectives for the development of new effective agents against ND are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ZaSHusBrRLVg90H21EOLACvtfcHk0lgO3brENiAzpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVaitbc%253D&md5=e24c36e8ae06cec84bfde893cc63ebb3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fmed.20148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20148%26sid%3Dliteratum%253Aachs%26aulast%3DBolognin%26aufirst%3DS.%26aulast%3DDrago%26aufirst%3DD.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DZatta%26aufirst%3DP.%26atitle%3DChelation%2520therapy%2520for%2520neurodegenerative%2520diseases%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D547%26epage%3D570%26doi%3D10.1002%2Fmed.20148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Nanoparticle-based theranostic agents</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1064</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span><span class="refDoi"> DOI: 10.1016/j.addr.2010.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.addr.2010.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=20691229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGitb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1064-1079&author=J.+Xieauthor=S.+Leeauthor=X.+Chen&title=Nanoparticle-based+theranostic+agents&doi=10.1016%2Fj.addr.2010.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle-based theranostic agents</span></div><div class="casAuthors">Xie, Jin; Lee, Seulki; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1064-1079</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Theranostic nanomedicine is emerging as a promising therapeutic paradigm.  It takes advantage of the high capacity of nanoplatforms to ferry cargo and loads onto them both imaging and therapeutic functions.  The resulting nanosystems, capable of diagnosis, drug delivery and monitoring of therapeutic response, are expected to play a significant role in the dawning era of personalized medicine, and much research effort was devoted toward that goal.  A convenience in constructing such function-integrated agents is that many nanoplatforms are already, themselves, imaging agents.  Their well-developed surface chem. makes it easy to load them with pharmaceutics and promote them to be theranostic nanosystems.  Iron oxide nanoparticles, quantum dots, carbon nanotubes, gold nanoparticles and silica nanoparticles, were previously well investigated in the imaging setting and are candidate nanoplatforms for building up nanoparticle-based theranostics.  In the current article, the authors will outline the progress along this line, organized by the category of the core materials.  The authors will focus on construction strategies and will discuss the challenges and opportunities assocd. with this emerging technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxlx_c5HYBQLVg90H21EOLACvtfcHk0lgO3brENiAzpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGitb7J&md5=87873807b175591d2fa5db581677acb2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2010.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2010.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DNanoparticle-based%2520theranostic%2520agents%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D1064%26epage%3D1079%26doi%3D10.1016%2Fj.addr.2010.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Mattsson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolcheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, R. J.</span><span> </span><span class="NLM_article-title">Revolutionizing Alzheimer’s disease and clinical trials through biomarkers</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1016/j.dadm.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.dadm.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FkslyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=412-419&author=N.+Mattssonauthor=M.+C.+Carrilloauthor=R.+A.+Deanauthor=M.+D.+Devousauthor=T.+Nikolchevaauthor=P.+Pesiniauthor=H.+Salterauthor=W.+Z.+Potterauthor=R.+S.+Sperlingauthor=R.+J.+Bateman&title=Revolutionizing+Alzheimer%E2%80%99s+disease+and+clinical+trials+through+biomarkers&doi=10.1016%2Fj.dadm.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Revolutionizing Alzheimer's disease and clinical trials through biomarkers</span></div><div class="casAuthors">Mattsson Niklas; Carrillo Maria C; Dean Robert A; Devous Michael D Sr; Nikolcheva Tania; Pesini Pedro; Salter Hugh; Potter William Z; Sperling Reisa S; Bateman Randall J; Bain Lisa J; Liu Enchi</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">412-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Alzheimer's Association's Research Roundtable met in May 2014 to explore recent progress in developing biomarkers to improve understanding of disease pathogenesis and expedite drug development.  Although existing biomarkers have proved extremely useful for enrichment of subjects in clinical trials, there is a clear need to develop novel biomarkers that are minimally invasive and that more broadly characterize underlying pathogenic mechanisms, including neurodegeneration, neuroinflammation, and synaptic dysfunction.  These may include blood-based assays and new neuropsychological testing protocols, as well as novel ligands for positron emission tomography imaging, and advanced magnetic resonance imaging methodologies.  In addition, there is a need for biomarkers that can serve as theragnostic markers of response to treatment.  Standardization remains a challenge, although international consortia have made substantial progress in this area and provide lessons for future standardization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDIlimZmZ04pNiNltV31zlfW6udTcc2eaCeok9cd7e5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FkslyjsA%253D%253D&md5=1dfbef224fc9340fea1fc27147d9f9d8</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.dadm.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dadm.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DN.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DNikolcheva%26aufirst%3DT.%26aulast%3DPesini%26aufirst%3DP.%26aulast%3DSalter%26aufirst%3DH.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DSperling%26aufirst%3DR.%2BS.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DRevolutionizing%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520clinical%2520trials%2520through%2520biomarkers%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D1%26spage%3D412%26epage%3D419%26doi%3D10.1016%2Fj.dadm.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Inès Li de
la Sierra-Gallay, Mathilde Belnou, Béatrice Chambraud, Melanie Genet, Herman van Tilbeurgh, Magali Aumont-Nicaise, Michel Desmadril, Etienne-Emile Baulieu, Yves Jacquot, <span class="NLM_string-name hlFld-ContribAuthor">Cillian Byrne</span>. </span><span class="cited-content_cbyCitation_article-title">Bioinspired Hybrid Fluorescent Ligands for the FK1 Domain of FKBP52. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10330-10338. <a href="https://doi.org/10.1021/acs.jmedchem.0c00825" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBioinspired%252BHybrid%252BFluorescent%252BLigands%252Bfor%252Bthe%252BFK1%252BDomain%252Bof%252BFKBP52%26aulast%3Dde%2Bla%2BSierra-Gallay%26aufirst%3DIn%25C3%25A8s%2BLi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14052020%26date%3D15092020%26date%3D31082020%26volume%3D63%26issue%3D18%26spage%3D10330%26epage%3D10338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marina Sagnou, Barbara Mavroidi, Antonio Shegani, Maria Paravatou-Petsotas, Catherine Raptopoulou, Vassilis Psycharis, Ioannis Pirmettis, Minas S. Papadopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Maria Pelecanou</span>. </span><span class="cited-content_cbyCitation_article-title">Remarkable Brain Penetration of Cyclopentadienyl M(CO)3+ (M = 99mTc, Re) Derivatives of Benzothiazole and Benzimidazole Paves the Way for Their Application as Diagnostic, with Single-Photon-Emission Computed Tomography (SPECT), and Therapeutic Agents for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2638-2650. <a href="https://doi.org/10.1021/acs.jmedchem.8b01949" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01949%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRemarkable%252BBrain%252BPenetration%252Bof%252BCyclopentadienyl%252BM%252528CO%2525293%25252B%252B%252528M%252B%25253D%252B99mTc%25252C%252BRe%252529%252BDerivatives%252Bof%252BBenzothiazole%252Band%252BBenzimidazole%252BPaves%252Bthe%252BWay%252Bfor%252BTheir%252BApplication%252Bas%252BDiagnostic%25252C%252Bwith%252BSingle-Photon-Emission%252BComputed%252BTomography%252B%252528SPECT%252529%25252C%252Band%252BTherapeutic%252BAgents%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSagnou%26aufirst%3DMarina%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13122018%26date%3D28022019%26date%3D15022019%26volume%3D62%26issue%3D5%26spage%3D2638%26epage%3D2650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elisa Uliassi, Luis Emiliano Peña-Altamira, Aixa V. Morales, Francesca Massenzio, Sabrina Petralla, Michele Rossi, Marinella Roberti, Loreto Martinez Gonzalez, Ana Martinez, Barbara Monti, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 279-294. <a href="https://doi.org/10.1021/acschemneuro.8b00242" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00242%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BFocused%252BLibrary%252Bof%252BPsychotropic%252BAnalogues%252Bwith%252BNeuroprotective%252Band%252BNeuroregenerative%252BPotential%26aulast%3DUliassi%26aufirst%3DElisa%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20052018%26date%3D25092018%26date%3D09102018%26date%3D25092018%26volume%3D10%26issue%3D1%26spage%3D279%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinghua Li, Runguo Tian, Chaochao Ge, Ying Chen, Xiaodan liu, Yuxia Wang, Yacheng Yang, Wen Luo, Fujun Dai, Senzhen Wang, Shuai Chen, Songqiang Xie, <span class="NLM_string-name hlFld-ContribAuthor">Chaojie Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of the Polyamine Conjugate with Benzo[cd]indol-2(1H)-one as a Lysosome-Targeted Antimetastatic Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6814-6829. <a href="https://doi.org/10.1021/acs.jmedchem.8b00694" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00694%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BPolyamine%252BConjugate%252Bwith%252BBenzo%25255Bcd%25255Dindol-2%2525281H%252529-one%252Bas%252Ba%252BLysosome-Targeted%252BAntimetastatic%252BAgent%26aulast%3DLi%26aufirst%3DJinghua%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02052018%26date%3D23072018%26date%3D10072018%26volume%3D61%26issue%3D15%26spage%3D6814%26epage%3D6829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyang  Zhang</span>, <span class="hlFld-ContribAuthor ">Pingrong  Yu</span>, <span class="hlFld-ContribAuthor ">Yanping  Yang</span>, <span class="hlFld-ContribAuthor ">Yaqin  Hou</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Zhigang  Liang</span>, <span class="hlFld-ContribAuthor ">Jing  Lu</span>, <span class="hlFld-ContribAuthor ">Baian  Chen</span>, <span class="hlFld-ContribAuthor ">Jiapei  Dai</span>, <span class="hlFld-ContribAuthor ">Boli  Liu</span>, and <span class="hlFld-ContribAuthor ">Mengchao  Cui</span>  . </span><span class="cited-content_cbyCitation_article-title">99mTc-Labeled 2-Arylbenzothiazoles: Aβ Imaging Probes with Favorable Brain Pharmacokinetics for Single-Photon Emission Computed Tomography. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (10)
                                     , 2493-2504. <a href="https://doi.org/10.1021/acs.bioconjchem.6b00444" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.6b00444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.6b00444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.6b00444%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3D99mTc-Labeled%252B2-Arylbenzothiazoles%25253A%252BA%2525CE%2525B2%252BImaging%252BProbes%252Bwith%252BFavorable%252BBrain%252BPharmacokinetics%252Bfor%252BSingle-Photon%252BEmission%252BComputed%252BTomography%26aulast%3DZhang%26aufirst%3DXiaoyang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09082016%26date%3D21092016%26date%3D07102016%26date%3D19102016%26date%3D26092016%26volume%3D27%26issue%3D10%26spage%3D2493%26epage%3D2504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Yin</span>, <span class="hlFld-ContribAuthor ">Richard  Van</span>, <span class="hlFld-ContribAuthor ">Keyi  Yin</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">Biyue  Zhu</span>, <span class="hlFld-ContribAuthor ">Kathleen  Ran</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>, <span class="hlFld-ContribAuthor ">Mohanraja  Kumar</span>, <span class="hlFld-ContribAuthor ">Yihan  Shao</span>, <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>. </span><span class="cited-content_cbyCitation_article-title">Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-17783-4" title="DOI URL">https://doi.org/10.1038/s41467-020-17783-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-17783-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-17783-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DTurn-on%252Bchemiluminescence%252Bprobes%252Band%252Bdual-amplification%252Bof%252Bsignal%252Bfor%252Bdetection%252Bof%252Bamyloid%252Bbeta%252Bspecies%252Bin%252Bvivo%26aulast%3DYang%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas B. G.  Poulsen</span>, <span class="hlFld-ContribAuthor ">Azra  Karamehmedovic</span>, <span class="hlFld-ContribAuthor ">Christopher  Aboo</span>, <span class="hlFld-ContribAuthor ">Malene Møller  Jørgensen</span>, <span class="hlFld-ContribAuthor ">Xiaobo  Yu</span>, <span class="hlFld-ContribAuthor ">Xiangdong  Fang</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Blackburn</span>, <span class="hlFld-ContribAuthor ">Claus H.  Nielsen</span>, <span class="hlFld-ContribAuthor ">Tue W.  Kragstrup</span>, <span class="hlFld-ContribAuthor ">Allan  Stensballe</span>. </span><span class="cited-content_cbyCitation_article-title">Protein array-based companion diagnostics in precision medicine. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Molecular Diagnostics</span><span> <strong>2020,</strong> <em>20 </em>
                                    (12)
                                     , 1183-1198. <a href="https://doi.org/10.1080/14737159.2020.1857734" title="DOI URL">https://doi.org/10.1080/14737159.2020.1857734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737159.2020.1857734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737159.2020.1857734%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Molecular%2520Diagnostics%26atitle%3DProtein%252Barray-based%252Bcompanion%252Bdiagnostics%252Bin%252Bprecision%252Bmedicine%26aulast%3DPoulsen%26aufirst%3DThomas%2BB.%2BG.%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D12%26spage%3D1183%26epage%3D1198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Biyue  Zhu</span>, <span class="hlFld-ContribAuthor ">Wei  Yin</span>, <span class="hlFld-ContribAuthor ">Zhihao  Han</span>, <span class="hlFld-ContribAuthor ">Chao  Zheng</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Chongzhao  Ran</span>. </span><span class="cited-content_cbyCitation_article-title">Differentiating Aβ40 and Aβ42 in amyloid plaques with a small molecule fluorescence probe. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (20)
                                     , 5238-5245. <a href="https://doi.org/10.1039/D0SC02060E" title="DOI URL">https://doi.org/10.1039/D0SC02060E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC02060E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC02060E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDifferentiating%252BA%2525CE%2525B240%252Band%252BA%2525CE%2525B242%252Bin%252Bamyloid%252Bplaques%252Bwith%252Ba%252Bsmall%252Bmolecule%252Bfluorescence%252Bprobe%26aulast%3DYang%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D20%26spage%3D5238%26epage%3D5245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harshit  Arora</span>, <span class="hlFld-ContribAuthor ">Madhu  Ramesh</span>, <span class="hlFld-ContribAuthor ">Kolla  Rajasekhar</span>, <span class="hlFld-ContribAuthor ">Thimmaiah  Govindaraju</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Tools to Detect Alloforms of Aβ and Tau: Implications for Multiplexing and Multimodal Diagnosis of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Chemical Society of Japan</span><span> <strong>2020,</strong> <em>93 </em>
                                    (4)
                                     , 507-546. <a href="https://doi.org/10.1246/bcsj.20190356" title="DOI URL">https://doi.org/10.1246/bcsj.20190356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/bcsj.20190356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fbcsj.20190356%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Chemical%2520Society%2520of%2520Japan%26atitle%3DMolecular%252BTools%252Bto%252BDetect%252BAlloforms%252Bof%252BA%2525CE%2525B2%252Band%252BTau%25253A%252BImplications%252Bfor%252BMultiplexing%252Band%252BMultimodal%252BDiagnosis%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DArora%26aufirst%3DHarshit%26date%3D2020%26volume%3D93%26issue%3D4%26spage%3D507%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James T.  Brewster</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Thiabaud</span>, <span class="hlFld-ContribAuthor ">Peter  Harvey</span>, <span class="hlFld-ContribAuthor ">Hadiqa  Zafar</span>, <span class="hlFld-ContribAuthor ">James F.  Reuther</span>, <span class="hlFld-ContribAuthor ">Simone  Dell’Acqua</span>, <span class="hlFld-ContribAuthor ">Rachel M.  Johnson</span>, <span class="hlFld-ContribAuthor ">Harrison D.  Root</span>, <span class="hlFld-ContribAuthor ">Pedro  Metola</span>, <span class="hlFld-ContribAuthor ">Alan  Jasanoff</span>, <span class="hlFld-ContribAuthor ">Luigi  Casella</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Sessler</span>. </span><span class="cited-content_cbyCitation_article-title">Metallotexaphyrins as MRI-Active Catalytic Antioxidants for Neurodegenerative Disease: A Study on Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Chem</span><span> <strong>2020,</strong> <em>6 </em>
                                    (3)
                                     , 703-724. <a href="https://doi.org/10.1016/j.chempr.2019.12.016" title="DOI URL">https://doi.org/10.1016/j.chempr.2019.12.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chempr.2019.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chempr.2019.12.016%26sid%3Dliteratum%253Aachs%26jtitle%3DChem%26atitle%3DMetallotexaphyrins%252Bas%252BMRI-Active%252BCatalytic%252BAntioxidants%252Bfor%252BNeurodegenerative%252BDisease%25253A%252BA%252BStudy%252Bon%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBrewster%26aufirst%3DJames%2BT.%26date%3D2020%26volume%3D6%26issue%3D3%26spage%3D703%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serena  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Nina  Ogrinc</span>, <span class="hlFld-ContribAuthor ">Lieke  Lamont</span>, <span class="hlFld-ContribAuthor ">Graziella  Vecchio</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Pappalardo</span>, <span class="hlFld-ContribAuthor ">Ron M. A.  Heeren</span>. </span><span class="cited-content_cbyCitation_article-title">Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer’s disease on Aβ1-40 peptide early assembly. </span><span class="cited-content_cbyCitation_journal-name">Analytical and Bioanalytical Chemistry</span><span> <strong>2019,</strong> <em>411 </em>
                                    (24)
                                     , 6353-6363. <a href="https://doi.org/10.1007/s00216-019-02030-7" title="DOI URL">https://doi.org/10.1007/s00216-019-02030-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00216-019-02030-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00216-019-02030-7%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520and%2520Bioanalytical%2520Chemistry%26atitle%3DIon%252Bmobility%252Bspectrometry%252Bcombined%252Bwith%252Bmultivariate%252Bstatistical%252Banalysis%25253A%252Brevealing%252Bthe%252Beffects%252Bof%252Ba%252Bdrug%252Bcandidate%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bon%252BA%2525CE%2525B21-40%252Bpeptide%252Bearly%252Bassembly%26aulast%3DLazzaro%26aufirst%3DSerena%26date%3D2019%26date%3D2019%26volume%3D411%26issue%3D24%26spage%3D6353%26epage%3D6363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhavesh D.  Kevadiya</span>, <span class="hlFld-ContribAuthor ">Brendan M.  Ottemann</span>, <span class="hlFld-ContribAuthor ">Midhun Ben  Thomas</span>, <span class="hlFld-ContribAuthor ">Insiya  Mukadam</span>, <span class="hlFld-ContribAuthor ">Saumya  Nigam</span>, <span class="hlFld-ContribAuthor ">JoEllyn  McMillan</span>, <span class="hlFld-ContribAuthor ">Santhi  Gorantla</span>, <span class="hlFld-ContribAuthor ">Tatiana K.  Bronich</span>, <span class="hlFld-ContribAuthor ">Benson  Edagwa</span>, <span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>. </span><span class="cited-content_cbyCitation_article-title">Neurotheranostics as personalized medicines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2019,</strong> <em>148 </em>, 252-289. <a href="https://doi.org/10.1016/j.addr.2018.10.011" title="DOI URL">https://doi.org/10.1016/j.addr.2018.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2018.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2018.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DNeurotheranostics%252Bas%252Bpersonalized%252Bmedicines%26aulast%3DKevadiya%26aufirst%3DBhavesh%2BD.%26date%3D2019%26volume%3D148%26spage%3D252%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praveena  Velpurisiva</span>, <span class="hlFld-ContribAuthor ">Janel L.  Kydd</span>, <span class="hlFld-ContribAuthor ">Rahul  Jadia</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Morris</span>, <span class="hlFld-ContribAuthor ">Prakash  Rai</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 3-12. <a href="https://doi.org/10.1007/978-3-030-01775-0_1" title="DOI URL">https://doi.org/10.1007/978-3-030-01775-0_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-01775-0_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-01775-0_1%26sid%3Dliteratum%253Aachs%26atitle%3DIntroduction%26aulast%3DVelpurisiva%26aufirst%3DPraveena%26date%3D2019%26date%3D2018%26spage%3D3%26epage%3D12%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNanotheranostics%252Bfor%252BCancer%252BApplications%26aulast%3DRai%26aufirst%3DPrakash%26date%3D2019%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohui  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Wang</span>, <span class="hlFld-ContribAuthor ">Zijian  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2018,</strong> <em>362 </em>, 72-84. <a href="https://doi.org/10.1016/j.ccr.2018.03.010" title="DOI URL">https://doi.org/10.1016/j.ccr.2018.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2018.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2018.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DMetal-involved%252Btheranostics%25253A%252BAn%252Bemerging%252Bstrategy%252Bfor%252Bfighting%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DWang%26aufirst%3DXiaohui%26date%3D2018%26volume%3D362%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Liu</span>, <span class="hlFld-ContribAuthor ">Yunwei  Qu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Amyloid β-targeted metal complexes for potential applications in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (6)
                                     , 679-701. <a href="https://doi.org/10.4155/fmc-2017-0248" title="DOI URL">https://doi.org/10.4155/fmc-2017-0248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0248%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAmyloid%252B%2525CE%2525B2-targeted%252Bmetal%252Bcomplexes%252Bfor%252Bpotential%252Bapplications%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DLiu%26aufirst%3DHao%26date%3D2018%26volume%3D10%26issue%3D6%26spage%3D679%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Karanasiou</span>, <span class="hlFld-ContribAuthor ">Maria  Koutsoupidou</span>. </span><span class="cited-content_cbyCitation_article-title">Towards Multispectral Multimodal Non-ionising Diagnosis and Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 211-241. <a href="https://doi.org/10.1007/978-3-319-75007-1_8" title="DOI URL">https://doi.org/10.1007/978-3-319-75007-1_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-75007-1_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-75007-1_8%26sid%3Dliteratum%253Aachs%26atitle%3DTowards%252BMultispectral%252BMultimodal%252BNon-ionising%252BDiagnosis%252Band%252BTherapy%26aulast%3DKaranasiou%26aufirst%3DIrene%26date%3D2018%26date%3D2018%26spage%3D211%26epage%3D241%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEmerging%252BElectromagnetic%252BTechnologies%252Bfor%252BBrain%252BDiseases%252BDiagnostics%25252C%252BMonitoring%252Band%252BTherapy%26aulast%3DCrocco%26aufirst%3DLorenzo%26date%3D2018%26volume%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ehtesham  Jameel</span>, <span class="hlFld-ContribAuthor ">Poonam  Meena</span>, <span class="hlFld-ContribAuthor ">Mudasir  Maqbool</span>, <span class="hlFld-ContribAuthor ">Jitendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Waqar  Ahmed</span>, <span class="hlFld-ContribAuthor ">Syed  Mumtazuddin</span>, <span class="hlFld-ContribAuthor ">Manisha  Tiwari</span>, <span class="hlFld-ContribAuthor ">Nasimul  Hoda</span>, <span class="hlFld-ContribAuthor ">B.  Jayaram</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>136 </em>, 36-51. <a href="https://doi.org/10.1016/j.ejmech.2017.04.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bscreening%252Bof%252Btriazine-triazolopyrimidine%252Bhybrids%252Bas%252Bmultitarget%252Banti-Alzheimer%252Bagents%26aulast%3DJameel%26aufirst%3DEhtesham%26date%3D2017%26volume%3D136%26spage%3D36%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ludovica  Zaccagnini</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>, <span class="hlFld-ContribAuthor ">Sandra  Gemma</span>, <span class="hlFld-ContribAuthor ">Giulia  Chemi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Legname</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Campiani</span>, <span class="hlFld-ContribAuthor ">Stefania  Butini</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel fluorescent probes preventing PrP Sc replication in prion diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 859-873. <a href="https://doi.org/10.1016/j.ejmech.2016.10.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.10.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.10.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252Bfluorescent%252Bprobes%252Bpreventing%252BPrP%252BSc%252Breplication%252Bin%252Bprion%252Bdiseases%26aulast%3DZaccagnini%26aufirst%3DLudovica%26date%3D2017%26volume%3D127%26spage%3D859%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloe F.  Allen</span>, <span class="hlFld-ContribAuthor ">Pamela J.  Shaw</span>, <span class="hlFld-ContribAuthor ">Laura  Ferraiuolo</span>. </span><span class="cited-content_cbyCitation_article-title">Can Astrocytes Be a Target for Precision Medicine?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 111-128. <a href="https://doi.org/10.1007/978-3-319-60733-7_7" title="DOI URL">https://doi.org/10.1007/978-3-319-60733-7_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-60733-7_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-60733-7_7%26sid%3Dliteratum%253Aachs%26atitle%3DCan%252BAstrocytes%252BBe%252Ba%252BTarget%252Bfor%252BPrecision%252BMedicine%25253F%26aulast%3DAllen%26aufirst%3DChloe%2BF.%26date%3D2017%26date%3D2017%26spage%3D111%26epage%3D128%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPersonalised%252BMedicine%26aulast%3DEl-Khamisy%26aufirst%3DSherif%26date%3D2017%26volume%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From Imaging Agents to Theranostic Drugs in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 74-106. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12285-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12285-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12285-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12285-1%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BImaging%252BAgents%252Bto%252BTheranostic%252BDrugs%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBolognesi%26aufirst%3DM.L.%26date%3D2017%26spage%3D74%26epage%3D106%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annachiara  Gandini</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Approaches to Prion Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 433-453. <a href="https://doi.org/10.1016/bs.pmbts.2017.06.013" title="DOI URL">https://doi.org/10.1016/bs.pmbts.2017.06.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmbts.2017.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmbts.2017.06.013%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BApproaches%252Bto%252BPrion%252BDiseases%26aulast%3DGandini%26aufirst%3DAnnachiara%26date%3D2017%26spage%3D433%26epage%3D453%26pub%3DElsevier%26atitle%3DPrion%252BProtein%26date%3D2017%26volume%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Mignani</span>, <span class="hlFld-ContribAuthor ">Maria  Bryszewska</span>, <span class="hlFld-ContribAuthor ">Maria  Zablocka</span>, <span class="hlFld-ContribAuthor ">Barbara  Klajnert-Maculewicz</span>, <span class="hlFld-ContribAuthor ">Josep  Cladera</span>, <span class="hlFld-ContribAuthor ">Dzmitry  Shcharbin</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Majoral</span>. </span><span class="cited-content_cbyCitation_article-title">Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches. </span><span class="cited-content_cbyCitation_journal-name">Progress in Polymer Science</span><span> <strong>2017,</strong> <em>64 </em>, 23-51. <a href="https://doi.org/10.1016/j.progpolymsci.2016.09.006" title="DOI URL">https://doi.org/10.1016/j.progpolymsci.2016.09.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.progpolymsci.2016.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.progpolymsci.2016.09.006%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Polymer%2520Science%26atitle%3DCan%252Bdendrimer%252Bbased%252Bnanoparticles%252Bfight%252Bneurodegenerative%252Bdiseases%25253F%252BCurrent%252Bsituation%252Bversus%252Bother%252Bestablished%252Bapproaches%26aulast%3DMignani%26aufirst%3DSerge%26date%3D2017%26volume%3D64%26spage%3D23%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pu Chun  Ke</span>, <span class="hlFld-ContribAuthor ">Marc-Antonie  Sani</span>, <span class="hlFld-ContribAuthor ">Feng  Ding</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kakinen</span>, <span class="hlFld-ContribAuthor ">Ibrahim  Javed</span>, <span class="hlFld-ContribAuthor ">Frances  Separovic</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Davis</span>, <span class="hlFld-ContribAuthor ">Raffaele  Mezzenga</span>. </span><span class="cited-content_cbyCitation_article-title">Implications of peptide assemblies in amyloid diseases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2017,</strong> <em>46 </em>
                                    (21)
                                     , 6492-6531. <a href="https://doi.org/10.1039/C7CS00372B" title="DOI URL">https://doi.org/10.1039/C7CS00372B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CS00372B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CS00372B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DImplications%252Bof%252Bpeptide%252Bassemblies%252Bin%252Bamyloid%252Bdiseases%26aulast%3DKe%26aufirst%3DPu%2BChun%26date%3D2017%26date%3D2017%26volume%3D46%26issue%3D21%26spage%3D6492%26epage%3D6531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margit  Pissarek</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule-Assisted PET: Approaches to Imaging of Conformational Diseases of the Brain. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Neuroscience</span><span> <strong>2017,</strong> <em>07 </em>
                                    (01)
                                     , 106-139. <a href="https://doi.org/10.4236/wjns.2017.71010" title="DOI URL">https://doi.org/10.4236/wjns.2017.71010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4236/wjns.2017.71010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4236%2Fwjns.2017.71010%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Neuroscience%26atitle%3DSmall%252BMolecule-Assisted%252BPET%25253A%252BApproaches%252Bto%252BImaging%252Bof%252BConformational%252BDiseases%252Bof%252Bthe%252BBrain%26aulast%3DPissarek%26aufirst%3DMargit%26date%3D2017%26volume%3D07%26issue%3D01%26spage%3D106%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Amyloid PET imaging agents used in clinics (<b>1</b>–<b>3</b>) or in vivo human studies (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of BACE-1 inhibitor <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Development of the first fluorescent CDx validated in an AD mouse model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design strategy of theranostics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Theranostic profile of <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Theranostic profile of <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Rational pathway to curcumin-based theranostic <b>11</b> and its theranostic profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Theranostic profile of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/medium/jm-2016-001517_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Theranostic profile of <b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00151/20160901/images/large/jm-2016-001517_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00151&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i15">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 86 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eaRxNWDigHF1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>World Alzheimer Report 2015: The global impact of dementia, Alzheimer’s Disease International 2015. <a href="http://www.alz.co.uk/research/statistics" class="extLink">http://www.alz.co.uk/research/statistics</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report+2015%3A+The+global+impact+of+dementia%2C+Alzheimer%E2%80%99s+Disease+International+2015.+http%3A%2F%2Fwww.alz.co.uk%2Fresearch%2Fstatistics+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Fargo, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Au, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drachman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gitlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrup, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khachaturian, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khachaturian, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukull, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logsdon, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesulam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plassman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span> </span><span class="NLM_article-title">2014 Report on the milestones for the US national plan to address Alzheimer’s Disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">S430</span><span class="NLM_x">–</span> <span class="NLM_lpage">S452</span><span class="refDoi"> DOI: 10.1016/j.jalz.2014.08.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.jalz.2014.08.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=S430-S452&author=K.+N.+Fargoauthor=P.+Aisenauthor=M.+Albertauthor=R.+Auauthor=M.+M.+Corradaauthor=S.+DeKoskyauthor=D.+Drachmanauthor=H.+Fillitauthor=L.+Gitlinauthor=M.+Haasauthor=K.+Herrupauthor=C.+Kawasauthor=A.+S.+Khachaturianauthor=Z.+S.+Khachaturianauthor=W.+Klunkauthor=D.+Knopmanauthor=W.+A.+Kukullauthor=B.+Lambauthor=R.+G.+Logsdonauthor=P.+Maruffauthor=M.+Mesulamauthor=W.+Mobleyauthor=R.+Mohsauthor=D.+Morganauthor=R.+A.+Nixonauthor=S.+Paulauthor=R.+Petersenauthor=B.+Plassmanauthor=W.+Potterauthor=E.+Reimanauthor=B.+Reisbergauthor=M.+Sanoauthor=R.+Schindlerauthor=L.+S.+Schneiderauthor=P.+J.+Snyderauthor=R.+A.+Sperlingauthor=K.+Yaffeauthor=L.+J.+Bainauthor=W.+H.+Thiesauthor=M.+C.+Carrillo&title=2014+Report+on+the+milestones+for+the+US+national+plan+to+address+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.jalz.2014.08.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.08.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.08.103%26sid%3Dliteratum%253Aachs%26aulast%3DFargo%26aufirst%3DK.%2BN.%26aulast%3DAisen%26aufirst%3DP.%26aulast%3DAlbert%26aufirst%3DM.%26aulast%3DAu%26aufirst%3DR.%26aulast%3DCorrada%26aufirst%3DM.%2BM.%26aulast%3DDeKosky%26aufirst%3DS.%26aulast%3DDrachman%26aufirst%3DD.%26aulast%3DFillit%26aufirst%3DH.%26aulast%3DGitlin%26aufirst%3DL.%26aulast%3DHaas%26aufirst%3DM.%26aulast%3DHerrup%26aufirst%3DK.%26aulast%3DKawas%26aufirst%3DC.%26aulast%3DKhachaturian%26aufirst%3DA.%2BS.%26aulast%3DKhachaturian%26aufirst%3DZ.%2BS.%26aulast%3DKlunk%26aufirst%3DW.%26aulast%3DKnopman%26aufirst%3DD.%26aulast%3DKukull%26aufirst%3DW.%2BA.%26aulast%3DLamb%26aufirst%3DB.%26aulast%3DLogsdon%26aufirst%3DR.%2BG.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DMesulam%26aufirst%3DM.%26aulast%3DMobley%26aufirst%3DW.%26aulast%3DMohs%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DNixon%26aufirst%3DR.%2BA.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DPetersen%26aufirst%3DR.%26aulast%3DPlassman%26aufirst%3DB.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DReiman%26aufirst%3DE.%26aulast%3DReisberg%26aufirst%3DB.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DYaffe%26aufirst%3DK.%26aulast%3DBain%26aufirst%3DL.%2BJ.%26aulast%3DThies%26aufirst%3DW.%2BH.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26atitle%3D2014%2520Report%2520on%2520the%2520milestones%2520for%2520the%2520US%2520national%2520plan%2520to%2520address%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3DS430%26epage%3DS452%26doi%3D10.1016%2Fj.jalz.2014.08.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Reardon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledford, H.</span><span> </span><span class="NLM_article-title">Biomedicine wins big in US budget deal</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">528</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="refDoi"> DOI: 10.1038/nature.2015.19057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnature.2015.19057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=528&publication_year=2015&pages=446&author=S.+Reardonauthor=C.+Cesareauthor=H.+Ledford&title=Biomedicine+wins+big+in+US+budget+deal&doi=10.1038%2Fnature.2015.19057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature.2015.19057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature.2015.19057%26sid%3Dliteratum%253Aachs%26aulast%3DReardon%26aufirst%3DS.%26aulast%3DCesare%26aufirst%3DC.%26aulast%3DLedford%26aufirst%3DH.%26atitle%3DBiomedicine%2520wins%2520big%2520in%2520US%2520budget%2520deal%26jtitle%3DNature%26date%3D2015%26volume%3D528%26spage%3D446%26doi%3D10.1038%2Fnature.2015.19057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Amyloid chemical probes and theranostics: steps toward personalized medicine in neurodegenerative diseases</span>. In  <span class="citation_source-book">Medicinal Chemistry Approaches to Personalized Medicine</span>; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span>, DOI: <span class="refDoi"> DOI: 10.1002/9783527677252.ch09</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2F9783527677252.ch09" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=211-226&author=M.+L.+Bolognesi&title=Medicinal+Chemistry+Approaches+to+Personalized+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F9783527677252.ch09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677252.ch09%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DAmyloid%2520chemical%2520probes%2520and%2520theranostics%253A%2520steps%2520toward%2520personalized%2520medicine%2520in%2520neurodegenerative%2520diseases%26btitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Personalized%2520Medicine%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2013%26spage%3D211%26epage%3D226%26doi%3D10.1002%2F9783527677252.ch09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Souslova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marple, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiekerman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, A. A.</span><span> </span><span class="NLM_article-title">Personalized medicine in Alzheimer’s disease and depression</span> <span class="citation_source-journal">Contemp. Clin. Trials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1016/j.cct.2013.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.cct.2013.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23816492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC3sjntV2jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=616-623&author=T.+Souslovaauthor=T.+C.+Marpleauthor=A.+M.+Spiekermanauthor=A.+A.+Mohammad&title=Personalized+medicine+in+Alzheimer%E2%80%99s+disease+and+depression&doi=10.1016%2Fj.cct.2013.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Personalized medicine in Alzheimer's disease and depression</span></div><div class="casAuthors">Souslova Tatiana; Marple Teresa C; Spiekerman A Michael; Mohammad Amin A</div><div class="citationInfo"><span class="NLM_cas:title">Contemporary clinical trials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">616-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Latest research in the mental health field brings new hope to patients and promises to revolutionize the field of psychiatry.  Personalized pharmacogenetic tests that aid in diagnosis and treatment choice are now becoming available for clinical practice.  Amyloid beta peptide biomarkers in the cerebrospinal fluid of patients with Alzheimer's disease are now available.  For the first time, radiologists are able to visualize amyloid plaques specific to Alzheimer's disease in live patients using Positron Emission Tomography-based tests approved by the FDA.  A novel blood-based assay has been developed to aid in the diagnosis of depression based on activation of the HPA axis, metabolic, inflammatory and neurochemical pathways.  Serotonin reuptake inhibitors have shown increased remission rates in specific ethnic subgroups and Cytochrome P450 gene polymorphisms can predict antidepressant tolerability.  The latest research will help to eradicate "trial and error" prescription, ushering in the most personalized medicine to date.  Like all major medical breakthroughs, integration of new algorithms and technologies requires sound science and time.  But for many mentally ill patients, diagnosis and effective therapy cannot happen fast enough.  This review will describe the newest diagnostic tests, treatments and clinical studies for the diagnosis and treatment of Alzheimer's disease and unipolar, major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyswBhY31_vthSDZx9hyjKfW6udTcc2eYl1lR0JMzf0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjntV2jtw%253D%253D&md5=33a0c6b1220658c92e3ddb38f7f6cbf2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cct.2013.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cct.2013.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DSouslova%26aufirst%3DT.%26aulast%3DMarple%26aufirst%3DT.%2BC.%26aulast%3DSpiekerman%26aufirst%3DA.%2BM.%26aulast%3DMohammad%26aufirst%3DA.%2BA.%26atitle%3DPersonalized%2520medicine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520depression%26jtitle%3DContemp.%2520Clin.%2520Trials%26date%3D2013%26volume%3D36%26spage%3D616%26epage%3D623%26doi%3D10.1016%2Fj.cct.2013.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieves, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganley, C.</span><span> </span><span class="NLM_article-title">Brain amyloid imaging-FDA approval of florbetapir F18 injection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span><span class="refDoi"> DOI: 10.1056/NEJMp1208061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1056%2FNEJMp1208061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22931256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlChsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=885-887&author=L.+Yangauthor=D.+Rievesauthor=C.+Ganley&title=Brain+amyloid+imaging-FDA+approval+of+florbetapir+F18+injection&doi=10.1056%2FNEJMp1208061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Brain amyloid imaging - FDA approval of florbetapir F18 injection</span></div><div class="casAuthors">Yang, Lucie; Rieves, Dwaine; Ganley, Charles</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">885-887</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquQxrP57ikw7Vg90H21EOLACvtfcHk0lgtdXXlJcw7Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlChsLnK&md5=d28e3e41b842a718ca63f2ee53294986</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1208061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1208061%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DRieves%26aufirst%3DD.%26aulast%3DGanley%26aufirst%3DC.%26atitle%3DBrain%2520amyloid%2520imaging-FDA%2520approval%2520of%2520florbetapir%2520F18%2520injection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D885%26epage%3D887%26doi%3D10.1056%2FNEJMp1208061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography radioligands for in vivo imaging of Abeta plaques</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1002/jlcr.2989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fjlcr.2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24285314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=89-95&author=N.+S.+Masonauthor=C.+A.+Mathisauthor=W.+E.+Klunk&title=Positron+emission+tomography+radioligands+for+in+vivo+imaging+of+Abeta+plaques&doi=10.1002%2Fjlcr.2989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span></div><div class="casAuthors">Mason, N. Scott; Mathis, Chester A.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) radioligands for the non-invasive imaging of amyloid-β plaque burden has been the focus of intense research efforts over the last decade.  A variety of structural backbones have been investigated and several radiolabeled mols. have been evaluated in phase I (and later) clin. studies.  These efforts have been driven by the desire not only to develop a suitable diagnostic imaging agent but also to develop a means to evaluate potential therapies for Alzheimer's disease.  This review focuses on the development of these ligands, as well as the radiochem. and current regulatory status of these PET radioligands.  Particular attention is given to those ligands that have progressed to the later stages of drug development (phase II/III clin. trial studies) or approved New Drug Application status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhPmau7iHILVg90H21EOLACvtfcHk0lgtdXXlJcw7Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D&md5=423e02bcc2709e718d7a32adb552f81f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2989%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520Abeta%2520plaques%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D89%26epage%3D95%26doi%3D10.1002%2Fjlcr.2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span> </span><span class="NLM_article-title">Discovery of innovative therapeutics: today’s realities and tomorrow’s vision. 2. Pharma’s challenges and their commitment to innovation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5525</span><span class="NLM_x">–</span> <span class="NLM_lpage">5553</span><span class="refDoi"> DOI: 10.1021/jm401564r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401564r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5525-5553&author=M.+Abou-Gharbiaauthor=W.+E.+Childers&title=Discovery+of+innovative+therapeutics%3A+today%E2%80%99s+realities+and+tomorrow%E2%80%99s+vision.+2.+Pharma%E2%80%99s+challenges+and+their+commitment+to+innovation&doi=10.1021%2Fjm401564r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision. 2. Pharma's Challenges and Their Commitment to Innovation</span></div><div class="casAuthors">Abou-Gharbia, Magid; Childers, Wayne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is facing enormous challenges, including reduced efficiency, stagnant success rate, patent expirations for key drugs, fierce price competition from generics, high regulatory hurdles, and the industry's perceived tarnished image.  Pharma has responded by embarking on a range of initiatives.  Other sectors, including NIH, have also responded.  Academic drug discovery groups have appeared to support the transition of innovative academic discoveries and ideas into attractive drug discovery opportunities.  Part 1 of this two-part series discussed the criticisms that have been leveled at the pharmaceutical industry over the past 3 decades and summarized the supporting data for and against these criticisms.  This second installment will focus on the current challenges facing the pharmaceutical industry and Pharma's responses, focusing on the industry's changing perspective and new business models for coping with the loss of talent and declining clin. pipelines as well as presenting some examples of recent drug discovery successes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4lpJv0KTwLVg90H21EOLACvtfcHk0lgtdXXlJcw7Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeksw%253D%253D&md5=81598458e7db3879f2e5bb67d5b40eb3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401564r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401564r%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26atitle%3DDiscovery%2520of%2520innovative%2520therapeutics%253A%2520today%25E2%2580%2599s%2520realities%2520and%2520tomorrow%25E2%2580%2599s%2520vision.%25202.%2520Pharma%25E2%2580%2599s%2520challenges%2520and%2520their%2520commitment%2520to%2520innovation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5525%26epage%3D5553%26doi%3D10.1021%2Fjm401564r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">The beta-amyloid hypothesis in Alzheimer’s disease: seeing is believing</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1021/ml300058m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300058m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=265-267&author=H.+F.+Kung&title=The+beta-amyloid+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+seeing+is+believing&doi=10.1021%2Fml300058m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml300058m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300058m%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DThe%2520beta-amyloid%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520seeing%2520is%2520believing%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D265%26epage%3D267%26doi%3D10.1021%2Fml300058m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipf, P.</span><span> </span><span class="NLM_article-title">Contributions of academic laboratories to the discovery and development of chemical biology tools</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7161</span><span class="NLM_x">–</span> <span class="NLM_lpage">7176</span><span class="refDoi"> DOI: 10.1021/jm400132d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400132d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7161-7176&author=D.+M.+Hurynauthor=L.+O.+Resnickauthor=P.+Wipf&title=Contributions+of+academic+laboratories+to+the+discovery+and+development+of+chemical+biology+tools&doi=10.1021%2Fjm400132d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm400132d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400132d%26sid%3Dliteratum%253Aachs%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DResnick%26aufirst%3DL.%2BO.%26aulast%3DWipf%26aufirst%3DP.%26atitle%3DContributions%2520of%2520academic%2520laboratories%2520to%2520the%2520discovery%2520and%2520development%2520of%2520chemical%2520biology%2520tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7161%26epage%3D7176%26doi%3D10.1021%2Fjm400132d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lidnribRIbCrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghbel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langstrom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoilund-Carlsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Amyloid-beta positron emission tomography imaging probes: a critical review</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span><span class="refDoi"> DOI: 10.3233/JAD-130485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3233%2FJAD-130485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23648516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=613-631&author=V.+Kepeauthor=M.+C.+Moghbelauthor=B.+Langstromauthor=H.+Zaidiauthor=H.+V.+Vintersauthor=S.+C.+Huangauthor=N.+Satyamurthyauthor=D.+Doudetauthor=E.+Mishaniauthor=R.+M.+Cohenauthor=P.+F.+Hoilund-Carlsenauthor=A.+Alaviauthor=J.+R.+Barrio&title=Amyloid-beta+positron+emission+tomography+imaging+probes%3A+a+critical+review&doi=10.3233%2FJAD-130485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review</span></div><div class="casAuthors">Kepe, Vladimir; Moghbel, Mateen C.; Langstroem, Bengt; Zaidi, Habib; Vinters, Harry V.; Huang, Sung-Cheng; Satyamurthy, Nagichettiar; Doudet, Doris; Mishani, Eyal; Cohen, Robert M.; Hoilund-Carlsen, Poul F.; Alavi, Abass; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-631</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The rapidly rising prevalence and cost of Alzheimer's disease in recent decades has made the imaging of amyloid-β deposits the focus of intense research.  Several amyloid imaging probes with purported specificity for amyloid-β plaques are currently at various stages of FDA approval.  However, a no. of factors appear to preclude these probes from clin. utilization.  As the available "amyloid specific" positron emission tomog. imaging probes have failed to demonstrate diagnostic value and have shown limited utility for monitoring therapeutic interventions in humans, a debate on their significance has emerged.  The aim of this review is to identify and discuss critically the scientific issues contributing to the extensive inconsistencies reported in the literature on their purported in vivo amyloid specificity and potential utilization in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVE_xuB1karVg90H21EOLACvtfcHk0lidnribRIbCrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI&md5=deefdf403451d2621afdbc31ae9cc4a9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJAD-130485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130485%26sid%3Dliteratum%253Aachs%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DMoghbel%26aufirst%3DM.%2BC.%26aulast%3DLangstrom%26aufirst%3DB.%26aulast%3DZaidi%26aufirst%3DH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DDoudet%26aufirst%3DD.%26aulast%3DMishani%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DR.%2BM.%26aulast%3DHoilund-Carlsen%26aufirst%3DP.%2BF.%26aulast%3DAlavi%26aufirst%3DA.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DAmyloid-beta%2520positron%2520emission%2520tomography%2520imaging%2520probes%253A%2520a%2520critical%2520review%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D36%26spage%3D613%26epage%3D631%26doi%3D10.3233%2FJAD-130485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/S1474-4422(14)70252-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions&doi=10.1016%2FS1474-4422%2814%2970252-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2ebMIUAUCjFnObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124%26doi%3D10.1016%2FS1474-4422%2814%2970252-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span> </span><span class="NLM_article-title">Tau positron emission tomography (PET) imaging: past, present, and future</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4382</span><span class="refDoi"> DOI: 10.1021/jm5017544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4365-4382&author=M.+Arizaauthor=H.+C.+Kolbauthor=D.+Moecharsauthor=F.+Romboutsauthor=J.+I.+Andres&title=Tau+positron+emission+tomography+%28PET%29+imaging%3A+past%2C+present%2C+and+future&doi=10.1021%2Fjm5017544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future</span></div><div class="casAuthors">Ariza, Manuela; Kolb, Hartmuth C.; Moechars, Dieder; Rombouts, Frederik; Andres, Jose Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4365-4382</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population.  The good correlation of the d. and neocortical spread of neurofibrillary tangles (NFTs) with clin. AD disease progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging technique such as positron emission tomog. (PET).  Thus, PET imaging of NFTs not only holds promise as a diagnostic tool but also may enable the development of disease modifying therapeutics for AD.  In this review, we focus on the structural diversity of tau PET tracers, the challenges related to the identification of high affinity and highly selective NFT ligands, and recent progress in the clin. development of tau PET radioligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr59qS3XVaWtrVg90H21EOLACvtfcHk0liN82RDC_i00A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D&md5=4d6974529735d3483482e5d7365440e0</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017544%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26atitle%3DTau%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4365%26epage%3D4382%26doi%3D10.1021%2Fjm5017544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Characteristics of tau and its ligands in PET imaging</span> <span class="citation_source-journal">Biomolecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="refDoi"> DOI: 10.3390/biom6010007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3390%2Fbiom6010007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=7&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=T.+Tagoauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=Characteristics+of+tau+and+its+ligands+in+PET+imaging&doi=10.3390%2Fbiom6010007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3390%2Fbiom6010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom6010007%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DCharacteristics%2520of%2520tau%2520and%2520its%2520ligands%2520in%2520PET%2520imaging%26jtitle%3DBiomolecules%26date%3D2016%26volume%3D6%26spage%3D7%26doi%3D10.3390%2Fbiom6010007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.07.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.neuron.2013.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24050400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1094-1108&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.+R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.+K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+a+tauopathy+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls&doi=10.1016%2Fj.neuron.2013.07.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls</span></div><div class="casAuthors">Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M.-Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1108</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies.  Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders.  In vivo optical and positron emission tomog. (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs.  A pyridinated PBB, [11C]PBB3, was next applied in a clin. PET study, and its robust signal in the AD hippocampus wherein tau pathol. is enriched contrasted strikingly with that of a senile plaque radioligand, [11C]Pittsburgh Compd.-B ([11C]PIB). [11C]PBB3-PET data were also consistent with the spreading of tau pathol. with AD progression.  Furthermore, increased [11C]PBB3 signals were found in a corticobasal syndrome patient neg. for [11C]PIB-PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD931Df6cdi7Vg90H21EOLACvtfcHk0ljjaTY-TfeOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL&md5=7f1092519ce6b0f9c33a67e5364ba7b6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520a%2520tauopathy%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1094%26epage%3D1108%26doi%3D10.1016%2Fj.neuron.2013.07.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Xia, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.+F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B%2818%29F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2eZPey4wbHQW5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.%2BF.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B%252818%2529F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span><span class="refDoi"> DOI: 10.1007/s00259-013-2681-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1007%2Fs00259-013-2681-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24514874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=816-826&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=J.+Hodgesauthor=R.+Haradaauthor=P.+Yatesauthor=O.+Piguetauthor=S.+Pejoskaauthor=V.+Doreauthor=K.+Yanaiauthor=C.+L.+Mastersauthor=Y.+Kudoauthor=C.+C.+Roweauthor=N.+Okamura&title=In+vivo+evaluation+of+a+novel+tau+imaging+tracer+for+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-013-2681-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle T.; Mulligan, Rachel S.; Hodges, John; Harada, Ryuichi; Yates, Paul; Piguet, Olivier; Pejoska, Svetlana; Dore, Vincent; Yanai, Kazuhiko; Masters, Colin L.; Kudo, Yukitsuka; Rowe, Christopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Diagnosis of tauopathies such as Alzheimer's disease (AD) still relies on post-mortem examn. of the human brain.  A non-invasive method of detg. brain tau burden in vivo would allow a better understanding of the pathophysiol. of tauopathies.  The purpose of the study was to evaluate 18F-THK523 as a potential tau imaging tracer.  Methods: Ten healthy elderly controls, three semantic dementia (SD) and ten AD patients underwent neuropsychol. examn., MRI as well as 18F-THK523 and 11C-Pittsburgh compd. B (PIB) positron emission tomog. (PET) scans.  Composite memory and non-memory scores, global and hippocampal brain vol., and partial vol.-cor. tissue ratios for 18F-THK523 and 11C-PIB were estd. for all participants.  Correlational analyses were performed between global and regional 18F-THK523, 11C-PIB, cognition and brain volumetrics.  Results: 18F-THK523 presented with fast reversible kinetics.  Significantly higher 18F-THK523 retention was obsd. in the temporal, parietal, orbitofrontal and hippocampi of AD patients when compared to healthy controls and SD patients.  White matter retention was significantly higher than gray matter retention in all participants.  The pattern of cortical 18F-THK523 retention did not correlate with Aβ distribution as assessed by 11C-PIB and followed the known distribution of tau in the AD brain, being higher in temporal and parietal areas than in the frontal region.  Unlike 11C-PIB, hippocampal 18F-THK523 retention was correlated with several cognitive parameters and with hippocampal atrophy.  Conclusion: 18F-THK523 does not bind to Aβ in vivo, while following the known distribution of paired helical filaments (PHF)-tau in the brain.  Significantly higher cortical 18F-THK523 retention in AD patients as well as the assocn. of hippocampal 18F-THK523 retention with cognitive parameters and hippocampal vol. suggests 18F-THK523 selectively binds to tau in AD patients.  Unfortunately, the very high 18F-THK523 retention in white matter precludes simple visual inspection of the images, preventing its use in research or clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkefkNuzPCr7Vg90H21EOLACvtfcHk0lj9g5vzbdlEyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D&md5=d995c47f394f706c5164913e7024f1fa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2681-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2681-7%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHodges%26aufirst%3DJ.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPiguet%26aufirst%3DO.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DDore%26aufirst%3DV.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520a%2520novel%2520tau%2520imaging%2520tracer%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D816%26epage%3D826%26doi%3D10.1007%2Fs00259-013-2681-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.2967/jnumed.115.164848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2967%2Fjnumed.115.164848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26541774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=208-214&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=T.+Tagoauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=18F-THK5351%3A+a+novel+PET+radiotracer+for+imaging+neurofibrillary+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.115.164848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Tago, Tetsuro; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Imaging of neurofibrillary pathol. in the brain helps in diagnosing dementia, tracking disease progression, and evaluating the therapeutic efficacy of antidementia drugs.  The radiotracers used in this imaging must be highly sensitive and specific for tau protein fibrils in the human brain.  We developed a novel tau PET tracer, 18F-THK5351, through compd. optimization of arylquinoline derivs.  Methods: The in vitro binding properties, pharmacokinetics, and safety of 18F-THK5351 were investigated, and a clin. study on Alzheimer disease (AD) patients was performed.  Results:18F-THK5351 demonstrated higher binding affinity for hippocampal homogenates from AD brains and faster dissocn. from white-matter tissue than did 18F-THK5117.  The THK5351 binding amt. correlated with the amt. of tau deposits in human brain samples.  Autoradiog. of brain sections revealed that THK5351 bound to neurofibrillary tangles selectively and with a higher signal-to-background ratio than did THK5117.  THK5351 exhibited favorable pharmacokinetics and no defluorination in mice.  In first-in-human PET studies in AD patients, 18F-THK5351 demonstrated faster kinetics, higher contrast, and lower retention in subcortical white matter than 18F-THK5117.  Conclusion:18F-THK5351 is a useful PET tracer for the early detection of neurofibrillary pathol. in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1_bH5nh_KBLVg90H21EOLACvtfcHk0ljabl1krkgocA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D&md5=f488c442abb7ca31d5b66fbe60afd14e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.164848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.164848%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D18F-THK5351%253A%2520a%2520novel%2520PET%2520radiotracer%2520for%2520imaging%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D208%26epage%3D214%26doi%3D10.2967%2Fjnumed.115.164848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Nordberg, A.</span><span> </span><span class="NLM_article-title">The use of amyloid imaging in clinical praxis: a critical review</span> <span class="citation_source-journal">Clin. Transl. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1007/s40336-015-0100-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1007%2Fs40336-015-0100-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=7-11&author=A.+Nordberg&title=The+use+of+amyloid+imaging+in+clinical+praxis%3A+a+critical+review&doi=10.1007%2Fs40336-015-0100-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs40336-015-0100-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40336-015-0100-8%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DThe%2520use%2520of%2520amyloid%2520imaging%2520in%2520clinical%2520praxis%253A%2520a%2520critical%2520review%26jtitle%3DClin.%2520Transl.%2520Imaging%26date%3D2015%26volume%3D3%26spage%3D7%26epage%3D11%26doi%3D10.1007%2Fs40336-015-0100-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Weissleder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahrendorf, M.</span><span> </span><span class="NLM_article-title">Advancing biomedical imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">14424</span><span class="NLM_x">–</span> <span class="NLM_lpage">14428</span><span class="refDoi"> DOI: 10.1073/pnas.1508524112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1073%2Fpnas.1508524112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=14424-14428&author=R.+Weisslederauthor=M.+Nahrendorf&title=Advancing+biomedical+imaging&doi=10.1073%2Fpnas.1508524112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1508524112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1508524112%26sid%3Dliteratum%253Aachs%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DNahrendorf%26aufirst%3DM.%26atitle%3DAdvancing%2520biomedical%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D14424%26epage%3D14428%26doi%3D10.1073%2Fpnas.1508524112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Patterson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saba, R.</span><span> </span><span class="NLM_article-title">The emerging use of in vivo optical imaging in the study of neurodegenerative diseases</span> <span class="citation_source-journal">BioMed Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2014</span><span class="NLM_x">, </span> <span class="NLM_fpage">401306</span><span class="refDoi"> DOI: 10.1155/2014/401306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1155%2F2014%2F401306" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=401306&author=A.+P.+Pattersonauthor=S.+A.+Boothauthor=R.+Saba&title=The+emerging+use+of+in+vivo+optical+imaging+in+the+study+of+neurodegenerative+diseases&doi=10.1155%2F2014%2F401306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1155%2F2014%2F401306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F401306%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DA.%2BP.%26aulast%3DBooth%26aufirst%3DS.%2BA.%26aulast%3DSaba%26aufirst%3DR.%26atitle%3DThe%2520emerging%2520use%2520of%2520in%2520vivo%2520optical%2520imaging%2520in%2520the%2520study%2520of%2520neurodegenerative%2520diseases%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D401306%26doi%3D10.1155%2F2014%2F401306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hintersteiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaton, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kneuer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeckli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederhold, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremlich, H. U.</span><span> </span><span class="NLM_article-title">In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span><span class="refDoi"> DOI: 10.1038/nbt1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnbt1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=15834405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvV2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=577-583&author=M.+Hintersteinerauthor=A.+Enzauthor=P.+Freyauthor=A.+L.+Jatonauthor=W.+Kinzyauthor=R.+Kneuerauthor=U.+Neumannauthor=M.+Rudinauthor=M.+Staufenbielauthor=M.+Stoeckliauthor=K.+H.+Wiederholdauthor=H.+U.+Gremlich&title=In+vivo+detection+of+amyloid-beta+deposits+by+near-infrared+imaging+using+an+oxazine-derivative+probe&doi=10.1038%2Fnbt1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe</span></div><div class="casAuthors">Hintersteiner, Martin; Enz, Albert; Frey, Peter; Jaton, Anne-Lise; Kinzy, Willy; Kneuer, Rainer; Neumann, Ulf; Rudin, Markus; Staufenbiel, Matthias; Stoeckli, Markus; Wiederhold, Karl-Heinz; Gremlich, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">577-583</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">As Alzheimer's disease pathogenesis is assocd. with the formation of insol. aggregates of amyloid β-peptide, approaches allowing the direct, noninvasive visualization of plaque growth in vivo would be beneficial for biomedical research.  Here we describe the synthesis and characterization of the near-IR fluorescence oxazine dye AOI987, which readily penetrates the intact blood-brain barrier and binds to amyloid plaques.  Using near-IR fluorescence imaging, we demonstrated specific interaction of AOI987 with amyloid plaques in APP23 transgenic mice in vivo, as confirmed by postmortem anal. of brain slices.  Quant. anal. revealed increasing fluorescence signal intensity with increasing plaque load of the animals, and significant binding of AOI987 was obsd. for APP23 transgenic mice aged 9 mo and older.  Thus, AOI987 is an attractive probe to noninvasively monitor disease progression in animal models of Alzheimer disease and to evaluate effects of potential Alzheimer disease drugs on the plaque load.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV-7ZQiYjcRrVg90H21EOLACvtfcHk0liHLcNMKGSyOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvV2ntbo%253D&md5=d4664e3400e16e4cf11eb5fefd5f05d6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnbt1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1085%26sid%3Dliteratum%253Aachs%26aulast%3DHintersteiner%26aufirst%3DM.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DFrey%26aufirst%3DP.%26aulast%3DJaton%26aufirst%3DA.%2BL.%26aulast%3DKinzy%26aufirst%3DW.%26aulast%3DKneuer%26aufirst%3DR.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRudin%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DStoeckli%26aufirst%3DM.%26aulast%3DWiederhold%26aufirst%3DK.%2BH.%26aulast%3DGremlich%26aufirst%3DH.%2BU.%26atitle%3DIn%2520vivo%2520detection%2520of%2520amyloid-beta%2520deposits%2520by%2520near-infrared%2520imaging%2520using%2520an%2520oxazine-derivative%2520probe%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D577%26epage%3D583%26doi%3D10.1038%2Fnbt1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Going deeper than microscopy: the optical imaging frontier in biology</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1038/nmeth.1483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnmeth.1483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=20676081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFWktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=603-614&author=V.+Ntziachristos&title=Going+deeper+than+microscopy%3A+the+optical+imaging+frontier+in+biology&doi=10.1038%2Fnmeth.1483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Going deeper than microscopy: the optical imaging frontier in biology</span></div><div class="casAuthors">Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">603-614</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Optical microscopy was a fundamental tool of biol. discovery for more than 3 centuries, but its in vivo tissue imaging ability was restricted by light scattering to superficial investigations, even when confocal or multiphoton methods are used.  Recent advances in optical and optoacoustic (photoacoustic) imaging now allow imaging at depths and resolns. unprecedented for optical methods.  These abilities are increasingly important to understand the dynamic interactions of cellular processes at different systems levels, a major challenge of postgenome biol.  This review discusses promising photonic methods that have the ability to visualize cellular and subcellular components in tissues across different penetration scales.  The methods are classified into microscopic, mesoscopic and macroscopic approaches, according to the tissue depth at which they operate.  Key characteristics assocd. with different imaging implementations are described and the potential of these technologies in biol. applications is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW-553UGo1rLVg90H21EOLACvtfcHk0lhA__JFGgax-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFWktrw%253D&md5=fc156771476285e380880f6a20787839</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.1483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.1483%26sid%3Dliteratum%253Aachs%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DGoing%2520deeper%2520than%2520microscopy%253A%2520the%2520optical%2520imaging%2520frontier%2520in%2520biology%26jtitle%3DNat.%2520Methods%26date%3D2010%26volume%3D7%26spage%3D603%26epage%3D614%26doi%3D10.1038%2Fnmeth.1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Horton, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffer, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span> </span><span class="NLM_article-title">Three-photon microscopy of subcortical structures within an intact mouse brain</span> <span class="citation_source-journal">Nat. Photonics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1038/nphoton.2012.336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnphoton.2012.336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=205-209&author=N.+G.+Hortonauthor=K.+Wangauthor=D.+Kobatauthor=C.+G.+Clarkauthor=F.+W.+Wiseauthor=C.+B.+Schafferauthor=C.+Xu&title=Three-photon+microscopy+of+subcortical+structures+within+an+intact+mouse+brain&doi=10.1038%2Fnphoton.2012.336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo three-photon microscopy of subcortical structures within an intact mouse brain</span></div><div class="casAuthors">Horton, Nicholas G.; Wang, Ke; Kobat, Demirhan; Clark, Catharine G.; Wise, Frank W.; Schaffer, Chris B.; Xu, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Nature Photonics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-209</span>CODEN:
                <span class="NLM_cas:coden">NPAHBY</span>;
        ISSN:<span class="NLM_cas:issn">1749-4885</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two-photon fluorescence microscopy enables scientists in various fields including neuroscience, embryol. and oncol. to visualize in vivo and ex vivo tissue morphol. and physiol. at a cellular level deep within scattering tissue.  However, tissue scattering limits the max. imaging depth of two-photon fluorescence microscopy to the cortical layer within mouse brain, and imaging subcortical structures currently requires the removal of overlying brain tissue or the insertion of optical probes.  Here, we demonstrate non-invasive, high-resoln., in vivo imaging of subcortical structures within an intact mouse brain using three-photon fluorescence microscopy at a spectral excitation window of 1,700 nm.  Vascular structures as well as red fluorescent protein-labeled neurons within the mouse hippocampus are imaged.  The combination of the long excitation wavelength and the higher-order nonlinear excitation overcomes the limitations of two-photon fluorescence microscopy, enabling biol. investigations to take place at a greater depth within tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopuI0wojw38rVg90H21EOLACvtfcHk0lhA__JFGgax-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSmsro%253D&md5=5632c2e1351e985a9593236a6b2a35ae</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnphoton.2012.336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnphoton.2012.336%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DN.%2BG.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DKobat%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DWise%26aufirst%3DF.%2BW.%26aulast%3DSchaffer%26aufirst%3DC.%2BB.%26aulast%3DXu%26aufirst%3DC.%26atitle%3DThree-photon%2520microscopy%2520of%2520subcortical%2520structures%2520within%2520an%2520intact%2520mouse%2520brain%26jtitle%3DNat.%2520Photonics%26date%3D2013%26volume%3D7%26spage%3D205%26epage%3D209%26doi%3D10.1038%2Fnphoton.2012.336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antaris, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atochin, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span> </span><span class="NLM_article-title">Through-skull fluorescence imaging of the brain in a new near-infrared window</span> <span class="citation_source-journal">Nat. Photonics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1038/nphoton.2014.166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnphoton.2014.166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=27642366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gqtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=723-730&author=G.+Hongauthor=S.+Diaoauthor=J.+Changauthor=A.+L.+Antarisauthor=C.+Chenauthor=B.+Zhangauthor=S.+Zhaoauthor=D.+N.+Atochinauthor=P.+L.+Huangauthor=K.+I.+Andreassonauthor=C.+J.+Kuoauthor=H.+Dai&title=Through-skull+fluorescence+imaging+of+the+brain+in+a+new+near-infrared+window&doi=10.1038%2Fnphoton.2014.166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Through-skull fluorescence imaging of the brain in a new near-infrared window</span></div><div class="casAuthors">Hong, Guosong; Diao, Shuo; Chang, Junlei; Antaris, Alexander L.; Chen, Changxin; Zhang, Bo; Zhao, Su; Atochin, Dmitriy N.; Huang, Paul L.; Andreasson, Katrin I.; Kuo, Calvin J.; Dai, Hongjie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Photonics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">NPAHBY</span>;
        ISSN:<span class="NLM_cas:issn">1749-4885</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To date, brain imaging has largely relied on X-ray computed tomog. and magnetic resonance angiog., with their limited spatial resoln. and long scanning times.  Fluorescence-based brain imaging in the visible and traditional near-IR regions (400-900 nm) is an alternative, but at present it requires craniotomy, cranial windows and skull-thinning techniques, and the penetration depth is limited to 1-2 mm due to light scattering.  Here, we report through-scalp and through-skull fluorescence imaging of mouse cerebral vasculature without craniotomy, utilizing the intrinsic photoluminescence of single-walled carbon nanotubes in the 1.3-1.4 μm near-IR window (NIR-IIa window).  Reduced photon scattering in this spectral region allows fluorescence imaging to a depth of >2 mm in mouse brain with sub-10-μm resoln.  An imaging rate of ∼5.3 frames per s allows for dynamic recording of blood perfusion in the cerebral vessels with sufficient temporal resoln., providing real-time assessment of a blood flow anomaly in a mouse middle cerebral artery occlusion stroke model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvhesxmHWpbLVg90H21EOLACvtfcHk0lgwd5Mw049Aag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gqtr7P&md5=32b8a29327b6deb4e9113744f24373fe</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnphoton.2014.166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnphoton.2014.166%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DG.%26aulast%3DDiao%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DAntaris%26aufirst%3DA.%2BL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DAtochin%26aufirst%3DD.%2BN.%26aulast%3DHuang%26aufirst%3DP.%2BL.%26aulast%3DAndreasson%26aufirst%3DK.%2BI.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26aulast%3DDai%26aufirst%3DH.%26atitle%3DThrough-skull%2520fluorescence%2520imaging%2520of%2520the%2520brain%2520in%2520a%2520new%2520near-infrared%2520window%26jtitle%3DNat.%2520Photonics%26date%3D2014%26volume%3D8%26spage%3D723%26epage%3D730%26doi%3D10.1038%2Fnphoton.2014.166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolayev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohrs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Angelis, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography</span> <span class="citation_source-journal">Nat. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span><span class="refDoi"> DOI: 10.1038/nmeth.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnmeth.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22561987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFyjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=615-620&author=A.+Aleauthor=V.+Ermolayevauthor=E.+Herzogauthor=C.+Cohrsauthor=M.+H.+de+Angelisauthor=V.+Ntziachristos&title=FMT-XCT%3A+in+vivo+animal+studies+with+hybrid+fluorescence+molecular+tomography-X-ray+computed+tomography&doi=10.1038%2Fnmeth.2014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography</span></div><div class="casAuthors">Ale, Angelique; Ermolayev, Vladimir; Herzog, Eva; Cohrs, Christian; Hrabe de Angelis, Martin; Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">615-620</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of hybrid optical tomog. methods to improve imaging performance has been suggested over a decade ago and has been exptl. demonstrated in animals and humans.  Here we examd. in vivo performance of a camera-based hybrid fluorescence mol. tomog. (FMT) system for 360° imaging combined with X-ray computed tomog. (XCT).  Offering an accurately co-registered, information-rich hybrid data set, FMT-XCT has new imaging possibilities compared to stand-alone FMT and XCT.  We applied FMT-XCT to a s.c. 4T1 tumor mouse model, an Aga2 osteogenesis imperfecta model and a Kras lung cancer mouse model, using XCT information during FMT inversion.  We validated in vivo imaging results against post-mortem planar fluorescence images of cryoslices and histol. data.  Besides offering concurrent anatomical and functional information, FMT-XCT resulted in the most accurate FMT performance to date.  These findings indicate that addn. of FMT optics into the XCT gantry may be a potent upgrade for small-animal XCT systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdljBI7Q5QILVg90H21EOLACvtfcHk0lgwd5Mw049Aag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFyjtrw%253D&md5=914e10e04cf96080a99d62408779fce6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.2014%26sid%3Dliteratum%253Aachs%26aulast%3DAle%26aufirst%3DA.%26aulast%3DErmolayev%26aufirst%3DV.%26aulast%3DHerzog%26aufirst%3DE.%26aulast%3DCohrs%26aufirst%3DC.%26aulast%3Dde%2BAngelis%26aufirst%3DM.%2BH.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DFMT-XCT%253A%2520in%2520vivo%2520animal%2520studies%2520with%2520hybrid%2520fluorescence%2520molecular%2520tomography-X-ray%2520computed%2520tomography%26jtitle%3DNat.%2520Methods%26date%3D2012%26volume%3D9%26spage%3D615%26epage%3D620%26doi%3D10.1038%2Fnmeth.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gremse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doleschel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafarnia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnen-Dechent, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lederle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, F.</span><span> </span><span class="NLM_article-title">Hybrid μCT-FMT imaging and image analysis</span> <span class="citation_source-journal">J. Visualized Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52770</span><span class="refDoi"> DOI: 10.3791/52770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3791%2F52770" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=e52770&author=F.+Gremseauthor=D.+Doleschelauthor=S.+Zafarniaauthor=A.+Bablerauthor=W.+Jahnen-Dechentauthor=T.+Lammersauthor=W.+Lederleauthor=F.+Kiessling&title=Hybrid+%CE%BCCT-FMT+imaging+and+image+analysis&doi=10.3791%2F52770"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3791%2F52770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F52770%26sid%3Dliteratum%253Aachs%26aulast%3DGremse%26aufirst%3DF.%26aulast%3DDoleschel%26aufirst%3DD.%26aulast%3DZafarnia%26aufirst%3DS.%26aulast%3DBabler%26aufirst%3DA.%26aulast%3DJahnen-Dechent%26aufirst%3DW.%26aulast%3DLammers%26aufirst%3DT.%26aulast%3DLederle%26aufirst%3DW.%26aulast%3DKiessling%26aufirst%3DF.%26atitle%3DHybrid%2520%25CE%25BCCT-FMT%2520imaging%2520and%2520image%2520analysis%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2015%26spage%3De52770%26doi%3D10.3791%2F52770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">McCann, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueiredo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissleder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. W.</span><span> </span><span class="NLM_article-title">Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2008.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.neuroimage.2008.12.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2009&pages=360-369&author=C.+M.+McCannauthor=P.+Watermanauthor=J.+L.+Figueiredoauthor=E.+Aikawaauthor=R.+Weisslederauthor=J.+W.+Chen&title=Combined+magnetic+resonance+and+fluorescence+imaging+of+the+living+mouse+brain+reveals+glioma+response+to+chemotherapy&doi=10.1016%2Fj.neuroimage.2008.12.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2008.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2008.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DC.%2BM.%26aulast%3DWaterman%26aufirst%3DP.%26aulast%3DFigueiredo%26aufirst%3DJ.%2BL.%26aulast%3DAikawa%26aufirst%3DE.%26aulast%3DWeissleder%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26atitle%3DCombined%2520magnetic%2520resonance%2520and%2520fluorescence%2520imaging%2520of%2520the%2520living%2520mouse%2520brain%2520reveals%2520glioma%2520response%2520to%2520chemotherapy%26jtitle%3DNeuroImage%26date%3D2009%26volume%3D45%26spage%3D360%26epage%3D369%26doi%3D10.1016%2Fj.neuroimage.2008.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Razansky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deliolanis, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinegoni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span><span class="refDoi"> DOI: 10.2174/138920112799436258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2174%2F138920112799436258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22216767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVOnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=504-522&author=D.+Razanskyauthor=N.+C.+Deliolanisauthor=C.+Vinegoniauthor=V.+Ntziachristos&title=Deep+tissue+optical+and+optoacoustic+molecular+imaging+technologies+for+pre-clinical+research+and+drug+discovery&doi=10.2174%2F138920112799436258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Deep tissue optical and optoacoustic molecular imaging technologies for pre-clinical research and drug discovery</span></div><div class="casAuthors">Razansky, Daniel; Deliolanis, Nikolaos C.; Vinegoni, Claudio; Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">504-522</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For centuries, biol. discoveries were based on optical imaging, in particular microscopy but also several chromophoric assays and photog. approaches.  With the recent emergence of methods appropriate for bio-marker in vivo staining, such as bioluminescence, fluorescent mol. probes and proteins, as well as nanoparticle-based targeted agents, significant attention has been shifted toward in vivo interrogations of different dynamic biol. processes at the mol. level.  This progress has been largely supported by the development of advanced tomog. imaging technologies suitable for obtaining volumetric visualization of bio-marker distributions in small animals at a whole-body or whole-organ scale, an imaging frontier that is not accessible by the existing tissue-sectioning microscopic techniques due to intensive light scattering beyond the depth of a few hundred microns.  Major examples of such recently developed optical imaging modalities are reviewed here, including bioluminescence tomog. (BLT), fluorescence mol. tomog. (FMT), and optical projection tomog. (OPT).  The pharmaceutical imaging community has quickly appropriated itself of these novel forms of optical imaging, since they come with very compelling advantages, such as quant. three-dimensional capabilities, direct correlation to the biol. cultures, easiness and cost-effectiveness of use, and the use of safe non-ionizing radiation.  Some multi-modality approaches, combining light with other imaging modalities such as X-Ray CT or MRI, giving the ability to acquire both an optical contrast reconstruction along with a hi-fidelity anatomical images, are also reviewed.  A sep. section is devoted to the hybrid imaging techniques based on the optoacoustic phenomenon, such as multispectral optoacoustic tomog. (MSOT), which are poised to leverage the traditional contrast and specificity advantages of optical spectrum by delivering an ever powerful set of capabilities, including real-time operation and high spatial resoln., not affected by the scattering nature of biol. tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvMxiifWfmUbVg90H21EOLACvtfcHk0lgfM8yBheS4cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVOnurY%253D&md5=52ae1b8c6bba956aed0c101a9d6b4478</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F138920112799436258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920112799436258%26sid%3Dliteratum%253Aachs%26aulast%3DRazansky%26aufirst%3DD.%26aulast%3DDeliolanis%26aufirst%3DN.%2BC.%26aulast%3DVinegoni%26aufirst%3DC.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DDeep%2520tissue%2520optical%2520and%2520optoacoustic%2520molecular%2520imaging%2520technologies%2520for%2520pre-clinical%2520research%2520and%2520drug%2520discovery%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2012%26volume%3D13%26spage%3D504%26epage%3D522%26doi%3D10.2174%2F138920112799436258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Taruttis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Advances in real-time multispectral optoacoustic imaging and its applications</span> <span class="citation_source-journal">Nat. Photonics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1038/nphoton.2015.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnphoton.2015.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1ahu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=219-227&author=A.+Taruttisauthor=V.+Ntziachristos&title=Advances+in+real-time+multispectral+optoacoustic+imaging+and+its+applications&doi=10.1038%2Fnphoton.2015.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in real-time multispectral optoacoustic imaging and its applications</span></div><div class="casAuthors">Taruttis, Adrian; Ntziachristos, Vasilis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Photonics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-227</span>CODEN:
                <span class="NLM_cas:coden">NPAHBY</span>;
        ISSN:<span class="NLM_cas:issn">1749-4885</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Optoacoustic imaging, or photoacoustic imaging, is insensitive to photon scattering within biol. tissue and, unlike conventional optical imaging methods, makes high-resoln. optical visualization deep within tissue possible.  Recent advances in laser technol., detection strategies and inversion techniques led to significant improvements in the capabilities of optoacoustic systems.  A key empowering feature is the development of video-rate multispectral imaging in two and three dimensions, which offers fast, spectral differentiation of distinct photoabsorbing moieties.  The authors review recent advances and capabilities in the technol. and its corresponding emerging biol. and clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxf52rualDXLVg90H21EOLACvtfcHk0lhc76ZZEnRugQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1ahu78%253D&md5=751cc66e5b6cd4ed71ecb78f70e55585</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnphoton.2015.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnphoton.2015.29%26sid%3Dliteratum%253Aachs%26aulast%3DTaruttis%26aufirst%3DA.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DAdvances%2520in%2520real-time%2520multispectral%2520optoacoustic%2520imaging%2520and%2520its%2520applications%26jtitle%3DNat.%2520Photonics%26date%3D2015%26volume%3D9%26spage%3D219%26epage%3D227%26doi%3D10.1038%2Fnphoton.2015.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Burton, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morscher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driessen, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claussen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beziere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jetzfellner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taruttis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razansky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ntziachristos, V.</span><span> </span><span class="NLM_article-title">Multispectral opto-acoustic tomography (MSOT) of the brain and glioblastoma characterization</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2012.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.neuroimage.2012.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=522-528&author=N.+C.+Burtonauthor=M.+Patelauthor=S.+Morscherauthor=W.+H.+Driessenauthor=J.+Claussenauthor=N.+Beziereauthor=T.+Jetzfellnerauthor=A.+Taruttisauthor=D.+Razanskyauthor=B.+Bednarauthor=V.+Ntziachristos&title=Multispectral+opto-acoustic+tomography+%28MSOT%29+of+the+brain+and+glioblastoma+characterization&doi=10.1016%2Fj.neuroimage.2012.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2012.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2012.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DN.%2BC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DMorscher%26aufirst%3DS.%26aulast%3DDriessen%26aufirst%3DW.%2BH.%26aulast%3DClaussen%26aufirst%3DJ.%26aulast%3DBeziere%26aufirst%3DN.%26aulast%3DJetzfellner%26aufirst%3DT.%26aulast%3DTaruttis%26aufirst%3DA.%26aulast%3DRazansky%26aufirst%3DD.%26aulast%3DBednar%26aufirst%3DB.%26aulast%3DNtziachristos%26aufirst%3DV.%26atitle%3DMultispectral%2520opto-acoustic%2520tomography%2520%2528MSOT%2529%2520of%2520the%2520brain%2520and%2520glioblastoma%2520characterization%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D65%26spage%3D522%26epage%3D528%26doi%3D10.1016%2Fj.neuroimage.2012.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Pansare, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejazi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faenza, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prud’homme, R. K.</span><span> </span><span class="NLM_article-title">Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores and multifunctional nano carriers</span> <span class="citation_source-journal">Chem. Mater.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span><span class="refDoi"> DOI: 10.1021/cm2028367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cm2028367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=812-827&author=V.+Pansareauthor=S.+Hejaziauthor=W.+Faenzaauthor=R.+K.+Prud%E2%80%99homme&title=Review+of+long-wavelength+optical+and+NIR+imaging+materials%3A+contrast+agents%2C+fluorophores+and+multifunctional+nano+carriers&doi=10.1021%2Fcm2028367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores, and Multifunctional Nano Carriers</span></div><div class="casAuthors">Pansare, Vikram J.; Hejazi, Shahram; Faenza, William J.; Prud'homme, Robert K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Materials</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">812-827</span>CODEN:
                <span class="NLM_cas:coden">CMATEX</span>;
        ISSN:<span class="NLM_cas:issn">0897-4756</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The importance of long wavelength and near-IR (NIR) imaging has dramatically increased due to the desire to perform whole animal and deep tissue imaging.  The adoption of NIR imaging is also growing rapidly due to the availability of targeted biol. agents for diagnosis and basic medical research that can be imaged in vivo.  The wavelength range of 650-1450 nm falls in the region of the spectrum with the lowest absorption in tissue and therefore enables the deepest tissue penetration.  This is the wavelength range the authors focus on with this review.  To operate effectively, the imaging agents must both be excited and must emit in this long-wavelength window.  The authors review the agents used for imaging by absorption, scattering, and excitation (such as fluorescence).  Imaging agents comprise both aq. sol. and insol. species, both org. and inorg., and unimol. and supramol. constructs.  The interest in multimodal imaging, which involves delivery of actives, targeting, and imaging, requires nanoparticles or supramol. assemblies.  Nanoparticles for diagnostics also have advantages in increasing circulation time and increased imaging brightness relative to single mol. imaging agents.  This has led to rapid advances in nanocarriers for long-wavelength, NIR imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyBGiivmZ0ZrVg90H21EOLACvtfcHk0lhc76ZZEnRugQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVSkug%253D%253D&md5=600d4db2b41c5eb2e562c52339c33814</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcm2028367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcm2028367%26sid%3Dliteratum%253Aachs%26aulast%3DPansare%26aufirst%3DV.%26aulast%3DHejazi%26aufirst%3DS.%26aulast%3DFaenza%26aufirst%3DW.%26aulast%3DPrud%25E2%2580%2599homme%26aufirst%3DR.%2BK.%26atitle%3DReview%2520of%2520long-wavelength%2520optical%2520and%2520NIR%2520imaging%2520materials%253A%2520contrast%2520agents%252C%2520fluorophores%2520and%2520multifunctional%2520nano%2520carriers%26jtitle%3DChem.%2520Mater.%26date%3D2012%26volume%3D24%26spage%3D812%26epage%3D827%26doi%3D10.1021%2Fcm2028367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Staderini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, J. C.</span><span> </span><span class="NLM_article-title">Imaging of beta-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1819</span><span class="refDoi"> DOI: 10.1039/C4CS00337C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4CS00337C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25622714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=1807-1819&author=M.+Staderiniauthor=M.+A.+Martinauthor=M.+L.+Bolognesiauthor=J.+C.+Menendez&title=Imaging+of+beta-amyloid+plaques+by+near+infrared+fluorescent+tracers%3A+a+new+frontier+for+chemical+neuroscience&doi=10.1039%2FC4CS00337C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of β-amyloid plaques by near infrared fluorescent tracers- a new frontier for chemical neuroscience</span></div><div class="casAuthors">Staderini, Matteo; Martin, Maria Antonia; Bolognesi, Maria Laura; Menendez, J. Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1807-1819</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Brain amyloid depositions are the main hallmarks of Alzheimer's and other protein misfolding diseases.  Since they are believed to precede clin. symptoms by several years, imaging of such fibrillar aggregates is particularly suitable to diagnose the onset of the disease in its early stage and monitor its progression.  In this context, near IR (NIR) imaging has been proposed as a promising and non-invasive method to visualize amyloid plaques in vivo because of its acceptable depth of penetration and minimal degree of tissue damage.  In this tutorial review, we describe the main chem. and physicochem. features of probes assocd. with fluorescence emission in the NIR region.  The review focuses on the recent progress and improvements in the development of small-mol. NIR fluorescent probes and their in vivo application in living animals.  In addn., the possible therapeutic application of NIR probes to block the pathol. aggregation process will be discussed, raising the fascinating possibility of their exploitation as theranostic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoouYzHe3xvLVg90H21EOLACvtfcHk0lgyYKPP-DJL1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSmtLk%253D&md5=ffcb2d0bfd335d235883e585714b7e75</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2FC4CS00337C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00337C%26sid%3Dliteratum%253Aachs%26aulast%3DStaderini%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26atitle%3DImaging%2520of%2520beta-amyloid%2520plaques%2520by%2520near%2520infrared%2520fluorescent%2520tracers%253A%2520a%2520new%2520frontier%2520for%2520chemical%2520neuroscience%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D1807%26epage%3D1819%26doi%3D10.1039%2FC4CS00337C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Tong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer’s disease</span> <span class="citation_source-journal">Acta Pharm. Sin. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1016/j.apsb.2014.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.apsb.2014.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26579421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=25-33&author=H.+J.+Tongauthor=K.+Y.+Louauthor=W.+Wang&title=Near-infrared+fluorescent+probes+for+imaging+of+amyloid+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.apsb.2014.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer s disease</span></div><div class="casAuthors">Tong Hongjuan; Lou Kaiyan; Wang Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-33</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">One of the early pathological hallmarks of Alzheimer s disease (AD) is the deposition of amyloid-β (Aβ) plaques in the brain.  There has been a tremendous interest in the development of Aβ plaques imaging probes for early diagnosis of AD in the past decades.  Optical imaging, particularly near-infrared fluorescence (NIRF) imaging, has emerged as a safe, low cost, real-time, and widely available technique, providing an attractive approach for in vivo detection of Aβ plaques among many different imaging techniques.  In this review, we provide a brief overview of the state-of-the-art development of NIRF Aβ probes and their in vitro and in vivo applications with special focus on design strategies and optical, binding, and brain-kinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFlwvupmecNw_lfW6udTcc2eZsW9mUqbmG87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOnsA%253D%253D&md5=3335b356fe9487e6d99214033d7399f3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2014.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2014.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DH.%2BJ.%26aulast%3DLou%26aufirst%3DK.%2BY.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DNear-infrared%2520fluorescent%2520probes%2520for%2520imaging%2520of%2520amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D25%26epage%3D33%26doi%3D10.1016%2Fj.apsb.2014.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Recent advances in molecular imaging probes for β-amyloid plaques</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1039/C4MD00365A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4MD00365A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=391-402&author=M.+Onoauthor=H.+Saji&title=Recent+advances+in+molecular+imaging+probes+for+%CE%B2-amyloid+plaques&doi=10.1039%2FC4MD00365A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2FC4MD00365A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00365A%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRecent%2520advances%2520in%2520molecular%2520imaging%2520probes%2520for%2520%25CE%25B2-amyloid%2520plaques%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D391%26epage%3D402%26doi%3D10.1039%2FC4MD00365A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span>Roche Media Release. <a href="http://www.roche.com/media/store/releases/med_pha_2011-09-21.htm" class="extLink">http://www.roche.com/media/store/releases/med_pha_2011-09-21.htm</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Roche+Media+Release.+http%3A%2F%2Fwww.roche.com%2Fmedia%2Fstore%2Freleases%2Fmed_pha_2011-09-21.htm+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span>FDA. Guidance for Industry and Food and Drug Administration Staff. In Vitro Companion Diagnostic Devices. <a href="http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM262327.pdf" class="extLink">http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM262327.pdf</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FDA.+Guidance+for+Industry+and+Food+and+Drug+Administration+Staff.+In+Vitro+Companion+Diagnostic+Devices.+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FMedicalDevices%2FDeviceRegulationandGuidance%2FGuidanceDocuments%2FUCM262327.pdf+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Nikolcheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, G.</span><span> </span><span class="NLM_article-title">Challenges in the development of companion diagnostics for neuropsychiatric disorders</span> <span class="citation_source-journal">Expert Rev. Mol. Diagn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1586/erm.11.67</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1586%2Ferm.11.67" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22022945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGnsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=829-837&author=T.+Nikolchevaauthor=S.+Jagerauthor=T.+A.+Bushauthor=G.+Vargas&title=Challenges+in+the+development+of+companion+diagnostics+for+neuropsychiatric+disorders&doi=10.1586%2Ferm.11.67"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges in the development of companion diagnostics for neuropsychiatric disorders</span></div><div class="casAuthors">Nikolcheva, Tania; Jaeger, Stephan; Bush, Theresa Ambrose; Vargas, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Molecular Diagnostics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">829-837</span>CODEN:
                <span class="NLM_cas:coden">ERMDCW</span>;
        ISSN:<span class="NLM_cas:issn">1473-7159</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  There are few examples of successful CNS diagnostics owing to our poor understanding of the mechanisms of disease.  This article will discuss this and other challenges facing CNS diagnostic development with a focus on Alzheimer''s disease, along with a discussion of potential future diagnostic assays that may help in the development of new CNS medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHv-ozY6a1t7Vg90H21EOLACvtfcHk0li7zU4K-fv2XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGnsbbJ&md5=6db600e49d8ee5545e2b9774a13a1d69</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1586%2Ferm.11.67&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Ferm.11.67%26sid%3Dliteratum%253Aachs%26aulast%3DNikolcheva%26aufirst%3DT.%26aulast%3DJager%26aufirst%3DS.%26aulast%3DBush%26aufirst%3DT.%2BA.%26aulast%3DVargas%26aufirst%3DG.%26atitle%3DChallenges%2520in%2520the%2520development%2520of%2520companion%2520diagnostics%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Diagn.%26date%3D2011%26volume%3D11%26spage%3D829%26epage%3D837%26doi%3D10.1586%2Ferm.11.67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Agarwal, A.</span><span> </span><span class="NLM_article-title">Do companion diagnostics make economic sense for drug developers?</span> <span class="citation_source-journal">New Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span><span class="refDoi"> DOI: 10.1016/j.nbt.2012.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.nbt.2012.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KktbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=695-708&author=A.+Agarwal&title=Do+companion+diagnostics+make+economic+sense+for+drug+developers%3F&doi=10.1016%2Fj.nbt.2012.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Do companion diagnostics make economic sense for drug developers?</span></div><div class="casAuthors">Agarwal, Amit</div><div class="citationInfo"><span class="NLM_cas:title">New Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-708</span>CODEN:
                <span class="NLM_cas:coden">NBEIBR</span>;
        ISSN:<span class="NLM_cas:issn">1871-6784</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Drug developers are grappling with the impact of personalized medicine on their portfolios.  The combination of mol. diagnostics with targeted biol. therapies has been hailed as a recent innovation with few historical analogs to guide behavior.  However, if the definition of companion diagnostics is broadened to include any drug whose FDA approved label requires diagnostic testing before prescription then over 50 drugs across multiple therapeutic areas arise.  Most importantly for current drug developers, these drugs represent a wide variety of market situations and with sufficient historical data to evaluate different commercialization strategies for the combination.  Included in these examples are drugs which were not initially launched with companion diagnostics but were required to implement companion diagnostics after they were on the market for a period of time.  The historical case studies demonstrate that companion diagnostics are neither a universal panacea nor an unmitigated disaster for drug developers but require an understanding of specific situations to det. the utility of companion diagnostics.  Numerous case studies highlight how companion diagnostics have been a boon to drug developers including Iressa, statins, Soriatane, Arthrotec, Promacta, Nplate, Letairis, and Tracleer.  Other examples provide lessons on how to avoid pitfalls such as Accutane, Ticlid, Tegretol, Ziagen, Actigall and Clozaril.  By carefully evaluating these case studies, drug developers can gain insight on the appropriate companion diagnostic strategy to implement for their specific situation and develop the elements of a successful companion diagnostic strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruq7i3kgXksLVg90H21EOLACvtfcHk0li7zU4K-fv2XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KktbvM&md5=23e2857bb8d336884999ebfc4deea8d5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.nbt.2012.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbt.2012.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DA.%26atitle%3DDo%2520companion%2520diagnostics%2520make%2520economic%2520sense%2520for%2520drug%2520developers%253F%26jtitle%3DNew%2520Biotechnol.%26date%3D2012%26volume%3D29%26spage%3D695%26epage%3D708%26doi%3D10.1016%2Fj.nbt.2012.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Idee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louguet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corot, C.</span><span> </span><span class="NLM_article-title">Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint</span> <span class="citation_source-journal">Quant. Imaging Med. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span><span class="refDoi"> DOI: 10.3978/j.issn.2223-4292.2013.12.06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3978%2Fj.issn.2223-4292.2013.12.06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24404442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2czjsVygug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=292-297&author=J.+M.+Ideeauthor=S.+Louguetauthor=S.+Balletauthor=C.+Corot&title=Theranostics+and+contrast-agents+for+medical+imaging%3A+a+pharmaceutical+company+viewpoint&doi=10.3978%2Fj.issn.2223-4292.2013.12.06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint</span></div><div class="casAuthors">Idee Jean-Marc; Louguet Stephanie; Ballet Sebastien; Corot Claire</div><div class="citationInfo"><span class="NLM_cas:title">Quantitative imaging in medicine and surgery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">292-7</span>
        ISSN:<span class="NLM_cas:issn">2223-4292</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQR362tXUKtAOR_TJajKxJDfW6udTcc2eZmVgQTmtxq1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjsVygug%253D%253D&md5=d001890b95c0547f505ca8798e285764</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3978%2Fj.issn.2223-4292.2013.12.06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3978%252Fj.issn.2223-4292.2013.12.06%26sid%3Dliteratum%253Aachs%26aulast%3DIdee%26aufirst%3DJ.%2BM.%26aulast%3DLouguet%26aufirst%3DS.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DCorot%26aufirst%3DC.%26atitle%3DTheranostics%2520and%2520contrast-agents%2520for%2520medical%2520imaging%253A%2520a%2520pharmaceutical%2520company%2520viewpoint%26jtitle%3DQuant.%2520Imaging%2520Med.%2520Surg.%26date%3D2013%26volume%3D3%26spage%3D292%26epage%3D297%26doi%3D10.3978%2Fj.issn.2223-4292.2013.12.06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Jorgensen, J. T.</span><span> </span><span class="NLM_article-title">Companion diagnostics: the key to personalized medicine</span> <span class="citation_source-journal">Expert Rev. Mol. Diagn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span><span class="refDoi"> DOI: 10.1586/14737159.2015.1002470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1586%2F14737159.2015.1002470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25597758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=153-156&author=J.+T.+Jorgensen&title=Companion+diagnostics%3A+the+key+to+personalized+medicine&doi=10.1586%2F14737159.2015.1002470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Companion diagnostics: the key to personalized medicine</span></div><div class="casAuthors">Jorgensen, Jan Trost</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Molecular Diagnostics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-156</span>CODEN:
                <span class="NLM_cas:coden">ERMDCW</span>;
        ISSN:<span class="NLM_cas:issn">1473-7159</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This special focus issue of Expert Review of Mol. Diagnostics on in vitro companion diagnostics aims to provide the reader with up-to-date knowledge on this fast-evolving area of medical research.  Companion diagnostics takes up a central role in the development of targeted drugs and to a large extent, the success of this type of therapy depends on their performance.  Companion diagnostic assays have a single patient as a point of ref. and they will be decisive for the move toward a more precise and individualized pharmacotherapy.  The 'first generation' of companion diagnostic assays relies on single biomarker detection but with our increasing understanding of disease pathophysiol. a new generation of assays is under development, which will be based on patient profiling and multiplex platforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKMeLD5lxirbVg90H21EOLACvtfcHk0lhKBtwLk4y-Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSitL4%253D&md5=42bf90287d2792494531438c45ac109c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1586%2F14737159.2015.1002470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737159.2015.1002470%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DJ.%2BT.%26atitle%3DCompanion%2520diagnostics%253A%2520the%2520key%2520to%2520personalized%2520medicine%26jtitle%3DExpert%2520Rev.%2520Mol.%2520Diagn.%26date%3D2015%26volume%3D15%26spage%3D153%26epage%3D156%26doi%3D10.1586%2F14737159.2015.1002470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Lleo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavedo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parnetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderstichele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herukka, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewczuk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeromin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsolaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aarsland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinuevo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollenhauer, B.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1038/nrneurol.2014.232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnrneurol.2014.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25511894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKlsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=41-55&author=A.+Lleoauthor=E.+Cavedoauthor=L.+Parnettiauthor=H.+Vandersticheleauthor=S.+K.+Herukkaauthor=N.+Andreasenauthor=R.+Ghidoniauthor=P.+Lewczukauthor=A.+Jerominauthor=B.+Winbladauthor=M.+Tsolakiauthor=B.+Mroczkoauthor=P.+J.+Visserauthor=I.+Santanaauthor=P.+Svenningssonauthor=K.+Blennowauthor=D.+Aarslandauthor=J.+L.+Molinuevoauthor=H.+Zetterbergauthor=B.+Mollenhauer&title=Cerebrospinal+fluid+biomarkers+in+trials+for+Alzheimer+and+Parkinson+diseases&doi=10.1038%2Fnrneurol.2014.232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases</span></div><div class="casAuthors">Lleo, Alberto; Cavedo, Enrica; Parnetti, Lucilla; Vanderstichele, Hugo; Herukka, Sanna Kaisa; Andreasen, Niels; Ghidoni, Roberta; Lewczuk, Piotr; Jeromin, Andreas; Winblad, Bengt; Tsolaki, Magda; Mroczko, Barbara; Visser, Pieter Jelle; Santana, Isabel; Svenningsson, Per; Blennow, Kaj; Aarsland, Dag; Molinuevo, Jose Luis; Zetterberg, Henrik; Mollenhauer, Brit</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-55</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease (AD) and Parkinson disease (PD) are the most common neurodegenerative disorders.  For both diseases, early intervention is thought to be essential to the success of disease-modifying treatments.  Cerebrospinal fluid (CSF) can reflect some of the pathophysiol. changes that occur in the brain, and the no. of CSF biomarkers under investigation in neurodegenerative conditions has grown rapidly in the past 20 years.  In AD, CSF biomarkers are increasingly being used in clin. practice, and have been incorporated into the majority of clin. trials to demonstrate target engagement, to enrich or stratify patient groups, and to find evidence of disease modification.  In PD, CSF biomarkers have not yet reached the clinic, but are being studied in patients with parkinsonism, and are being used in clin. trials either to monitor progression or to demonstrate target engagement and downstream effects of drugs.  CSF biomarkers might also serve as surrogate markers of clin. benefit after a specific therapeutic intervention, although addnl. data are required.  It is anticipated that CSF biomarkers will have an important role in trials aimed at disease modification in the near future.  In this Review, we provide an overview of CSF biomarkers in AD and PD, and discuss their role in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowP6_zgSps8rVg90H21EOLACvtfcHk0ljwDm1yNk8pmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKlsL7J&md5=9d9f24840016742c9a19b3d226411c32</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2014.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2014.232%26sid%3Dliteratum%253Aachs%26aulast%3DLleo%26aufirst%3DA.%26aulast%3DCavedo%26aufirst%3DE.%26aulast%3DParnetti%26aufirst%3DL.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DHerukka%26aufirst%3DS.%2BK.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DGhidoni%26aufirst%3DR.%26aulast%3DLewczuk%26aufirst%3DP.%26aulast%3DJeromin%26aufirst%3DA.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DTsolaki%26aufirst%3DM.%26aulast%3DMroczko%26aufirst%3DB.%26aulast%3DVisser%26aufirst%3DP.%2BJ.%26aulast%3DSantana%26aufirst%3DI.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DAarsland%26aufirst%3DD.%26aulast%3DMolinuevo%26aufirst%3DJ.%2BL.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DMollenhauer%26aufirst%3DB.%26atitle%3DCerebrospinal%2520fluid%2520biomarkers%2520in%2520trials%2520for%2520Alzheimer%2520and%2520Parkinson%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2015%26volume%3D11%26spage%3D41%26epage%3D55%26doi%3D10.1038%2Fnrneurol.2014.232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ritter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span> </span><span class="NLM_article-title">Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics</span> <span class="citation_source-journal">Front. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.3389/fneur.2015.00186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.3389%2Ffneur.2015.00186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25699006" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1-14&author=A.+Ritterauthor=J.+Cummings&title=Fluid+biomarkers+in+clinical+trials+of+Alzheimer%E2%80%99s+disease+therapeutics&doi=10.3389%2Ffneur.2015.00186"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3389%2Ffneur.2015.00186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffneur.2015.00186%26sid%3Dliteratum%253Aachs%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DCummings%26aufirst%3DJ.%26atitle%3DFluid%2520biomarkers%2520in%2520clinical%2520trials%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DFront.%2520Neurol.%26date%3D2015%26volume%3D6%26spage%3D1%26epage%3D14%26doi%3D10.3389%2Ffneur.2015.00186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>A study of gantenerumab in patients with mild Alzheimer disease. <a href="https://clinicaltrials.gov/ct2/show/NCT02051608" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02051608</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+study+of+gantenerumab+in+patients+with+mild+Alzheimer+disease.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02051608+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>Progress of mild Alzheimer’s disease in participants on solanezumab versus placebo (EXPEDITION 3). <a href="https://clinicaltrials.gov/ct2/show/NCT01900665?term=Eli+Lilly+and+Alzheimer&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01900665?term=Eli+Lilly+and+Alzheimer&rank=1</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Progress+of+mild+Alzheimer%E2%80%99s+disease+in+participants+on+solanezumab+versus+placebo+%28EXPEDITION+3%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01900665%3Fterm%3DEli%2BLilly%2Band%2BAlzheimer%26rank%3D1+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>Alzforum therapeutics: gantenerumab. <a href="http://www.alzforum.org/therapeutics/gantenerumab" class="extLink">http://www.alzforum.org/therapeutics/gantenerumab</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzforum+therapeutics%3A+gantenerumab.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fgantenerumab+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>Q&A with Roche’s CNS leader Luca Santarelli. <a href="http://www.alzforum.org/news/conference-coverage/qa-roches-cns-leader-luca-santarelli" class="extLink">http://www.alzforum.org/news/conference-coverage/qa-roches-cns-leader-luca-santarelli</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Q%26A+with+Roche%E2%80%99s+CNS+leader+Luca+Santarelli.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fconference-coverage%2Fqa-roches-cns-leader-luca-santarelli+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Hollmer, M.</span><span> </span><span class="NLM_article-title">Eisai to deploy GE’s Alzheimer’s imaging agent for clinical trial screening</span>. <a href="http://www.fiercemedicaldevices.com/story/eisai-deploy-ges-alzheimers-imaging-agent-clinical-trial-screening/2013-04-24" class="extLink">http://www.fiercemedicaldevices.com/story/eisai-deploy-ges-alzheimers-imaging-agent-clinical-trial-screening/2013-04-24</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Hollmer&title=Eisai+to+deploy+GE%E2%80%99s+Alzheimer%E2%80%99s+imaging+agent+for+clinical+trial+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DHollmer%26aufirst%3DM.%26atitle%3DEisai%2520to%2520deploy%2520GE%25E2%2580%2599s%2520Alzheimer%25E2%2580%2599s%2520imaging%2520agent%2520for%2520clinical%2520trial%2520screening%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Stamford, A.</span><span> </span><span class="NLM_article-title">Discovery of MK-8931 (verubecestat) as a disease modifying treatment for Alzheimer’s disease</span>. <a href="http://www.bionomics.com.au/upload/research-development/poster-presentations-publications/cns-poster-presentations/Andy-Stamford_Bionomics_Merck.pdf" class="extLink">http://www.bionomics.com.au/upload/research-development/poster-presentations-publications/cns-poster-presentations/Andy-Stamford_Bionomics_Merck.pdf</a> (accessed Apr 7,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Stamford&title=Discovery+of+MK-8931+%28verubecestat%29+as+a+disease+modifying+treatment+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520MK-8931%2520%2528verubecestat%2529%2520as%2520a%2520disease%2520modifying%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span>Efficacy and safety trial of verubecestat (MK-8931) in participants with prodromal Alzheimer’s disease (MK-8931-019) (APECS). <a href="https://http://www.clinicaltrials.gov/ct2/show/NCT01953601?term=mk-8931&amp;rank=3" class="extLink">https://http://www.clinicaltrials.gov/ct2/show/NCT01953601?term=mk-8931&rank=3</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Efficacy+and+safety+trial+of+verubecestat+%28MK-8931%29+in+participants+with+prodromal+Alzheimer%E2%80%99s+disease+%28MK-8931-019%29+%28APECS%29.+https%3A%2F%2Fhttp%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01953601%3Fterm%3Dmk-8931%26rank%3D3+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span> </span><span class="NLM_article-title">Merck and Luminex corporation enter agreement to develop companion diagnostic to support investigational BACE inhibitor clinical development program for Alzheimer’s disease</span>. <a href="http://www.merck.com/licensing/our-partnership/luminex-partnership.html" class="extLink">http://www.merck.com/licensing/our-partnership/luminex-partnership.html</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+and+Luminex+corporation+enter+agreement+to+develop+companion+diagnostic+to+support+investigational+BACE+inhibitor+clinical+development+program+for+Alzheimer%E2%80%99s+disease.+http%3A%2F%2Fwww.merck.com%2Flicensing%2Four-partnership%2Fluminex-partnership.html+%28accessed+Jan+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DMerck%2520and%2520Luminex%2520corporation%2520enter%2520agreement%2520to%2520develop%2520companion%2520diagnostic%2520to%2520support%2520investigational%2520BACE%2520inhibitor%2520clinical%2520development%2520program%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="refDoi"> DOI: 10.1186/s13195-014-0089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1186%2Fs13195-014-0089-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25621019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=89&author=R.+Vassar&title=BACE1+inhibitor+drugs+in+clinical+trials+for+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs13195-014-0089-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 inhibitor drugs in clinical trials for Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">89/1-89/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the prodn. of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiol. of Alzheimer's disease (AD).  As a result, BACE1 has emerged as a prime drug target for reducing the levels of Aβ in the AD brain, and the development of BACE1 inhibitors as therapeutic agents is being vigorously pursued.  It has proven difficult for the pharmaceutical industry to design BACE1 inhibitor drugs that pass the blood-brain barrier, however this challenge has recently been met and BACE1 inhibitors are now in human clin. trials to test for safety and efficacy in AD patients and individuals with pre-symptomatic AD.  Initial results suggest that some of these BACE1 inhibitor drugs are well tolerated, although others have dropped out because of toxicity and it is still too early to know whether any will be effective for the prevention or treatment of AD.  Addnl., based on newly identified BACE1 substrates and phenotypes of mice that lack BACE1, concerns have emerged about potential mechanism-based side effects of BACE1 inhibitor drugs with chronic administration.  It is hoped that a therapeutic window can be achieved that balances safety and efficacy.  This review summarizes the current state of progress in the development of BACE1 inhibitor drugs and the evaluation of their therapeutic potential for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-BPlLZzu7rVg90H21EOLACvtfcHk0litzF8RRn4VSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVCqtL4%253D&md5=a9ec66c8f0254986406323efa56c6f5a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Fs13195-014-0089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-014-0089-7%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%2520inhibitor%2520drugs%2520in%2520clinical%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D89%26doi%3D10.1186%2Fs13195-014-0089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C. Z.</span><span> </span><span class="NLM_article-title">Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">9734</span><span class="NLM_x">–</span> <span class="NLM_lpage">9739</span><span class="refDoi"> DOI: 10.1073/pnas.1505420112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1073%2Fpnas.1505420112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26199414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2ku73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=9734-9739&author=X.+L.+Zhangauthor=Y.+L.+Tianauthor=C.+Zhangauthor=X.+Y.+Tianauthor=A.+W.+Rossauthor=R.+D.+Moirauthor=H.+B.+Sunauthor=R.+E.+Tanziauthor=A.+Mooreauthor=C.+Z.+Ran&title=Near-infrared+fluorescence+molecular+imaging+of+amyloid+beta+species+and+monitoring+therapy+in+animal+models+of+Alzheimer%E2%80%99s+disease&doi=10.1073%2Fpnas.1505420112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease</span></div><div class="casAuthors">Zhang, Xueli; Tian, Yanli; Zhang, Can; Tian, Xiaoyu; Ross, Alana W.; Moir, Robert D.; Sun, Hongbin; Tanzi, Rudolph E.; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">9734-9739</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Near-IR fluorescence (NIRF) mol. imaging has been widely applied to monitoring therapy of cancer and other diseases in preclin. studies; however, this technol. has not been applied successfully to monitoring therapy for Alzheimer's disease (AD).  Although several NIRF probes for detecting amyloid beta (Aβ) species of AD have been reported, none of these probes has been used to monitor changes of Aβs during therapy.  In this article, we demonstrated that CRANAD-3, a curcumin analog, is capable of detecting both sol. and insol. Aβ species.  In vivo imaging showed that the NIRF signal of CRANAD-3 from 4-mo-old transgenic AD (APP/PS1) mice was 2.29-fold higher than that from age-matched wild-type mice, indicating that CRANAD-3 is capable of detecting early mol. pathol.  To verify the feasibility of CRANAD-3 for monitoring therapy, we first used the fast Aβ-lowering drug LY2811376, a well-characterized beta-amyloid cleaving enzyme-1 inhibitor, to treat APP/PS1 mice.  Imaging data suggested that CRANAD-3 could monitor the decrease in Aβs after drug treatment.  To validate the imaging capacity of CRANAD-3 further, we used it to monitor the therapeutic effect of CRANAD-17, a curcumin analog for inhibition of Aβ crosslinking.  The imaging data indicated that the fluorescence signal in the CRANAD-17-treated group was significantly lower than that in the control group, and the result correlated with ELISA anal. of brain extn. and Aβ plaque counting.  It was the first time, to our knowledge, that NIRF was used to monitor AD therapy, and we believe that our imaging technol. has the potential to have a high impact on AD drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLMElOHab2pbVg90H21EOLACvtfcHk0litzF8RRn4VSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2ku73K&md5=c516dfe9c5930906a995c8cd5917f797</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1505420112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1505420112%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DTian%26aufirst%3DY.%2BL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DX.%2BY.%26aulast%3DRoss%26aufirst%3DA.%2BW.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DSun%26aufirst%3DH.%2BB.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%2BZ.%26atitle%3DNear-infrared%2520fluorescence%2520molecular%2520imaging%2520of%2520amyloid%2520beta%2520species%2520and%2520monitoring%2520therapy%2520in%2520animal%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D9734%26epage%3D9739%26doi%3D10.1073%2Fpnas.1505420112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ran, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medarova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">15257</span><span class="NLM_x">–</span> <span class="NLM_lpage">15261</span><span class="refDoi"> DOI: 10.1021/ja9047043</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9047043" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=15257-15261&author=C.+Ranauthor=X.+Xuauthor=S.+B.+Raymondauthor=B.+J.+Ferraraauthor=K.+Nealauthor=B.+J.+Bacskaiauthor=Z.+Medarovaauthor=A.+Moore&title=Design%2C+synthesis%2C+and+testing+of+difluoroboron-derivatized+curcumins+as+near-infrared+probes+for+in+vivo+detection+of+amyloid-beta+deposits&doi=10.1021%2Fja9047043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-β Deposits</span></div><div class="casAuthors">Ran, Chongzhao; Xu, Xiaoyin; Raymond, Scott B.; Ferrara, Brian J.; Neal, Krista; Bacskai, Brian J.; Medarova, Zdravka; Moore, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15257-15261</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) deposits have been identified as key players in the progression of Alzheimer's disease (AD).  Recent evidence indicates that the deposits probably precede and induce the neuronal atrophy.  Therefore, methods that enable monitoring the pathol. before clin. symptoms are obsd. would be beneficial for early AD detection.  Here, we report the design, synthesis, and testing of a curcumin-derivatized near-IR (NIR) probe, CRANAD-2.  Upon interacting with Aβ aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield.  Moreover, this probe also shows a high affinity for Aβ aggregates (Kd = 38.0 nM), a reasonable log P value (log P = 3), considerable stability in serum, and a weak interaction with albumin.  After i.v. injection of this probe, 19-mo-old Tg2576 mice exhibited significantly higher relative signal than that of the control mice over the same period of time.  In summary, CRANAD-2 meets all the requirements for a NIR contrast agent for the detection of Aβ plaques both in vitro and in vivo.  Our data point toward the feasibility of monitoring the progress of the disease by NIR imaging with CRANAD-2.  In addn., we believe that our probe could be potentially used as a tool for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVaezLehHv7Vg90H21EOLACvtfcHk0lgq33Uez8Vi3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artbfN&md5=e9c1f3cadd72bb69697404536ee66b16</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja9047043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9047043%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DRaymond%26aufirst%3DS.%2BB.%26aulast%3DFerrara%26aufirst%3DB.%2BJ.%26aulast%3DNeal%26aufirst%3DK.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DMedarova%26aufirst%3DZ.%26aulast%3DMoore%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520testing%2520of%2520difluoroboron-derivatized%2520curcumins%2520as%2520near-infrared%2520probes%2520for%2520in%2520vivo%2520detection%2520of%2520amyloid-beta%2520deposits%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D15257%26epage%3D15261%26doi%3D10.1021%2Fja9047043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C.</span><span> </span><span class="NLM_article-title">Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer’s disease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">16397</span><span class="NLM_x">–</span> <span class="NLM_lpage">16409</span><span class="refDoi"> DOI: 10.1021/ja405239v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405239v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Sqs7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=16397-16409&author=X.+Zhangauthor=Y.+Tianauthor=Z.+Liauthor=X.+Tianauthor=H.+Sunauthor=H.+Liuauthor=A.+Mooreauthor=C.+Ran&title=Design+and+synthesis+of+curcumin+analogues+for+in+vivo+fluorescence+imaging+and+inhibiting+copper-induced+cross-linking+of+amyloid+beta+species+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fja405239v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer's Disease</span></div><div class="casAuthors">Zhang, Xueli; Tian, Yanli; Li, Zeng; Tian, Xiaoyu; Sun, Hongbin; Liu, Hong; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">16397-16409</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this article, the authors first designed and synthesized curcumin-based near-IR (NIR) fluorescence imaging probes for detecting both sol. and insol. amyloid beta (Aβ) species and then an inhibitor that could attenuate crosslinking of Aβ induced by copper.  According to the authors' previous results and the possible structural stereohindrance compatibility of the Aβ peptide and the hydrophobic/hydrophilic property of the Aβ13-20 (HHQKLVFF) fragment, NIR imaging probe CRANAD-58 was designed and synthesized.  As expected CRANAD-58 showed significant fluorescence property changes upon mixing with both sol. and insol. Aβ species in vitro.  In vivo NIR imaging revealed that CRANAD-58 was capable of differentiating transgenic and wild-type mice as young as 4 mo old, the age that lacks apparently visible Aβ plaques and Aβ is likely in its sol. forms.  According to the authors' limited studies on the interaction mechanism between CRANAD-58 and Aβ, the authors also designed CRANAD-17 to attenuate the crosslinking of Aβ42 induced by copper.  It is well-known that the coordination of copper with imidazoles on Histidine-13 and 14 (H13, H14) of Aβ peptides could initialize covalent crosslinking of Aβ.  In CRANAD-17, a curcumin scaffold was used as an anchoring moiety to usher the designed compd. to the vicinity of H13 and H14 of Aβ, and imidazole rings were incorporated to compete with H13/H14 for copper binding.  The results of SDS-PAGE gel and Western blot indicated that CRANAD-17 was capable of inhibiting Aβ42 crosslinking induced by copper.  This raises a potential for CRANAD-17 to be considered for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzVMWcgO7gBbVg90H21EOLACvtfcHk0lgq33Uez8Vi3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Sqs7bM&md5=a247779a9ee595e81bef7b43861ecbd7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fja405239v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405239v%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520curcumin%2520analogues%2520for%2520in%2520vivo%2520fluorescence%2520imaging%2520and%2520inhibiting%2520copper-induced%2520cross-linking%2520of%2520amyloid%2520beta%2520species%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D16397%26epage%3D16409%26doi%3D10.1021%2Fja405239v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kelkar, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reineke, T. M.</span><span> </span><span class="NLM_article-title">Theranostics: combining imaging and therapy</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span><span class="refDoi"> DOI: 10.1021/bc200151q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200151q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2jt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1879-1903&author=S.+S.+Kelkarauthor=T.+M.+Reineke&title=Theranostics%3A+combining+imaging+and+therapy&doi=10.1021%2Fbc200151q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostics: Combining Imaging and Therapy</span></div><div class="casAuthors">Kelkar, Sneha S.; Reineke, Theresa M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1879-1903</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Employing theranostic nanoparticles, which combine both therapeutic and diagnostic capabilities in one dose, has promise to propel the biomedical field toward personalized medicine.  This review presents an overview of different theranostic strategies developed for the diagnosis and treatment of disease, with an emphasis on cancer.  Herein, therapeutic strategies such as nucleic acid delivery, chemotherapy, hyperthermia (photothermal ablation), photodynamic, and radiation therapy are combined with one or more imaging functionalities for both in vitro and in vivo studies.  Different imaging probes, such as MRI contrast agents (T1 and T2 agents), fluorescent markers (org. dyes and inorg. quantum dots), and nuclear imaging agents (PET/SPECT agents), can be decorated onto therapeutic agents or therapeutic delivery vehicles in order to facilitate their imaging and, in so doing, gain information about the trafficking pathway, kinetics of delivery, and therapeutic efficacy; several such strategies are outlined.  The creative approaches being developed for these classes of therapies and imaging modalities are discussed, and the recent developments in this field along with examples of technologies that hold promise for the future of cancer medicine are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjaSl-ko7EubVg90H21EOLACvtfcHk0liBTbiXjOWWEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2jt77K&md5=54add18153e2ad4c9c2aa30ba97dbc6d</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fbc200151q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200151q%26sid%3Dliteratum%253Aachs%26aulast%3DKelkar%26aufirst%3DS.%2BS.%26aulast%3DReineke%26aufirst%3DT.%2BM.%26atitle%3DTheranostics%253A%2520combining%2520imaging%2520and%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D1879%26epage%3D1903%26doi%3D10.1021%2Fbc200151q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Chen, X. S.</span><span> </span><span class="NLM_article-title">Introducing Theranostics Journal - From the Editor-in-Chief</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">2</span><span class="refDoi"> DOI: 10.7150/thno/v01p0001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.7150%2Fthno%2Fv01p0001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=1-2&author=X.+S.+Chen&title=Introducing+Theranostics+Journal+-+From+the+Editor-in-Chief&doi=10.7150%2Fthno%2Fv01p0001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.7150%2Fthno%2Fv01p0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno%252Fv01p0001%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%2BS.%26atitle%3DIntroducing%2520Theranostics%2520Journal%2520-%2520From%2520the%2520Editor-in-Chief%26jtitle%3DTheranostics%26date%3D2011%26volume%3D1%26spage%3D1%26epage%3D2%26doi%3D10.7150%2Fthno%2Fv01p0001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Kojima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fussenegger, M.</span><span> </span><span class="NLM_article-title">Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2015.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.cbpa.2015.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=26056952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=29-38&author=R.+Kojimaauthor=D.+Aubelauthor=M.+Fussenegger&title=Novel+theranostic+agents+for+next-generation+personalized+medicine%3A+small+molecules%2C+nanoparticles%2C+and+engineered+mammalian+cells&doi=10.1016%2Fj.cbpa.2015.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells</span></div><div class="casAuthors">Kojima, Ryosuke; Aubel, Dominique; Fussenegger, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Modern medicine is currently undergoing a paradigm shift from conventional disease treatments based on the diagnosis of a generalized disease state to a more personalized, customized treatment model based on mol.-level diagnosis.  This uses novel biosensors that can precisely ext. disease-related information from complex biol. systems.  Moreover, with the recent progress in chem. biol., materials science, and synthetic biol., it has become possible to simultaneously conduct diagnosis and targeted therapy (theranostics/theragnosis) by directly connecting the readout of a biosensor to a therapeutic output.  These advances pave the way for more advanced and better personalized treatment for intractable diseases with fewer side effects.  In this review, we describe recent advances in the development of cutting-edge theranostic agents that contain both diagnostic and therapeutic functions in a single integrated system.  By comparing the advantages and disadvantages of each modality, we discuss the future challenges and prospects of developing ideal theranostic agents for the next generation of personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXkVvWAJyRcrVg90H21EOLACvtfcHk0liBTbiXjOWWEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL3E&md5=d6bfef7d34cb2ea39069872b19438dcc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2015.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2015.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DKojima%26aufirst%3DR.%26aulast%3DAubel%26aufirst%3DD.%26aulast%3DFussenegger%26aufirst%3DM.%26atitle%3DNovel%2520theranostic%2520agents%2520for%2520next-generation%2520personalized%2520medicine%253A%2520small%2520molecules%252C%2520nanoparticles%252C%2520and%2520engineered%2520mammalian%2520cells%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D28%26spage%3D29%26epage%3D38%26doi%3D10.1016%2Fj.cbpa.2015.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Aulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legname, G.</span><span> </span><span class="NLM_article-title">Small-molecule theranostic probes: a promising future in neurodegenerative diseases</span> <span class="citation_source-journal">Int. J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">150952</span><span class="refDoi"> DOI: 10.1155/2013/150952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1155%2F2013%2F150952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=24324497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2cflsVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=150952&author=S.+Aulicauthor=M.+L.+Bolognesiauthor=G.+Legname&title=Small-molecule+theranostic+probes%3A+a+promising+future+in+neurodegenerative+diseases&doi=10.1155%2F2013%2F150952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule theranostic probes: a promising future in neurodegenerative diseases</span></div><div class="casAuthors">Aulic Suzana; Bolognesi Maria Laura; Legname Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cell biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">150952</span>
        ISSN:<span class="NLM_cas:issn">1687-8876</span>.
    </div><div class="casAbstract">Prion diseases are fatal neurodegenerative illnesses, which include Creutzfeldt-Jakob disease in humans and scrapie, chronic wasting disease, and bovine spongiform encephalopathy in animals.  They are caused by unconventional infectious agents consisting primarily of misfolded, aggregated, β -sheet-rich isoforms, denoted prions, of the physiological cellular prion protein (PrP(C)).  Many lines of evidence suggest that prions (PrP(Sc)) act both as a template for this conversion and as a neurotoxic agent causing neuronal dysfunction and cell death.  As such, PrP(Sc) may be considered as both a neuropathological hallmark of the disease and a therapeutic target.  Several diagnostic imaging probes have been developed to monitor cerebral amyloid lesions in patients with neurodegenerative disorders (such as Alzheimer's disease, Parkinson's disease, and prion disease).  Examples of these probes are Congo red, thioflavin T, and their derivatives.  We synthesized a series of styryl derivatives, denoted theranostics, and studied their therapeutic and/or diagnostic potentials.  Here we review the salient traits of these small molecules that are able to detect and modulate aggregated forms of several proteins involved in protein misfolding diseases.  We then highlight the importance of further studies for their practical implications in therapy and diagnostics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJvBOhVCPyOOQ4Pl9hzjQhfW6udTcc2ebz3NRYQBoRA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflsVejug%253D%253D&md5=b664149988ab2f7eab71c2e662b8f332</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1155%2F2013%2F150952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F150952%26sid%3Dliteratum%253Aachs%26aulast%3DAulic%26aufirst%3DS.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DLegname%26aufirst%3DG.%26atitle%3DSmall-molecule%2520theranostic%2520probes%253A%2520a%2520promising%2520future%2520in%2520neurodegenerative%2520diseases%26jtitle%3DInt.%2520J.%2520Cell%2520Biol.%26date%3D2013%26volume%3D2013%26spage%3D150952%26doi%3D10.1155%2F2013%2F150952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Bongarzone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staderini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.4155/fmc.14.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.4155%2Ffmc.14.56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25068985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wqt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1017-1029&author=S.+Bongarzoneauthor=M.+Staderiniauthor=M.+L.+Bolognesi&title=Multitarget+ligands+and+theranostics%3A+sharpening+the+medicinal+chemistry+sword+against+prion+diseases&doi=10.4155%2Ffmc.14.56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases</span></div><div class="casAuthors">Bongarzone, Salvatore; Staderini, Matteo; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1017-1029</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Prion diseases (PrDs) are fatal neurodegenerative disorders, for which no effective therapeutic and diagnostic tools exist.  The main pathogenic event has been identified as the misfolding of a disease-assocd. prion protein.  Nevertheless, pathogenesis seems to involve an intricate array of concomitant processes.  Thus, it may be unlikely that drugs acting on single targets can effectively control PrDs.  In addn., diagnosis occurs late in the disease process, by which point it is difficult to det. a successful therapeutic intervention.  In this context, multitarget ligands (MTLs) and theranostic ligands (TLs) emerge for their potential to effectively cure and diagnose PrDs.  In this review, we discuss the medicinal chem. challenges of identifying novel MTLs and TLs against PrDs, and envision their impact on prion drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgXqRu40_tbrVg90H21EOLACvtfcHk0ljovGqm3mTwyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wqt7zI&md5=5afe39afa704e7324d694dc154124293</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.56%26sid%3Dliteratum%253Aachs%26aulast%3DBongarzone%26aufirst%3DS.%26aulast%3DStaderini%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DMultitarget%2520ligands%2520and%2520theranostics%253A%2520sharpening%2520the%2520medicinal%2520chemistry%2520sword%2520against%2520prion%2520diseases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1017%26epage%3D1029%26doi%3D10.4155%2Ffmc.14.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Prati, F.; Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">Tackling neurodegeneration with multi-target and theranostic small molecules</span>. In  <span class="citation_source-book">2015 Medicinal Chemistry Reviews</span>; <span class="NLM_contrib-group">Manoj, C. D.</span>, Ed.; <span class="NLM_publisher-name">ACS Division of Medicinal Chemistry</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">50</span>, Chapter 13, pp  <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=347-356&author=F.+Prati&author=M.+L.+Bolognesiauthor=C.+D.+Manoj&title=2015+Medicinal+Chemistry+Reviews"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26atitle%3DTackling%2520neurodegeneration%2520with%2520multi-target%2520and%2520theranostic%2520small%2520molecules%26btitle%3D2015%2520Medicinal%2520Chemistry%2520Reviews%26aulast%3DManoj%26aufirst%3DC.%2BD.%26pub%3DACS%2520Division%2520of%2520Medicinal%2520Chemistry%26date%3D2015%26volume%3D50%26spage%3D347%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Sumer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span> </span><span class="NLM_article-title">Theranostic nanomedicine for cancer</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span><span class="refDoi"> DOI: 10.2217/17435889.3.2.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2217%2F17435889.3.2.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=18373419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BD1c3hvVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=137-140&author=B.+Sumerauthor=J.+Gao&title=Theranostic+nanomedicine+for+cancer&doi=10.2217%2F17435889.3.2.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic nanomedicine for cancer</span></div><div class="casAuthors">Sumer Baran; Gao Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, England)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS69fXHoqo4FhLDWw4HIq2sfW6udTcc2ebFNmZjTdWaZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3hvVCqtw%253D%253D&md5=7f8a40ef7881a2aad40d944e6206ba09</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2217%2F17435889.3.2.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17435889.3.2.137%26sid%3Dliteratum%253Aachs%26aulast%3DSumer%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DTheranostic%2520nanomedicine%2520for%2520cancer%26jtitle%3DNanomedicine%26date%3D2008%26volume%3D3%26spage%3D137%26epage%3D140%26doi%3D10.2217%2F17435889.3.2.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Lammers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aime, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennink, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, F.</span><span> </span><span class="NLM_article-title">Theranostic nanomedicine</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span><span class="refDoi"> DOI: 10.1021/ar200019c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar200019c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsF2jsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1029-1038&author=T.+Lammersauthor=S.+Aimeauthor=W.+E.+Henninkauthor=G.+Stormauthor=F.+Kiessling&title=Theranostic+nanomedicine&doi=10.1021%2Far200019c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Nanomedicines</span></div><div class="casAuthors">Lammers, Twan; Aime, Silvio; Hennink, Wim E.; Storm, Gert; Kiessling, Fabian</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1029-1038</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Nanomedicine formulations aim to improve the biodistribution and the target site accumulation of systemically administered (chemo)therapeutic agents.  Many different types of nanomedicines were evaluated over the years, including for instance liposomes, polymers, micelles and antibodies, and a significant amt. of evidence was obtained showing that these submicrometer-sized carrier materials are able to improve the balance between the efficacy and the toxicity of therapeutic interventions.  Besides for therapeutic purposes, nanomedicine formulations have in recent years also been increasingly employed for imaging applications.  Moreover, paralleled by advances in chem., biol., pharmacy, nanotechnol., medicine and imaging, several different systems were developed in the last decade in which disease diagnosis and therapy are combined.  These so-called (nano) theranostics contain both a drug and an imaging agent within a single formulation, and they can be used for various different purposes.  In this Account, the authors summarize several exemplary efforts in this regard, and the authors show that theranostic nanomedicines are highly suitable systems for monitoring drug delivery, drug release and drug efficacy.  The (pre)clin. most relevant applications of theranostic nanomedicines relate to their use for validating and optimizing the properties of drug delivery systems, and to their ability to be used for pre-screening patients and enabling personalized medicine.  Regarding the former, the combination of diagnostic and therapeutic agents within a single formulation provides real-time feedback on the pharmacokinetics, the target site localization and the (off-target) healthy organ accumulation of nanomedicines.  Various examples of this will be highlighted in this Account, illustrating that by non-invasively visualizing how well carrier materials are able to deliver pharmacol. active agents to the pathol. site, and how well they are able to prevent them from accumulating in potentially endangered healthy tissues, important information can be obtained for optimizing the basic properties of drug delivery systems, as well as for improving the balance between the efficacy and the toxicity of targeted therapeutic interventions.  Regarding personalized medicine, it can be reasoned that only in patients which show high levels of target site accumulation, and which respond well to the first couple of treatment cycles, targeted therapy should be continued, and that in those in which this is not the case, other therapeutic options should be considered.  Based on these insights, the authors expect that ever more efforts will be invested in developing theranostic nanomedicines, and that these systems and strategies will contribute substantially to realizing the potential of personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpYgcECdOPk7Vg90H21EOLACvtfcHk0lgvUFP6x9YVjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsF2jsrk%253D&md5=4334d64042d373a73c4a59d6ad1e181b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Far200019c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far200019c%26sid%3Dliteratum%253Aachs%26aulast%3DLammers%26aufirst%3DT.%26aulast%3DAime%26aufirst%3DS.%26aulast%3DHennink%26aufirst%3DW.%2BE.%26aulast%3DStorm%26aufirst%3DG.%26aulast%3DKiessling%26aufirst%3DF.%26atitle%3DTheranostic%2520nanomedicine%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2011%26volume%3D44%26spage%3D1029%26epage%3D1038%26doi%3D10.1021%2Far200019c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Kunjachan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storm, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, T.</span><span> </span><span class="NLM_article-title">Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">10907</span><span class="NLM_x">–</span> <span class="NLM_lpage">10937</span><span class="refDoi"> DOI: 10.1021/cr500314d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500314d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=10907-10937&author=S.+Kunjachanauthor=J.+Ehlingauthor=G.+Stormauthor=F.+Kiesslingauthor=T.+Lammers&title=Noninvasive+imaging+of+nanomedicines+and+nanotheranostics%3A+principles%2C+progress%2C+and+prospects&doi=10.1021%2Fcr500314d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects</span></div><div class="casAuthors">Kunjachan, Sijumon; Ehling, Josef; Storm, Gert; Kiessling, Fabian; Lammers, Twan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10907-10937</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the most important applications of noninvasive imaging techniques such as PET, SPECT, CT, MRI, OI and US in the use of nanomedicines and nanotheranostics (e.g., liposomes, polymers, micelles, dendrimers, nanoparticles, antibodies) for facilitating disease diagnosis, disease treatment, and treatment monitoring, including drug delivery research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc0xfnWIO7yLVg90H21EOLACvtfcHk0lgvUFP6x9YVjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhsbrO&md5=49745089d09f174e7b80c6a48bb4ebb7</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fcr500314d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500314d%26sid%3Dliteratum%253Aachs%26aulast%3DKunjachan%26aufirst%3DS.%26aulast%3DEhling%26aufirst%3DJ.%26aulast%3DStorm%26aufirst%3DG.%26aulast%3DKiessling%26aufirst%3DF.%26aulast%3DLammers%26aufirst%3DT.%26atitle%3DNoninvasive%2520imaging%2520of%2520nanomedicines%2520and%2520nanotheranostics%253A%2520principles%252C%2520progress%252C%2520and%2520prospects%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D10907%26epage%3D10937%26doi%3D10.1021%2Fcr500314d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Tosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandelli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruozi, B.</span><span> </span><span class="NLM_article-title">Nanomedicine and neurodegenerative disorders: so close yet so far</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1517/17425247.2015.1041374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1517%2F17425247.2015.1041374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1041-1044&author=G.+Tosiauthor=M.+A.+Vandelliauthor=F.+Forniauthor=B.+Ruozi&title=Nanomedicine+and+neurodegenerative+disorders%3A+so+close+yet+so+far&doi=10.1517%2F17425247.2015.1041374"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1517%2F17425247.2015.1041374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2015.1041374%26sid%3Dliteratum%253Aachs%26aulast%3DTosi%26aufirst%3DG.%26aulast%3DVandelli%26aufirst%3DM.%2BA.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DRuozi%26aufirst%3DB.%26atitle%3DNanomedicine%2520and%2520neurodegenerative%2520disorders%253A%2520so%2520close%2520yet%2520so%2520far%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2015%26volume%3D12%26spage%3D1041%26epage%3D1044%26doi%3D10.1517%2F17425247.2015.1041374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Brambilla, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Droumaguet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashemi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghimi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvreur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrieux, K.</span><span> </span><span class="NLM_article-title">Nanotechnologies for Alzheimer’s disease: diagnosis, therapy, and safety issues</span> <span class="citation_source-journal">Nanomedicine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span><span class="refDoi"> DOI: 10.1016/j.nano.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.nano.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=21477665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=521-540&author=D.+Brambillaauthor=B.+Le+Droumaguetauthor=J.+Nicolasauthor=S.+H.+Hashemiauthor=L.+P.+Wuauthor=S.+M.+Moghimiauthor=P.+Couvreurauthor=K.+Andrieux&title=Nanotechnologies+for+Alzheimer%E2%80%99s+disease%3A+diagnosis%2C+therapy%2C+and+safety+issues&doi=10.1016%2Fj.nano.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues</span></div><div class="casAuthors">Brambilla, Davide; Le Droumaguet, Benjamin; Nicolas, Julien; Hashemi, S. Hossein; Wu, Lin-Ping; Moghimi, S. Moein; Couvreur, Patrick; Andrieux, Karine</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (Philadelphia, PA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">521-540</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) represents the most common form of dementia worldwide, affecting more than 35 million people.  Advances in nanotechnol. are beginning to exert a significant impact in neurol.  These approaches, which are often based on the design and engineering of a plethora of nanoparticulate entities with high specificity for brain capillary endothelial cells, are currently being applied to early AD diagnosis and treatment.  In addn., nanoparticles (NPs) with high affinity for the circulating amyloid-β (Aβ) forms may induce "sink effect" and improve the AD condition.  There are also developments in relation to in vitro diagnostics for AD, including ultrasensitive NP-based bio-barcodes, immunosensors, as well as scanning tunneling microscopy procedures capable of detecting Aβ1-40 and Aβ1-42.  However, there are concerns regarding the initiation of possible NP-mediated adverse events in AD, thus demanding the use of precisely assembled nanoconstructs from biocompatible materials.  Key advances and safety issues are reviewed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphirzpnSLDnbVg90H21EOLACvtfcHk0lipmDyZWLq0Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSrtLrM&md5=d03b38defb88c094343e1b2f802c05b7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBrambilla%26aufirst%3DD.%26aulast%3DLe%2BDroumaguet%26aufirst%3DB.%26aulast%3DNicolas%26aufirst%3DJ.%26aulast%3DHashemi%26aufirst%3DS.%2BH.%26aulast%3DWu%26aufirst%3DL.%2BP.%26aulast%3DMoghimi%26aufirst%3DS.%2BM.%26aulast%3DCouvreur%26aufirst%3DP.%26aulast%3DAndrieux%26aufirst%3DK.%26atitle%3DNanotechnologies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520diagnosis%252C%2520therapy%252C%2520and%2520safety%2520issues%26jtitle%3DNanomedicine%26date%3D2011%26volume%3D7%26spage%3D521%26epage%3D540%26doi%3D10.1016%2Fj.nano.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Laurent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ejtehadi, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehoe, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmoudi, M.</span><span> </span><span class="NLM_article-title">Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer’s disease</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">5008</span><span class="NLM_x">–</span> <span class="NLM_lpage">5033</span><span class="refDoi"> DOI: 10.1039/c2ra01374f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2Fc2ra01374f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFOku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=5008-5033&author=S.+Laurentauthor=M.+R.+Ejtehadiauthor=M.+Rezaeiauthor=P.+G.+Kehoeauthor=M.+Mahmoudi&title=Interdisciplinary+challenges+and+promising+theranostic+effects+of+nanoscience+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc2ra01374f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease</span></div><div class="casAuthors">Laurent, Sophie; Ejtehadi, Mohammad Reza; Rezaei, Meisam; Kehoe, Patrick G.; Mahmoudi, Morteza</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5008-5033</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  During the last decade, reports show that the incidence and prevalence of Alzheimer's disease (AD) and other dementias have significantly increased.  AD poses an enormous escalating threat to health services and resources.  Early diagnosis of AD is recognized as one of the major challenges and primary aims in scientific communities.  With the arrival of nanoscience and nanotechnol. to medicine, hopes for early diagnosis and treatment of AD have considerably increased.  To this end, nanobioresearchers are focused on three major areas consisting of early detection and recognition, biol. markers and diagnosis, and pharmacotherapy.  Several efforts are in progress for the discovery of new nanodrugs with a sufficient effort on the fast therapy of AD.  In this review, a comprehensive overview of the conventional theories together with new conflicts and challenges on the major causes of AD is provided.  In addn., the opportunities and challenges of nanoscience and nanotechnol. as theranostic agents for AD are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJTdkUizLlDrVg90H21EOLACvtfcHk0lipmDyZWLq0Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFOku7o%253D&md5=ace62f1f6a6361a73b9b45fba2d69fc4</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1039%2Fc2ra01374f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ra01374f%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DS.%26aulast%3DEjtehadi%26aufirst%3DM.%2BR.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DKehoe%26aufirst%3DP.%2BG.%26aulast%3DMahmoudi%26aufirst%3DM.%26atitle%3DInterdisciplinary%2520challenges%2520and%2520promising%2520theranostic%2520effects%2520of%2520nanoscience%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26spage%3D5008%26epage%3D5033%26doi%3D10.1039%2Fc2ra01374f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Amiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeidi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manafirad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbi, V.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span><span class="refDoi"> DOI: 10.1021/cn4001582</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn4001582" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWku7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1417-1429&author=H.+Amiriauthor=K.+Saeidiauthor=P.+Borhaniauthor=A.+Manafiradauthor=M.+Ghavamiauthor=V.+Zerbi&title=Alzheimer%E2%80%99s+disease%3A+pathophysiology+and+applications+of+magnetic+nanoparticles+as+MRI+theranostic+agents&doi=10.1021%2Fcn4001582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: Pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents</span></div><div class="casAuthors">Amiri, Houshang; Saeidi, Kolsoum; Borhani, Parvin; Manafirad, Arash; Ghavami, Mahdi; Zerbi, Valerio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1429</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia.  During the recent decade, nanotechnol. has been widely considered, as a promising tool, for theranosis (diagnosis and therapy) of AD.  Here we first discuss pathophysiol. and characteristics of AD with a focus on the amyloid cascade hypothesis.  Then magnetic nanoparticles (MNPs) and recent works on their applications in AD, focusing on the superparamagnetic iron oxide nanoparticles (SPIONs), are reviewed.  Furthermore, the amyloid-nanoparticle interaction is highlighted, with the scope to be highly considered by the scientists aiming for diagnostics and/or treatment of AD employing nanoparticles.  Furthermore, recent findings on the "ignored" parameters (e.g., effect of protein "corona" at the surface of nanoparticles on amyloid-β (Aβ) fibrillation process) are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcaC_r5f9OFrVg90H21EOLACvtfcHk0lgVQJr7kxH6mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWku7jK&md5=a77bafe1ace864d21ff3e90731a8f7a0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcn4001582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn4001582%26sid%3Dliteratum%253Aachs%26aulast%3DAmiri%26aufirst%3DH.%26aulast%3DSaeidi%26aufirst%3DK.%26aulast%3DBorhani%26aufirst%3DP.%26aulast%3DManafirad%26aufirst%3DA.%26aulast%3DGhavami%26aufirst%3DM.%26aulast%3DZerbi%26aufirst%3DV.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520pathophysiology%2520and%2520applications%2520of%2520magnetic%2520nanoparticles%2520as%2520MRI%2520theranostic%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1417%26epage%3D1429%26doi%3D10.1021%2Fcn4001582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Ruozi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belletti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pederzoli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veratti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandelli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosi, G.</span><span> </span><span class="NLM_article-title">Nanotechnology and Alzheimer’s disease: what has been done and what to do</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4169</span><span class="NLM_x">–</span> <span class="NLM_lpage">4185</span><span class="refDoi"> DOI: 10.2174/0929867321666140716100056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2174%2F0929867321666140716100056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25039777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=4169-4185&author=B.+Ruoziauthor=D.+Bellettiauthor=F.+Pederzoliauthor=P.+Verattiauthor=F.+Forniauthor=M.+A.+Vandelliauthor=G.+Tosi&title=Nanotechnology+and+Alzheimer%E2%80%99s+disease%3A+what+has+been+done+and+what+to+do&doi=10.2174%2F0929867321666140716100056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnology and Alzheimer's Disease: What has been Done and What to Do'</span></div><div class="casAuthors">Ruozi, B.; Belletti, D.; Pederzoli, F.; Veratti, P.; Forni, F.; Vandelli, M. A.; Tosi, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">4169-4185</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Up to date, Alzheimer's Disease (AD) is considered as an "urgency" for public health, since it represents one of the most dramatic causes of death in adults.  The drugs currently used for AD are only symptomatic, thus not curing the pathol., but only trying to slow or delay the progression of the pathol.  Moreover, there is a total lack of early identification, with only "probable'' or ''possible'' diagnosis of AD patients.  With this review, we aimed to individuate and to highlight the most promising approaches for AD therapy and diagnosis.  In this view, at the cutting-edge of innovation, nanocarriers as polymeric nanoparticles, liposomes, nanoassembly and dendrimers, have been studied and investigated in order to ameliorate the detection (in vitro and in vivo) and/or the therapeutic options in AD.  In this review, the most outstanding nanomedicine-driven approaches in AD imaging/detection and treatments are summarized in order to help in individuating values and criticisms.  Moreover, an overview of one of the most innovative strategies in AD management, namely theranostic nanomedicine, is reported and commented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI9IOKNIq2pLVg90H21EOLACvtfcHk0lgVQJr7kxH6mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7vJ&md5=8d3989f32a1b789adff36a5b2c08b3b3</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140716100056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140716100056%26sid%3Dliteratum%253Aachs%26aulast%3DRuozi%26aufirst%3DB.%26aulast%3DBelletti%26aufirst%3DD.%26aulast%3DPederzoli%26aufirst%3DF.%26aulast%3DVeratti%26aufirst%3DP.%26aulast%3DForni%26aufirst%3DF.%26aulast%3DVandelli%26aufirst%3DM.%2BA.%26aulast%3DTosi%26aufirst%3DG.%26atitle%3DNanotechnology%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520what%2520has%2520been%2520done%2520and%2520what%2520to%2520do%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D4169%26epage%3D4185%26doi%3D10.2174%2F0929867321666140716100056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Nesterov, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swager, T. M.</span><span> </span><span class="NLM_article-title">In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5452</span><span class="NLM_x">–</span> <span class="NLM_lpage">5456</span><span class="refDoi"> DOI: 10.1002/anie.200500845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fanie.200500845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=16059955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5452-5456&author=E.+E.+Nesterovauthor=J.+Skochauthor=B.+T.+Hymanauthor=W.+E.+Klunkauthor=B.+J.+Bacskaiauthor=T.+M.+Swager&title=In+vivo+optical+imaging+of+amyloid+aggregates+in+brain%3A+design+of+fluorescent+markers&doi=10.1002%2Fanie.200500845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo optical imaging of amyloid aggregates in brain: Design of fluorescent markers</span></div><div class="casAuthors">Nesterov, Evgueni E.; Skoch, Jesse; Hyman, Bradley T.; Klunk, William E.; Bacskai, Brian J.; Swager, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5452-5456</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Routine diagnostics and studies of Alzheimer's disease might benefit form the noninvasive optical imaging of amyloid-β plaques in the brain.  A rational design strategy for in vivo amyloid-imaging agents that enter the brain and selectively stain amyloid plaques is presented (see picture), and properties of a promising lead biomarker candidate are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5E9TYWs6pyLVg90H21EOLACvtfcHk0liLPpR_6HcsPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D&md5=784428c9422af2b31caf739625afc87a</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fanie.200500845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200500845%26sid%3Dliteratum%253Aachs%26aulast%3DNesterov%26aufirst%3DE.%2BE.%26aulast%3DSkoch%26aufirst%3DJ.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DSwager%26aufirst%3DT.%2BM.%26atitle%3DIn%2520vivo%2520optical%2520imaging%2520of%2520amyloid%2520aggregates%2520in%2520brain%253A%2520design%2520of%2520fluorescent%2520markers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5452%26epage%3D5456%26doi%3D10.1002%2Fanie.200500845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Cui, M.</span><span> </span><span class="NLM_article-title">Past and recent progress of molecular imaging probes for beta-amyloid plaques in the brain</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.2174/09298673113209990216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.2174%2F09298673113209990216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=23992340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=82-112&author=M.+Cui&title=Past+and+recent+progress+of+molecular+imaging+probes+for+beta-amyloid+plaques+in+the+brain&doi=10.2174%2F09298673113209990216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Past and Recent Progress of Molecular Imaging Probes for β-Amyloid Plaques in the Brain</span></div><div class="casAuthors">Cui, Mengchao</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-112</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The deposition of β-amyloid (Aβ) plaques in the parenchymal and cortical brain is accepted as the main pathol. hallmark of Alzheimer's disease (AD).  According to the amyloid cascade hypothesis, the Aβ deposition in the brain appears to be a good diagnostic biomarker for AD and may also be a good predictive biomarker of this disease.  Mol. imaging of Aβ plaques in the brain with positron emission tomog. (PET), single photon emission computed tomog. (SPECT) or mol. optical imaging represents a promising approach to the early diagnosis of AD and monitoring the effectiveness of novel therapies for this devastating disease.  Our review focuses on the past and recent knowledge in this field with respect to small org. mols. that have been utilized for the development of Aβ imaging probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDkW-1MI-9ZLVg90H21EOLACvtfcHk0liLPpR_6HcsPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOhsbc%253D&md5=330b1b07dcabdb0a808183458702ec1b</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990216%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DM.%26atitle%3DPast%2520and%2520recent%2520progress%2520of%2520molecular%2520imaging%2520probes%2520for%2520beta-amyloid%2520plaques%2520in%2520the%2520brain%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D82%26epage%3D112%26doi%3D10.2174%2F09298673113209990216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Fu, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. L.</span><span> </span><span class="NLM_article-title">Highly sensitive near-infrared fluorophores for in vivo detection of amyloid-beta plaques in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6972</span><span class="NLM_x">–</span> <span class="NLM_lpage">6983</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00861</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00861" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSmt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6972-6983&author=H.+L.+Fuauthor=M.+C.+Cuiauthor=L.+Zhaoauthor=P.+Y.+Tuauthor=K.+X.+Zhouauthor=J.+P.+Daiauthor=B.+L.+Liu&title=Highly+sensitive+near-infrared+fluorophores+for+in+vivo+detection+of+amyloid-beta+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.5b00861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease</span></div><div class="casAuthors">Fu, Hualong; Cui, Mengchao; Zhao, Liu; Tu, Peiyu; Zhou, Kaixiang; Dai, Jiapei; Liu, Boli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6972-6983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is pathol. characterized by the accumulation of β-amyloid (Aβ) deposits in the parenchymal and cortical brain.  In this work, we designed, synthesized, and evaluated a series of near-IR (NIR) probes with electron donor-acceptor end groups interacting through a π-conjugated system for the detection of Aβ deposits in the brain.  Among these probes, 3b and 3c had excellent fluorescent properties (emission maxima > 650 nm and high quantum yields) and displayed high sensitivity and high affinities to Aβ aggregates (3b, Kd = 8.8 nM; 3c, Kd = 1.9 nM).  Both 3b and 3c could readily penetrate the blood-brain barrier with high initial brain uptake and fast to moderate washout from the brain.  In vivo NIR imaging revealed that 3b and 3c could efficiently differentiate transgenic and wild-type mice.  In summary, our research provides new hints for developing smarter and more activatable NIR probes targeting Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAQ3V2vzvTB7Vg90H21EOLACvtfcHk0liLPpR_6HcsPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSmt7nE&md5=454275cac002fcf02d97a8ba9d682b4c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00861%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%2BL.%26aulast%3DCui%26aufirst%3DM.%2BC.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DTu%26aufirst%3DP.%2BY.%26aulast%3DZhou%26aufirst%3DK.%2BX.%26aulast%3DDai%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DB.%2BL.%26atitle%3DHighly%2520sensitive%2520near-infrared%2520fluorophores%2520for%2520in%2520vivo%2520detection%2520of%2520amyloid-beta%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6972%26epage%3D6983%26doi%3D10.1021%2Facs.jmedchem.5b00861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Li, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span> </span><span class="NLM_article-title">Current drug research on PEGylation with small molecular agents</span> <span class="citation_source-journal">Prog. Polym. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/j.progpolymsci.2012.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.progpolymsci.2012.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=421-444&author=W.+J.+Liauthor=P.+Zhanauthor=E.+De+Clercqauthor=H.+X.+Louauthor=X.+Y.+Liu&title=Current+drug+research+on+PEGylation+with+small+molecular+agents&doi=10.1016%2Fj.progpolymsci.2012.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Current drug research on PEGylation with small molecular agents</span></div><div class="casAuthors">Li, Wenjun; Zhan, Peng; De Clercq, Erik; Lou, Hongxiang; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Polymer Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">421-444</span>CODEN:
                <span class="NLM_cas:coden">PRPSB8</span>;
        ISSN:<span class="NLM_cas:issn">0079-6700</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  PEGylation, covalent attaching polyethylene glycol (PEG) polymers to therapeutic agents, is one of the most promising techniques to improve the therapeutic effect of drugs.  Initially, this technol. is mainly applied with macromol. drugs, such as proteins, enzymes, with ten PEGylated biomacromols. approved by the FDA for the treatment of related diseases.  The clin. successful use of PEGylated macromol. drug has promoted the application of this technol. with small mols. drugs to overcome shortcomings assocd. with therapy, such as possible low soly., high toxicity, undesirable pharmaceutical characteristics and nonspecific biodistribution profiles.  So far, 4 PEGylated small drugs were taken into clin. trials.  This review mainly focuses on the recent advances of PEGylated small mols., including their general configuration, and the current merits and limits of PEG modification.  Herein PEG delivery systems are distinguished by therapeutic application (anti-tumor, anti-inflammatory, etc.) and their corresponding PEGylated small mols. are described in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1c3uJ8cWgm7Vg90H21EOLACvtfcHk0lj659vOiEOmIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlymurrE&md5=eb609a4d59ce7e8cc5cf443ce8def9b4</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.progpolymsci.2012.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.progpolymsci.2012.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%2BJ.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLou%26aufirst%3DH.%2BX.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26atitle%3DCurrent%2520drug%2520research%2520on%2520PEGylation%2520with%2520small%2520molecular%2520agents%26jtitle%3DProg.%2520Polym.%2520Sci.%26date%3D2013%26volume%3D38%26spage%3D421%26epage%3D444%26doi%3D10.1016%2Fj.progpolymsci.2012.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. S.</span><span> </span><span class="NLM_article-title">Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1804</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span><span class="refDoi"> DOI: 10.1002/anie.201104150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fanie.201104150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC383isleitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1804-1810&author=W.+Yangauthor=Y.+Wongauthor=O.+T.+Ngauthor=L.+P.+Baiauthor=D.+W.+Kwongauthor=Y.+Keauthor=Z.+H.+Jiangauthor=H.+W.+Liauthor=K.+K.+Yungauthor=M.+S.+Wong&title=Inhibition+of+beta-amyloid+peptide+aggregation+by+multifunctional+carbazole-based+fluorophores&doi=10.1002%2Fanie.201104150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores</span></div><div class="casAuthors">Yang Wanggui; Wong Yi; Ng Olivia T W; Bai Li-Ping; Kwong Daniel W J; Ke Ya; Jiang Zhi-Hong; Li Hung-Wing; Yung Ken K L; Wong Man Shing</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1804-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRN-c5U5ISDLHHuJhbyicZfW6udTcc2eZBD_6y_C2vgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383isleitA%253D%253D&md5=4b5e41db5ad9a5e5842249aa5b59f24e</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1002%2Fanie.201104150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201104150%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DO.%2BT.%26aulast%3DBai%26aufirst%3DL.%2BP.%26aulast%3DKwong%26aufirst%3DD.%2BW.%26aulast%3DKe%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%2BH.%26aulast%3DLi%26aufirst%3DH.%2BW.%26aulast%3DYung%26aufirst%3DK.%2BK.%26aulast%3DWong%26aufirst%3DM.%2BS.%26atitle%3DInhibition%2520of%2520beta-amyloid%2520peptide%2520aggregation%2520by%2520multifunctional%2520carbazole-based%2520fluorophores%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1804%26epage%3D1810%26doi%3D10.1002%2Fanie.201104150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Staderini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Ruiz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabezas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legname, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span> </span><span class="NLM_article-title">A Fluorescent styrylquinoline with combined therapeutic and diagnostic activities against Alzheimer’s and prion diseases</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span><span class="refDoi"> DOI: 10.1021/ml3003605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=225-229&author=M.+Staderiniauthor=S.+Aulicauthor=M.+Bartoliniauthor=H.+N.+Tranauthor=V.+Gonzalez-Ruizauthor=D.+I.+Perezauthor=N.+Cabezasauthor=A.+Martinezauthor=M.+A.+Martinauthor=V.+Andrisanoauthor=G.+Legnameauthor=J.+C.+Menendezauthor=M.+L.+Bolognesi&title=A+Fluorescent+styrylquinoline+with+combined+therapeutic+and+diagnostic+activities+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fml3003605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fml3003605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003605%26sid%3Dliteratum%253Aachs%26aulast%3DStaderini%26aufirst%3DM.%26aulast%3DAulic%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DH.%2BN.%26aulast%3DGonzalez-Ruiz%26aufirst%3DV.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DCabezas%26aufirst%3DN.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DMenendez%26aufirst%3DJ.%2BC.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DA%2520Fluorescent%2520styrylquinoline%2520with%2520combined%2520therapeutic%2520and%2520diagnostic%2520activities%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D225%26epage%3D229%26doi%3D10.1021%2Fml3003605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namm, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y. T.</span><span> </span><span class="NLM_article-title">Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1687</span><span class="refDoi"> DOI: 10.1002/cbic.200700154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fcbic.200700154" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1679-1687&author=Q.+Liauthor=J.+K.+Minauthor=Y.+H.+Ahnauthor=J.+H.+Nammauthor=E.+M.+Kimauthor=R.+Luiauthor=H.+Y.+Kimauthor=Y.+Jiauthor=H.+Z.+Wuauthor=T.+Wisniewskiauthor=Y.+T.+Chang&title=Styryl-based+compounds+as+potential+in+vivo+imaging+agents+for+beta-amyloid+plaques&doi=10.1002%2Fcbic.200700154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200700154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200700154%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMin%26aufirst%3DJ.%2BK.%26aulast%3DAhn%26aufirst%3DY.%2BH.%26aulast%3DNamm%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DE.%2BM.%26aulast%3DLui%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DH.%2BZ.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DY.%2BT.%26atitle%3DStyryl-based%2520compounds%2520as%2520potential%2520in%2520vivo%2520imaging%2520agents%2520for%2520beta-amyloid%2520plaques%26jtitle%3DChemBioChem%26date%3D2007%26volume%3D8%26spage%3D1679%26epage%3D1687%26doi%3D10.1002%2Fcbic.200700154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Cell biology. A unifying role for prions in neurodegenerative diseases</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span><span class="refDoi"> DOI: 10.1126/science.1222951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1126%2Fscience.1222951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=22723400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKmt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=1511-1513&author=S.+B.+Prusiner&title=Cell+biology.+A+unifying+role+for+prions+in+neurodegenerative+diseases&doi=10.1126%2Fscience.1222951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A unifying role for prions in neurodegenerative diseases</span></div><div class="casAuthors">Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6088</span>),
    <span class="NLM_cas:pages">1511-1513</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCuklhpVrmWbVg90H21EOLACvtfcHk0lhN2nkuxJRZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKmt7%252FN&md5=b2e3f8cec0e90aff1577b75a95095518</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222951%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DCell%2520biology.%2520A%2520unifying%2520role%2520for%2520prions%2520in%2520neurodegenerative%2520diseases%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D1511%26epage%3D1513%26doi%3D10.1126%2Fscience.1222951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaseen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutzendler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C. Z.</span><span> </span><span class="NLM_article-title">A bifunctional curcumin analogue for two-photon imaging and inhibiting crosslinking of amyloid beta in Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">11550</span><span class="NLM_x">–</span> <span class="NLM_lpage">11553</span><span class="refDoi"> DOI: 10.1039/C4CC03731F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4CC03731F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=11550-11553&author=X.+L.+Zhangauthor=Y.+L.+Tianauthor=P.+Yuanauthor=Y.+Y.+Liauthor=M.+A.+Yaseenauthor=J.+Grutzendlerauthor=A.+Mooreauthor=C.+Z.+Ran&title=A+bifunctional+curcumin+analogue+for+two-photon+imaging+and+inhibiting+crosslinking+of+amyloid+beta+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CC03731F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1039%2FC4CC03731F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC03731F%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DTian%26aufirst%3DY.%2BL.%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DYaseen%26aufirst%3DM.%2BA.%26aulast%3DGrutzendler%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%2BZ.%26atitle%3DA%2520bifunctional%2520curcumin%2520analogue%2520for%2520two-photon%2520imaging%2520and%2520inhibiting%2520crosslinking%2520of%2520amyloid%2520beta%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D11550%26epage%3D11553%26doi%3D10.1039%2FC4CC03731F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Tian, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoup, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmaleh, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, C. Z.</span><span> </span><span class="NLM_article-title">Crown ethers attenuate aggregation of amyloid beta of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">15792</span><span class="NLM_x">–</span> <span class="NLM_lpage">15795</span><span class="refDoi"> DOI: 10.1039/C4CC06029F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC4CC06029F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=25372154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVemsrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=15792-15795&author=Y.+L.+Tianauthor=X.+L.+Zhangauthor=Y.+Y.+Liauthor=T.+M.+Shoupauthor=X.+Tengauthor=D.+R.+Elmalehauthor=A.+Mooreauthor=C.+Z.+Ran&title=Crown+ethers+attenuate+aggregation+of+amyloid+beta+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC4CC06029F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease</span></div><div class="casAuthors">Tian, Yanli; Zhang, Xueli; Li, Yuyan; Shoup, Timothy M.; Teng, Xin; Elmaleh, David R.; Moore, Anna; Ran, Chongzhao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">99</span>),
    <span class="NLM_cas:pages">15792-15795</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this report, we reasoned that non-covalent modification of amyloid beta (Aβ) by crown ethers could inhibit its aggregation.  We demonstrated that PiB-C, a conjugate PiB and crown ether, could significantly reduce the aggregation in vitro.  Addnl., two-photon imaging showed that PiB-C could efficiently label Aβ plaques and CAAs in AD mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDHH0b6SuvcrVg90H21EOLACvtfcHk0lhN2nkuxJRZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVemsrzP&md5=8da0a82f1f654f9ea84ac3d11e712c9e</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1039%2FC4CC06029F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CC06029F%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DLi%26aufirst%3DY.%2BY.%26aulast%3DShoup%26aufirst%3DT.%2BM.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DElmaleh%26aufirst%3DD.%2BR.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DRan%26aufirst%3DC.%2BZ.%26atitle%3DCrown%2520ethers%2520attenuate%2520aggregation%2520of%2520amyloid%2520beta%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Commun.%26date%3D2014%26volume%3D50%26spage%3D15792%26epage%3D15795%26doi%3D10.1039%2FC4CC06029F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aucoin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Nostrand, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. O.</span><span> </span><span class="NLM_article-title">Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1038/nsmb.1799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1038%2Fnsmb.1799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=20383142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFalurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=561-567&author=M.+Ahmedauthor=J.+Davisauthor=D.+Aucoinauthor=T.+Satoauthor=S.+Ahujaauthor=S.+Aimotoauthor=J.+I.+Elliottauthor=W.+E.+Van+Nostrandauthor=S.+O.+Smith&title=Structural+conversion+of+neurotoxic+amyloid-beta%281-42%29+oligomers+to+fibrils&doi=10.1038%2Fnsmb.1799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils</span></div><div class="casAuthors">Ahmed, Mahiuddin; Davis, Judianne; Aucoin, Darryl; Sato, Takeshi; Ahuja, Shivani; Aimoto, Saburo; Elliott, James I.; Van Nostrand, William E.; Smith, Steven O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">561-567</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The amyloid-β1-42 (Aβ42) peptide rapidly aggregates to form oligomers, protofibrils and fibrils en route to the deposition of amyloid plaques assocd. with Alzheimer's disease.  We show that low-temp. and low-salt conditions can stabilize disk-shaped oligomers (pentamers) that are substantially more toxic to mouse cortical neurons than protofibrils and fibrils.  We find that these neurotoxic oligomers do not have the β-sheet structure characteristic of fibrils.  Rather, the oligomers are composed of loosely aggregated strands whose C termini are protected from solvent exchange and which have a turn conformation, placing Phe19 in contact with Leu34.  On the basis of NMR spectroscopy, we show that the structural conversion of Aβ42 oligomers to fibrils involves the assocn. of these loosely aggregated strands into β-sheets whose individual β-strands polymerize in a parallel, in-register orientation and are staggered at an intermonomer contact between Gln15 and Gly37.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzXwa2kdCLS7Vg90H21EOLACvtfcHk0liLWl4ORGzn0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFalurY%253D&md5=0d0c19141fd3cfe17fe5ee788eb248ab</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1799%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DAucoin%26aufirst%3DD.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DAimoto%26aufirst%3DS.%26aulast%3DElliott%26aufirst%3DJ.%2BI.%26aulast%3DVan%2BNostrand%26aufirst%3DW.%2BE.%26aulast%3DSmith%26aufirst%3DS.%2BO.%26atitle%3DStructural%2520conversion%2520of%2520neurotoxic%2520amyloid-beta%25281-42%2529%2520oligomers%2520to%2520fibrils%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D561%26epage%3D567%26doi%3D10.1038%2Fnsmb.1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Yang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Specific self-monitoring of metal-associated amyloid-beta peptide disaggregation by a fluorescent chelator</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2245</span><span class="NLM_x">–</span> <span class="NLM_lpage">2248</span><span class="refDoi"> DOI: 10.1039/C5CC08898D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1039%2FC5CC08898D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=2245-2248&author=T.+Yangauthor=X.+Wangauthor=C.+Zhangauthor=X.+Maauthor=K.+Wangauthor=Y.+Wangauthor=J.+Luoauthor=L.+Yangauthor=C.+Yaoauthor=X.+Wang&title=Specific+self-monitoring+of+metal-associated+amyloid-beta+peptide+disaggregation+by+a+fluorescent+chelator&doi=10.1039%2FC5CC08898D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1039%2FC5CC08898D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC08898D%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DSpecific%2520self-monitoring%2520of%2520metal-associated%2520amyloid-beta%2520peptide%2520disaggregation%2520by%2520a%2520fluorescent%2520chelator%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26spage%3D2245%26epage%3D2248%26doi%3D10.1039%2FC5CC08898D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Bolognin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatta, P.</span><span> </span><span class="NLM_article-title">Chelation therapy for neurodegenerative diseases</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1002/med.20148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1002%2Fmed.20148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=19177468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVaitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=547-570&author=S.+Bologninauthor=D.+Dragoauthor=L.+Messoriauthor=P.+Zatta&title=Chelation+therapy+for+neurodegenerative+diseases&doi=10.1002%2Fmed.20148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Chelation therapy for neurodegenerative diseases</span></div><div class="casAuthors">Bolognin, Silvia; Drago, Denise; Messori, Luigi; Zatta, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">547-570</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Mounting evidence suggests a central role for transition biometals in the etiopathogenesis of neurodegenerative diseases (ND).  Indeed, while studying the mol. basis for this heterogeneous group of diseases, it has become increasingly evident that biometals and nonphysiol. Al are often involved in pathol. onset and progression, either by affecting the conformation of specific proteins or by exacerbating local oxidative stress.  The apparently crit. role played by metal dishomeostasis in ND makes chelation therapy an attractive pharmacol. option.  However, classical metal chelation approaches, relying on potent metal ligands, turned out to be successful only in those rare cases where exceptional brain metal accumulation occurs due to specific defects in metal metab.  In contrast, metal-targeted approaches using ligand of intermediate strength seem to be more appropriate in fighting the major ND, although their benefits are still questioned.  We report here a survey of recent evidences supporting the use of a variety of metal ligands, and even functionalized nanoparticles, for the treatment of the most common ND.  The beneficial neuropharmacol. actions of metal-targeted agents most likely arise from local metal redistribution rather than from massive metal removal.  The perspectives for the development of new effective agents against ND are critically discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ZaSHusBrRLVg90H21EOLACvtfcHk0liLWl4ORGzn0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVaitbc%253D&md5=e24c36e8ae06cec84bfde893cc63ebb3</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fmed.20148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20148%26sid%3Dliteratum%253Aachs%26aulast%3DBolognin%26aufirst%3DS.%26aulast%3DDrago%26aufirst%3DD.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DZatta%26aufirst%3DP.%26atitle%3DChelation%2520therapy%2520for%2520neurodegenerative%2520diseases%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D547%26epage%3D570%26doi%3D10.1002%2Fmed.20148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Nanoparticle-based theranostic agents</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1064</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span><span class="refDoi"> DOI: 10.1016/j.addr.2010.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.addr.2010.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=20691229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGitb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1064-1079&author=J.+Xieauthor=S.+Leeauthor=X.+Chen&title=Nanoparticle-based+theranostic+agents&doi=10.1016%2Fj.addr.2010.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle-based theranostic agents</span></div><div class="casAuthors">Xie, Jin; Lee, Seulki; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1064-1079</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Theranostic nanomedicine is emerging as a promising therapeutic paradigm.  It takes advantage of the high capacity of nanoplatforms to ferry cargo and loads onto them both imaging and therapeutic functions.  The resulting nanosystems, capable of diagnosis, drug delivery and monitoring of therapeutic response, are expected to play a significant role in the dawning era of personalized medicine, and much research effort was devoted toward that goal.  A convenience in constructing such function-integrated agents is that many nanoplatforms are already, themselves, imaging agents.  Their well-developed surface chem. makes it easy to load them with pharmaceutics and promote them to be theranostic nanosystems.  Iron oxide nanoparticles, quantum dots, carbon nanotubes, gold nanoparticles and silica nanoparticles, were previously well investigated in the imaging setting and are candidate nanoplatforms for building up nanoparticle-based theranostics.  In the current article, the authors will outline the progress along this line, organized by the category of the core materials.  The authors will focus on construction strategies and will discuss the challenges and opportunities assocd. with this emerging technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxlx_c5HYBQLVg90H21EOLACvtfcHk0lgvf7T22hKk3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGitb7J&md5=87873807b175591d2fa5db581677acb2</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2010.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2010.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DNanoparticle-based%2520theranostic%2520agents%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D1064%26epage%3D1079%26doi%3D10.1016%2Fj.addr.2010.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Mattsson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolcheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, R. J.</span><span> </span><span class="NLM_article-title">Revolutionizing Alzheimer’s disease and clinical trials through biomarkers</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1016/j.dadm.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=10.1016%2Fj.dadm.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FkslyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=412-419&author=N.+Mattssonauthor=M.+C.+Carrilloauthor=R.+A.+Deanauthor=M.+D.+Devousauthor=T.+Nikolchevaauthor=P.+Pesiniauthor=H.+Salterauthor=W.+Z.+Potterauthor=R.+S.+Sperlingauthor=R.+J.+Bateman&title=Revolutionizing+Alzheimer%E2%80%99s+disease+and+clinical+trials+through+biomarkers&doi=10.1016%2Fj.dadm.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Revolutionizing Alzheimer's disease and clinical trials through biomarkers</span></div><div class="casAuthors">Mattsson Niklas; Carrillo Maria C; Dean Robert A; Devous Michael D Sr; Nikolcheva Tania; Pesini Pedro; Salter Hugh; Potter William Z; Sperling Reisa S; Bateman Randall J; Bain Lisa J; Liu Enchi</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">412-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Alzheimer's Association's Research Roundtable met in May 2014 to explore recent progress in developing biomarkers to improve understanding of disease pathogenesis and expedite drug development.  Although existing biomarkers have proved extremely useful for enrichment of subjects in clinical trials, there is a clear need to develop novel biomarkers that are minimally invasive and that more broadly characterize underlying pathogenic mechanisms, including neurodegeneration, neuroinflammation, and synaptic dysfunction.  These may include blood-based assays and new neuropsychological testing protocols, as well as novel ligands for positron emission tomography imaging, and advanced magnetic resonance imaging methodologies.  In addition, there is a need for biomarkers that can serve as theragnostic markers of response to treatment.  Standardization remains a challenge, although international consortia have made substantial progress in this area and provide lessons for future standardization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDIlimZmZ04pNiNltV31zlfW6udTcc2eaBpP4rMADHjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FkslyjsA%253D%253D&md5=1dfbef224fc9340fea1fc27147d9f9d8</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.dadm.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dadm.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DMattsson%26aufirst%3DN.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DNikolcheva%26aufirst%3DT.%26aulast%3DPesini%26aufirst%3DP.%26aulast%3DSalter%26aufirst%3DH.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DSperling%26aufirst%3DR.%2BS.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DRevolutionizing%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520clinical%2520trials%2520through%2520biomarkers%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D1%26spage%3D412%26epage%3D419%26doi%3D10.1016%2Fj.dadm.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00151&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-17%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00151%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00151" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799499aab4f24d3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
